0000822746 false Q3 --12-31 0000822746 2022-01-01 2022-09-30 0000822746 2022-11-16 0000822746 2022-09-30 0000822746 2021-12-31 0000822746 IFNY:SeriesAConvertiblePreferredStockMember 2022-09-30 0000822746 IFNY:SeriesAConvertiblePreferredStockMember 2021-12-31 0000822746 2022-07-01 2022-09-30 0000822746 2021-07-01 2021-09-30 0000822746 2021-01-01 2021-09-30 0000822746 us-gaap:PreferredStockMember 2020-12-31 0000822746 us-gaap:CommonStockMember 2020-12-31 0000822746 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000822746 us-gaap:RetainedEarningsMember 2020-12-31 0000822746 2020-12-31 0000822746 us-gaap:PreferredStockMember 2021-03-31 0000822746 us-gaap:CommonStockMember 2021-03-31 0000822746 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0000822746 us-gaap:RetainedEarningsMember 2021-03-31 0000822746 2021-03-31 0000822746 us-gaap:PreferredStockMember 2021-06-30 0000822746 us-gaap:CommonStockMember 2021-06-30 0000822746 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0000822746 us-gaap:RetainedEarningsMember 2021-06-30 0000822746 2021-06-30 0000822746 us-gaap:PreferredStockMember 2021-12-31 0000822746 us-gaap:CommonStockMember 2021-12-31 0000822746 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000822746 us-gaap:RetainedEarningsMember 2021-12-31 0000822746 us-gaap:PreferredStockMember 2022-03-31 0000822746 us-gaap:CommonStockMember 2022-03-31 0000822746 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000822746 us-gaap:RetainedEarningsMember 2022-03-31 0000822746 2022-03-31 0000822746 us-gaap:PreferredStockMember 2022-06-30 0000822746 us-gaap:CommonStockMember 2022-06-30 0000822746 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0000822746 us-gaap:RetainedEarningsMember 2022-06-30 0000822746 2022-06-30 0000822746 us-gaap:PreferredStockMember 2021-01-01 2021-03-31 0000822746 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0000822746 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0000822746 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0000822746 2021-01-01 2021-03-31 0000822746 us-gaap:PreferredStockMember 2021-04-01 2021-06-30 0000822746 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0000822746 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0000822746 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0000822746 2021-04-01 2021-06-30 0000822746 us-gaap:PreferredStockMember 2021-07-01 2021-09-30 0000822746 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0000822746 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0000822746 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0000822746 us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0000822746 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0000822746 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0000822746 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0000822746 2022-01-01 2022-03-31 0000822746 us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0000822746 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0000822746 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0000822746 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0000822746 2022-04-01 2022-06-30 0000822746 us-gaap:PreferredStockMember 2022-07-01 2022-09-30 0000822746 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0000822746 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0000822746 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0000822746 us-gaap:PreferredStockMember 2021-09-30 0000822746 us-gaap:CommonStockMember 2021-09-30 0000822746 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0000822746 us-gaap:RetainedEarningsMember 2021-09-30 0000822746 2021-09-30 0000822746 us-gaap:PreferredStockMember 2022-09-30 0000822746 us-gaap:CommonStockMember 2022-09-30 0000822746 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0000822746 us-gaap:RetainedEarningsMember 2022-09-30 0000822746 2021-12-07 0000822746 IFNY:SeriesAConvertiblePreferredStockMember 2021-12-07 0000822746 2021-03-30 2021-04-02 0000822746 2021-04-02 0000822746 IFNY:OperatingAgreementMember IFNY:GMDOCMember 2022-05-03 0000822746 IFNY:OperatingAgreementMember IFNY:GMDOCMember 2022-05-02 2022-05-03 0000822746 2022-05-03 0000822746 2022-05-15 2022-05-16 0000822746 IFNY:CastelliEnergyLLCMember IFNY:OperatingAgreementMember IFNY:GMDOCMember 2022-05-03 0000822746 IFNY:GMDOCLLCMember IFNY:OperatingAgreementMember 2022-05-03 0000822746 2020-12-30 2021-01-02 0000822746 2021-01-02 0000822746 IFNY:WestTexasIntermediateMember 2021-12-31 0000822746 2012-12-31 0000822746 IFNY:TexasOilAndGasMember 2012-12-31 0000822746 IFNY:WyomingAndColoradoOilAndGasMember 2012-12-31 0000822746 IFNY:AssetPurchaseAndSaleAgreementMember IFNY:CoreEnergyLLCMember 2020-12-14 0000822746 IFNY:CoreEnergyLLCMember 2021-04-02 0000822746 IFNY:FarmoutAgreementMember 2022-04-03 2022-04-04 0000822746 2022-04-03 2022-04-04 0000822746 IFNY:CoreEnergyLLCMember 2022-09-30 0000822746 IFNY:GMDOCLLCMember 2022-06-30 0000822746 IFNY:GMDOCLLCMember 2021-12-31 0000822746 IFNY:GMDOCLLCMember 2022-07-01 2022-09-30 0000822746 IFNY:GMDOCLLCMember 2022-01-01 2022-09-30 0000822746 IFNY:GMDOCLLCMember 2022-09-30 0000822746 IFNY:GMDOCLLCMember 2022-05-03 0000822746 IFNY:GMDOCLLCMember 2022-05-15 2022-05-16 0000822746 IFNY:OperatingAgreementMember IFNY:GMDOCMember 2022-01-01 2022-09-30 0000822746 IFNY:OperatingAgreementMember IFNY:GMDOCMember 2022-09-30 0000822746 IFNY:OperatingAgreementMember IFNY:GMDOCMember srt:MinimumMember 2022-09-30 0000822746 IFNY:OperatingAgreementMember IFNY:GMDOCMember srt:MaximumMember 2022-09-30 0000822746 IFNY:OperatingAgreementMember IFNY:GMDOCMember IFNY:MemberLoanMember srt:MaximumMember 2022-09-30 0000822746 IFNY:ConvertiblePromissoryNotesPayableMember 2022-01-01 2022-09-30 0000822746 IFNY:ConvertiblePromissoryNotesPayableOneMember 2022-01-01 2022-09-30 0000822746 IFNY:ConvertiblePromissoryNotesPayableTwoMember 2022-01-01 2022-09-30 0000822746 IFNY:ConvertiblePromissoryNotesPayableMember 2022-09-30 0000822746 IFNY:ConvertiblePromissoryNotesPayableMember 2021-12-31 0000822746 IFNY:ConvertiblePromissoryNotesPayableOneMember 2022-09-30 0000822746 IFNY:ConvertiblePromissoryNotesPayableOneMember 2021-12-31 0000822746 IFNY:ConvertiblePromissoryNotesPayableTwoMember 2022-09-30 0000822746 IFNY:ConvertiblePromissoryNotesPayableTwoMember 2021-12-31 0000822746 IFNY:ConvertiblePromissoryNotesPayableThreeMember 2022-09-30 0000822746 IFNY:ConvertiblePromissoryNotesPayableThreeMember 2021-12-31 0000822746 IFNY:ConvertiblePromissoryNotesPayableMember 2021-01-01 2021-12-31 0000822746 IFNY:ConvertiblePromissoryNotesPayableOneMember 2021-01-01 2021-12-31 0000822746 IFNY:ConvertiblePromissoryNotesPayableTwoMember 2021-01-01 2021-12-31 0000822746 IFNY:ConvertiblePromissoryNotesPayableThreeMember 2022-01-01 2022-09-30 0000822746 IFNY:ConvertiblePromissoryNotesPayableThreeMember 2021-01-01 2021-12-31 0000822746 IFNY:DebtSettlementAgreementMember IFNY:ThreePercentageConvertiblePromissoryNotesMember 2021-03-30 2021-03-31 0000822746 IFNY:DebtSettlementAgreementMember IFNY:ThreePercentageConvertiblePromissoryNotesMember 2021-03-31 0000822746 IFNY:ThreePercentageConvertiblePromissoryNotesMember IFNY:DebtSettlementAgreementsMembersMember IFNY:FiveRelatedPartiesMember 2021-03-30 2021-03-31 0000822746 IFNY:ThreePercentageConvertiblePromissoryNotesMember IFNY:DebtSettlementAgreementsMembersMember IFNY:FiveRelatedPartiesMember 2021-03-31 0000822746 IFNY:DebtSettlementAgreementMember IFNY:SixCreditorsMember IFNY:ThreePercentageConvertiblePromissoryNotesMember 2022-03-30 2022-03-31 0000822746 IFNY:EightPercentageConvertiblePromissoryNotesMember IFNY:SecuritiesPurchaseAgreementMember 2021-08-29 2021-08-30 0000822746 IFNY:EightPercentageConvertiblePromissoryNotesMember IFNY:SecuritiesPurchaseAgreementMember 2021-08-30 0000822746 IFNY:EightPercentageConvertiblePromissoryNotesMember IFNY:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2021-08-29 2021-08-30 0000822746 IFNY:EightPercentageConvertiblePromissoryNotesMember IFNY:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2021-08-30 0000822746 IFNY:EightPercentageConvertiblePromissoryNotesMember IFNY:SecuritiesPurchaseAgreementMember 2021-10-28 2021-10-29 0000822746 IFNY:EightPercentageConvertiblePromissoryNotesMember IFNY:SecuritiesPurchaseAgreementMember 2021-10-29 0000822746 IFNY:EightPercentageConvertiblePromissoryNotesMember us-gaap:CommonStockMember IFNY:SecuritiesPurchaseAgreementMember 2021-10-28 2021-10-29 0000822746 IFNY:SeniorUnsecuredConvertibleNoteMember us-gaap:BeneficialOwnerMember IFNY:SecuritiesPurchaseAgreementMember 2021-10-28 2021-10-29 0000822746 IFNY:SeniorUnsecuredConvertibleNoteMember IFNY:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2021-10-28 2021-10-29 0000822746 IFNY:EightPercentageConvertiblePromissoryNotesMember IFNY:SecuritiesPurchaseAgreementMember 2022-06-08 0000822746 IFNY:EightPercentageConvertiblePromissoryNotesMember IFNY:SecuritiesPurchaseAgreementMember 2022-06-07 2022-06-08 0000822746 IFNY:JuneTwoThousandTwentyTwoNotesMember 2022-09-30 0000822746 IFNY:EightPercentageConvertiblePromissoryNotesMember IFNY:SecuritiesPurchaseAgreementMember 2022-05-12 2022-05-13 0000822746 IFNY:EightPercentageConvertiblePromissoryNotesMember IFNY:SecuritiesPurchaseAgreementMember 2022-05-13 0000822746 IFNY:MayInvestorMember IFNY:EightPercentageConvertiblePromissoryNotesMember us-gaap:CommonStockMember IFNY:SecuritiesPurchaseAgreementMember 2022-05-12 2022-05-13 0000822746 IFNY:SeniorUnsecuredConvertibleNoteMember us-gaap:BeneficialOwnerMember IFNY:SecuritiesPurchaseAgreementMember 2022-05-12 2022-05-13 0000822746 IFNY:SeniorUnsecuredConvertibleNoteMember IFNY:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2022-05-12 2022-05-13 0000822746 2022-06-29 0000822746 IFNY:ConvertiblePromissoryNotesPayableTwoMember 2022-05-31 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2022-03-31 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-03-31 0000822746 us-gaap:WarrantMember 2021-03-31 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputExercisePriceMember 2021-03-31 0000822746 us-gaap:WarrantMember 2021-03-30 0000822746 IFNY:ConvertiblePromissoryNotesPayableMember IFNY:DueSeptemberFifteenTwoThousandAndTwentyTwoMember 2022-09-30 0000822746 IFNY:ConvertiblePromissoryNotesPayableMember IFNY:DueJuneTwentyNineTwoThousandAndTwentyTwoMember 2022-09-30 0000822746 us-gaap:MeasurementInputPriceVolatilityMember IFNY:ConvertiblePromissoryNotesPayableMember 2021-08-30 0000822746 us-gaap:MeasurementInputPriceVolatilityMember IFNY:ConvertiblePromissoryNotesPayableMember 2021-10-30 0000822746 us-gaap:MeasurementInputRiskFreeInterestRateMember IFNY:ConvertiblePromissoryNotesPayableMember 2021-08-30 0000822746 us-gaap:MeasurementInputRiskFreeInterestRateMember IFNY:ConvertiblePromissoryNotesPayableMember 2021-10-30 0000822746 us-gaap:MeasurementInputExpectedTermMember IFNY:ConvertiblePromissoryNotesPayableMember 2021-08-30 0000822746 us-gaap:MeasurementInputExpectedTermMember IFNY:ConvertiblePromissoryNotesPayableMember 2021-10-30 0000822746 us-gaap:MeasurementInputExercisePriceMember IFNY:ConvertiblePromissoryNotesPayableMember 2021-08-30 0000822746 us-gaap:MeasurementInputExercisePriceMember IFNY:ConvertiblePromissoryNotesPayableMember 2021-10-30 0000822746 IFNY:ConvertiblePromissoryNotesPayableMember 2021-08-30 0000822746 IFNY:ConvertiblePromissoryNotesPayableMember 2021-10-30 0000822746 us-gaap:MeasurementInputPriceVolatilityMember IFNY:ConvertiblePromissoryNotesPayableOneMember 2022-06-08 0000822746 us-gaap:MeasurementInputRiskFreeInterestRateMember IFNY:ConvertiblePromissoryNotesPayableOneMember 2022-06-08 0000822746 us-gaap:MeasurementInputExpectedTermMember IFNY:ConvertiblePromissoryNotesPayableOneMember 2022-06-08 0000822746 us-gaap:MeasurementInputExercisePriceMember IFNY:ConvertiblePromissoryNotesPayableOneMember 2022-06-08 0000822746 IFNY:ConvertiblePromissoryNotesPayableOneMember 2022-06-08 0000822746 us-gaap:EmployeeStockOptionMember 2022-07-01 2022-09-30 0000822746 us-gaap:EmployeeStockOptionMember 2021-07-01 2021-09-30 0000822746 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-09-30 0000822746 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-09-30 0000822746 us-gaap:RestrictedStockMember 2022-07-01 2022-09-30 0000822746 us-gaap:RestrictedStockMember 2021-07-01 2021-09-30 0000822746 us-gaap:RestrictedStockMember 2022-01-01 2022-09-30 0000822746 us-gaap:RestrictedStockMember 2021-01-01 2021-09-30 0000822746 us-gaap:WarrantMember 2022-07-01 2022-09-30 0000822746 us-gaap:WarrantMember 2021-07-01 2021-09-30 0000822746 us-gaap:WarrantMember 2022-01-01 2022-09-30 0000822746 us-gaap:WarrantMember 2021-01-01 2021-09-30 0000822746 IFNY:TwoThowsandAndFifteenPlanMember 2015-09-25 0000822746 IFNY:TwoThowsandAndTwentyOnePlanMember 2021-10-13 0000822746 IFNY:TwoThowsandAndTwentyOnePlanAndTwoThousandAndFifteenMember 2022-09-30 0000822746 2021-01-01 2021-06-30 0000822746 us-gaap:StockOptionMember 2022-07-01 2022-09-30 0000822746 us-gaap:StockOptionMember 2021-07-01 2021-09-30 0000822746 us-gaap:StockOptionMember 2022-01-01 2022-09-30 0000822746 us-gaap:StockOptionMember 2021-01-01 2021-09-30 0000822746 us-gaap:StockOptionMember 2021-01-01 2021-12-31 0000822746 us-gaap:RestrictedStockMember IFNY:OfficersDirectorsAndConsultantMember 2022-05-01 2022-05-31 0000822746 us-gaap:RestrictedStockMember IFNY:OfficersDirectorsAndConsultantMember 2020-08-01 2020-08-31 0000822746 IFNY:ExercisePriceOneMember 2022-09-30 0000822746 IFNY:ExercisePriceOneMember 2022-01-01 2022-09-30 0000822746 IFNY:ExercisePriceTwoMember 2022-09-30 0000822746 IFNY:ExercisePriceTwoMember 2022-01-01 2022-09-30 0000822746 2021-06-03 2021-06-04 0000822746 2021-06-04 0000822746 us-gaap:RestrictedStockMember 2020-12-31 0000822746 us-gaap:RestrictedStockMember 2021-09-30 0000822746 us-gaap:RestrictedStockMember 2021-12-31 0000822746 us-gaap:RestrictedStockMember 2022-09-30 0000822746 us-gaap:WarrantMember 2020-12-31 0000822746 IFNY:ConvertiblePromissoryNotesMember 2021-09-30 0000822746 IFNY:ConvertiblePromissoryNotesPayableOneMember 2021-09-30 0000822746 us-gaap:WarrantMember 2021-09-30 0000822746 us-gaap:WarrantMember 2021-12-31 0000822746 IFNY:ConvertiblePromissoryNotesMember 2022-09-30 0000822746 us-gaap:WarrantMember 2022-09-30 0000822746 us-gaap:WarrantMember 2022-09-30 0000822746 us-gaap:WarrantMember 2022-01-01 2022-09-30 0000822746 us-gaap:WarrantMember 2021-01-01 2021-12-31 0000822746 IFNY:LetterAgreementMember 2021-11-09 0000822746 2021-11-09 0000822746 2021-11-08 2021-11-09 0000822746 IFNY:LetterAgreementMember 2021-11-08 2021-11-09 0000822746 IFNY:BoardOfAdvisorsMember IFNY:LetterAgreementMember 2021-11-09 0000822746 us-gaap:WarrantMember IFNY:LetterAgreementMember 2022-07-01 2022-09-30 0000822746 us-gaap:WarrantMember IFNY:LetterAgreementMember 2022-01-01 2022-09-30 0000822746 us-gaap:WarrantMember IFNY:LetterAgreementMember 2021-11-09 0000822746 us-gaap:WarrantMember IFNY:LetterAgreementMember 2021-11-08 2021-11-09 0000822746 IFNY:LetterAgreementMember 2022-09-30 0000822746 IFNY:ExercisePriceThreeMember 2022-09-30 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2021-11-09 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-11-09 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputExpectedTermMember 2021-11-09 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputExercisePriceMember 2021-11-09 0000822746 us-gaap:WarrantMember 2021-11-09 0000822746 2022-04-02 0000822746 2022-04-02 2022-04-02 0000822746 IFNY:ThreePercentageConvertiblePromissoryNotesMember IFNY:RelatedPartiesMember 2021-03-30 2021-03-31 0000822746 IFNY:ThreePercentageConvertiblePromissoryNotesMember IFNY:RelatedPartiesMember 2021-03-31 0000822746 2021-03-26 0000822746 IFNY:DebtSettlementAgreementsMembersMember 2021-03-30 2021-03-31 0000822746 IFNY:DebtSettlementAgreementsMembersMember IFNY:ConvertiblePromissoryNotesMember 2021-03-31 0000822746 IFNY:AugustNoteMember 2021-03-26 0000822746 2021-04-01 0000822746 IFNY:HugotonGasFieldMember 2022-07-01 2022-09-30 0000822746 IFNY:HugotonGasFieldMember 2022-01-01 2022-09-30 0000822746 IFNY:ConsultantsMember 2021-11-09 0000822746 2012-10-01 2012-10-31 0000822746 2012-10-31 0000822746 IFNY:CambrianConsultantsAmericaIncMember 2014-12-07 2014-12-08 0000822746 IFNY:TorreyHillsCapitalIncMember 2014-08-14 2014-08-15 0000822746 IFNY:ConsultingAgreementMember 2013-10-17 2013-10-18 0000822746 IFNY:ConsultingAgreementMember 2013-01-01 2013-12-31 0000822746 IFNY:JosephRyanMember 2020-03-19 2020-03-20 0000822746 IFNY:JosephRyanMember 2020-12-22 2020-12-23 0000822746 IFNY:JosephRyanMember 2021-02-09 2021-02-10 0000822746 IFNY:JosephRyanMember 2022-01-01 2022-09-30 0000822746 IFNY:SeriesAConvertiblePreferredStockMember 2021-03-16 0000822746 IFNY:SeriesAConvertiblePreferredStockMember 2021-03-15 2021-03-16 0000822746 IFNY:SeriesAConvertiblePreferredStockMember 2021-03-25 2021-03-26 0000822746 IFNY:SeriesAConvertiblePreferredStockMember 2021-03-26 0000822746 IFNY:SeriesAConvertiblePreferredStockMember IFNY:MarchTwoThousandTwentyOneIssuanceMember 2022-01-01 2022-09-30 0000822746 IFNY:SeriesAConvertiblePreferredStockMember IFNY:MarchTwoThousandTwentyOneIssuanceMember 2021-01-01 2021-09-30 0000822746 IFNY:SeriesAConvertiblePreferredStockMember 2022-01-01 2022-09-30 0000822746 IFNY:OzarkCapitalLLCMember 2021-03-25 2021-03-26 0000822746 IFNY:OzarkCapitalLLCMember 2021-03-26 0000822746 IFNY:OzarkCapitalLLCMember 2022-09-30 0000822746 IFNY:OzarkCapitalLLCMember 2022-07-01 2022-09-30 0000822746 IFNY:OzarkCapitalLLCMember 2021-07-01 2021-09-30 0000822746 IFNY:OzarkCapitalLLCMember 2022-01-01 2022-09-30 0000822746 IFNY:OzarkCapitalLLCMember 2021-01-01 2021-09-30 0000822746 IFNY:SeriesAConvertiblePreferredStockMember 2022-06-12 2022-06-15 0000822746 IFNY:SeriesAConvertiblePreferredStockMember 2022-06-15 0000822746 IFNY:SeriesAConvertiblePreferredStockMember IFNY:JuneTwoThousandTwentyTwoIssuanceMember 2022-01-01 2022-09-30 0000822746 IFNY:SeriesAConvertiblePreferredStockMember IFNY:JuneTwoThousandTwentyTwoIssuanceMember 2021-01-01 2021-09-30 0000822746 IFNY:SeriesAConvertiblePreferredStockMember 2022-09-01 2022-09-30 0000822746 IFNY:SeriesAConvertiblePreferredStockMember 2022-09-29 2022-09-30 0000822746 IFNY:SeriesAConvertiblePreferredStockMember 2022-08-01 2022-08-31 0000822746 IFNY:SeriesAConvertiblePreferredStockMember IFNY:AugustSeptemberTwoThousandTwentyTwoIssuanceMember 2022-01-01 2022-09-30 0000822746 IFNY:SeriesAConvertiblePreferredStockMember IFNY:AugustSeptemberTwoThousandTwentyTwoIssuanceMember 2021-01-01 2021-09-30 0000822746 IFNY:SeriesAConvertiblePreferredStockMember 2020-12-31 0000822746 IFNY:SeriesAConvertiblePreferredStockMember 2021-01-01 2021-09-30 0000822746 IFNY:SeriesAConvertiblePreferredStockMember 2021-09-30 0000822746 IFNY:AssetPurchaseAgreementMember 2021-03-30 2021-04-02 0000822746 IFNY:AssetPurchaseAgreementMember 2021-03-25 2021-03-26 0000822746 IFNY:ConvertiblePromissoryNoteMember IFNY:DebtSettlementAgreementMember 2021-03-30 2021-03-31 0000822746 IFNY:ConvertiblePromissoryNoteMember IFNY:DebtSettlementAgreementMember 2021-03-31 0000822746 IFNY:ConvertiblePromissoryNoteMember IFNY:DebtSettlementAgreementMember 2021-12-31 0000822746 IFNY:ConvertiblePromissoryNoteOneMember IFNY:DebtSettlementAgreementMember 2021-03-30 2021-03-31 0000822746 IFNY:ConvertiblePromissoryNoteOneMember IFNY:DebtSettlementAgreementMember 2021-03-31 0000822746 IFNY:ConvertiblePromissoryNoteOneMember IFNY:DebtSettlementAgreementMember 2021-12-31 0000822746 IFNY:ConvertiblePromissoryNoteTwoMember IFNY:DebtSettlementAgreementMember 2021-03-30 2021-03-31 0000822746 IFNY:ConvertiblePromissoryNoteTwoMember IFNY:DebtSettlementAgreementMember 2021-03-31 0000822746 IFNY:ConvertiblePromissoryNoteTwoMember IFNY:DebtSettlementAgreementMember 2021-12-31 0000822746 IFNY:ConvertiblePromissoryNotesPayableDueOnOctoberMember 2022-09-30 0000822746 IFNY:ConvertiblePromissoryNotesPayableDueOnSeptemberMember 2022-09-30 0000822746 IFNY:ConvertiblePromissoryNotesPayableDueOnJuneMember 2022-09-30 0000822746 IFNY:ConvertiblePromissoryNotesPayableDueOnOctoberMember 2022-01-01 2022-09-30 0000822746 IFNY:ConvertiblePromissoryNotesPayableDueOnSeptemberMember 2022-01-01 2022-09-30 0000822746 IFNY:ConvertiblePromissoryNotesPayableDueOnJuneMember 2022-01-01 2022-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:acre utr:bbl

0000822746 false Q1 --12-31 0000822746 2023-01-01 2023-03-31 0000822746 2023-06-08 0000822746 2023-03-31 0000822746 2022-12-31 0000822746 us-gaap:RelatedPartyMember 2023-03-31 0000822746 us-gaap:RelatedPartyMember 2022-12-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2023-03-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2022-12-31 0000822746 2022-01-01 2022-03-31 0000822746 us-gaap:PreferredStockMember 2021-12-31 0000822746 us-gaap:CommonStockMember 2021-12-31 0000822746 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000822746 us-gaap:RetainedEarningsMember 2021-12-31 0000822746 2021-12-31 0000822746 us-gaap:PreferredStockMember 2022-12-31 0000822746 us-gaap:CommonStockMember 2022-12-31 0000822746 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000822746 us-gaap:RetainedEarningsMember 2022-12-31 0000822746 us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0000822746 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0000822746 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0000822746 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0000822746 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0000822746 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0000822746 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0000822746 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000822746 us-gaap:PreferredStockMember 2022-03-31 0000822746 us-gaap:CommonStockMember 2022-03-31 0000822746 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000822746 us-gaap:RetainedEarningsMember 2022-03-31 0000822746 2022-03-31 0000822746 us-gaap:PreferredStockMember 2023-03-31 0000822746 us-gaap:CommonStockMember 2023-03-31 0000822746 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000822746 us-gaap:RetainedEarningsMember 2023-03-31 0000822746 2021-03-30 2021-04-02 0000822746 2021-04-02 0000822746 2022-01-01 2022-12-31 0000822746 AMNI:OperatingAgreementMember AMNI:GMDOCMember 2022-05-03 0000822746 AMNI:OperatingAgreementMember AMNI:GMDOCMember 2022-05-02 2022-05-03 0000822746 2022-05-15 2022-05-16 0000822746 AMNI:CastelliEnergyLLCMember AMNI:OperatingAgreementMember AMNI:GMDOCMember 2022-05-03 0000822746 AMNI:GMDOCLLCMember AMNI:OperatingAgreementMember 2022-05-03 0000822746 us-gaap:SeriesAPreferredStockMember 2023-03-31 0000822746 AMNI:WestTexasIntermediateMember 2022-12-31 0000822746 2012-12-31 0000822746 AMNI:TexasOilAndGasMember 2012-12-31 0000822746 AMNI:WyomingAndColoradoOilAndGasMember 2012-12-31 0000822746 us-gaap:FairValueInputsLevel1Member 2023-03-31 0000822746 us-gaap:FairValueInputsLevel2Member 2023-03-31 0000822746 us-gaap:FairValueInputsLevel3Member 2023-03-31 0000822746 us-gaap:FairValueInputsLevel1Member 2022-12-31 0000822746 us-gaap:FairValueInputsLevel2Member 2022-12-31 0000822746 us-gaap:FairValueInputsLevel3Member 2022-12-31 0000822746 AMNI:CentralKansasUpliftMember 2023-03-31 0000822746 AMNI:CentralKansasUpliftMember 2022-12-31 0000822746 AMNI:HugotonGasFieldMember 2023-03-31 0000822746 AMNI:HugotonGasFieldMember 2022-12-31 0000822746 AMNI:GMDOCLLCMember 2022-12-31 0000822746 AMNI:GMDOCLLCMember 2023-01-01 2023-03-31 0000822746 AMNI:GMDOCLLCMember 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableMember 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableMember 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableMember 2023-01-01 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableMember 2022-01-01 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableOneMember 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableOneMember 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableOneMember 2023-01-01 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableOneMember 2022-01-01 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableTwoMember 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableTwoMember 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableTwoMember 2023-01-01 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableTwoMember 2022-01-01 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableThreeMember 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableThreeMember 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableThreeMember 2023-01-01 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableThreeMember 2022-01-01 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableFourMember 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableFourMember 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableFourMember 2023-01-01 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableFourMember 2022-01-01 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableFiveMember 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableFiveMember 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableFiveMember 2023-01-01 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableFiveMember 2022-01-01 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableMember 2022-09-30 0000822746 AMNI:ConvertiblePromissoryNotesPayableMember 2021-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableFiveMember 2021-12-31 0000822746 AMNI:DebtSettlementAgreementMember AMNI:ThreePercentageConvertiblePromissoryNotesMember 2021-03-30 2021-03-31 0000822746 AMNI:DebtSettlementAgreementMember AMNI:ThreePercentageConvertiblePromissoryNotesMember 2021-03-31 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2021-10-28 2021-10-29 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2021-10-29 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2021-10-28 2021-10-29 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2021-08-29 2021-08-30 0000822746 us-gaap:ConvertibleNotesPayableMember us-gaap:BeneficialOwnerMember AMNI:SecuritiesPurchaseAgreementMember 2021-10-28 2021-10-29 0000822746 AMNI:SeniorUnsecuredConvertibleNoteMember AMNI:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2021-10-28 2021-10-29 0000822746 2021-10-29 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember 2023-05-04 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember 2023-05-05 0000822746 AMNI:OctoberEightPercentageNotesMember 2023-01-01 2023-03-31 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2021-08-30 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2021-08-29 2021-08-30 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2021-08-30 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember us-gaap:ConvertibleNotesPayableMember 2021-10-28 2021-10-29 0000822746 AMNI:SeniorUnsecuredConvertibleNoteMember us-gaap:BeneficialOwnerMember AMNI:SecuritiesPurchaseAgreementMember 2021-10-28 2021-10-29 0000822746 us-gaap:ConvertibleNotesPayableMember AMNI:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2021-10-28 2021-10-29 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember us-gaap:SubsequentEventMember 2023-05-05 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember us-gaap:SubsequentEventMember 2023-05-04 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember 2023-03-31 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember 2022-12-31 0000822746 AMNI:SecondEightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2021-10-29 0000822746 AMNI:SecondEightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2021-10-28 2021-10-29 0000822746 AMNI:SecondEightPercentageConvertiblePromissoryNotesMember us-gaap:BeneficialOwnerMember AMNI:SecuritiesPurchaseAgreementMember 2021-10-28 2021-10-29 0000822746 AMNI:SecondEightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2021-10-28 2021-10-29 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2022-06-08 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2022-06-07 2022-06-08 0000822746 AMNI:ConvertiblePromissoryNotesPayableDueOnOctoberMember 2023-05-05 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2023-05-05 0000822746 us-gaap:ConvertibleNotesPayableMember 2023-03-31 0000822746 us-gaap:ConvertibleNotesPayableMember 2022-12-31 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2022-05-12 2022-05-13 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2022-05-13 0000822746 AMNI:MayInvestorMember AMNI:EightPercentageConvertiblePromissoryNotesMember us-gaap:CommonStockMember AMNI:SecuritiesPurchaseAgreementMember 2022-05-12 2022-05-13 0000822746 AMNI:SeniorUnsecuredConvertibleNoteMember us-gaap:BeneficialOwnerMember AMNI:SecuritiesPurchaseAgreementMember 2022-05-12 2022-05-13 0000822746 AMNI:SeniorUnsecuredConvertibleNoteMember AMNI:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2022-05-12 2022-05-13 0000822746 2022-06-29 0000822746 AMNI:MayNotesMember 2023-01-09 2023-01-10 0000822746 AMNI:May2022NotesMember 2023-01-10 0000822746 AMNI:May2022NotesMember 2023-01-09 2023-01-10 0000822746 AMNI:May2022NotesMember 2023-03-31 0000822746 AMNI:May2022NotesMember 2022-12-31 0000822746 AMNI:OctoberEightPercentageNotesMember 2023-01-10 0000822746 AMNI:OctoberEightPercentageNotesMember 2023-01-09 2023-01-10 0000822746 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-03-31 0000822746 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-03-31 0000822746 us-gaap:RestrictedStockMember 2023-01-01 2023-03-31 0000822746 us-gaap:RestrictedStockMember 2022-01-01 2022-03-31 0000822746 us-gaap:WarrantMember 2023-01-01 2023-03-31 0000822746 us-gaap:WarrantMember 2022-01-01 2022-03-31 0000822746 AMNI:TwoThowsandAndFifteenPlanMember 2015-09-25 0000822746 AMNI:TwoThowsandAndTwentyOnePlanMember 2021-10-13 0000822746 AMNI:TwoThowsandAndTwentyOnePlanAndTwoThousandAndFifteenMember 2023-03-31 0000822746 us-gaap:StockOptionMember 2023-01-01 2023-03-31 0000822746 us-gaap:StockOptionMember 2022-01-01 2022-03-31 0000822746 us-gaap:RestrictedStockMember AMNI:OfficersDirectorsAndConsultantMember 2022-05-01 2022-05-31 0000822746 us-gaap:RestrictedStockMember AMNI:OfficersDirectorsAndConsultantMember 2020-08-01 2020-08-31 0000822746 2021-01-01 2021-09-30 0000822746 AMNI:ExercisePriceOneMember 2023-03-31 0000822746 AMNI:ExercisePriceOneMember 2023-01-01 2023-03-31 0000822746 AMNI:ExercisePriceTwoMember 2023-03-31 0000822746 AMNI:ExercisePriceTwoMember 2023-01-01 2023-03-31 0000822746 us-gaap:RestrictedStockMember 2021-12-31 0000822746 us-gaap:RestrictedStockMember 2022-03-31 0000822746 us-gaap:RestrictedStockMember 2022-12-31 0000822746 us-gaap:RestrictedStockMember 2023-03-31 0000822746 us-gaap:WarrantMember 2021-12-31 0000822746 us-gaap:WarrantMember 2022-03-31 0000822746 us-gaap:WarrantMember 2022-12-31 0000822746 us-gaap:WarrantMember 2023-03-31 0000822746 us-gaap:WarrantMember 2023-03-31 0000822746 us-gaap:WarrantMember 2023-01-01 2023-03-31 0000822746 us-gaap:WarrantMember 2022-01-01 2022-03-31 0000822746 AMNI:LetterAgreementMember 2021-11-09 0000822746 2021-11-09 0000822746 2021-11-08 2021-11-09 0000822746 AMNI:LetterAgreementMember 2021-11-08 2021-11-09 0000822746 AMNI:BoardOfAdvisorsMember AMNI:LetterAgreementMember 2021-11-09 0000822746 AMNI:USNGLetterAgreementMember 2021-11-09 0000822746 us-gaap:WarrantMember AMNI:LetterAgreementMember 2023-01-01 2023-03-31 0000822746 us-gaap:WarrantMember AMNI:LetterAgreementMember 2022-01-01 2022-03-31 0000822746 us-gaap:WarrantMember AMNI:LetterAgreementMember 2023-03-31 0000822746 us-gaap:WarrantMember AMNI:LetterAgreementMember 2021-11-08 2021-11-09 0000822746 AMNI:LetterAgreementMember 2023-03-31 0000822746 AMNI:ExercisePriceThreeMember 2023-03-31 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2021-11-09 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-11-09 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputExpectedTermMember 2021-11-09 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputExercisePriceMember 2021-11-09 0000822746 us-gaap:WarrantMember 2021-11-09 0000822746 AMNI:ConvertiableNotesPayableOneMember 2023-01-01 2023-03-31 0000822746 AMNI:ConvertiableNotesPayableOneMember 2022-01-01 2022-03-31 0000822746 AMNI:ConvertiableNotesPayableTwoMember 2023-01-01 2023-03-31 0000822746 AMNI:ConvertiableNotesPayableTwoMember 2022-01-01 2022-03-31 0000822746 AMNI:TexasandWyomingWellsMember 2023-03-31 0000822746 AMNI:TexasandWyomingWellsMember 2022-12-31 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2023-03-31 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2022-12-31 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-03-31 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputExpectedTermMember 2023-01-01 2023-03-31 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputExpectedTermMember 2022-01-01 2022-12-31 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputExercisePriceMember 2023-03-31 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputExercisePriceMember 2022-12-31 0000822746 us-gaap:WarrantMember 2022-12-31 0000822746 us-gaap:WarrantMember 2021-12-31 0000822746 AMNI:ConsultantsMember 2023-03-31 0000822746 2012-10-01 2012-10-31 0000822746 2012-10-31 0000822746 AMNI:CambrianConsultantsAmericaIncMember 2014-12-07 2014-12-08 0000822746 AMNI:TorreyHillsCapitalIncMember 2014-08-14 2014-08-15 0000822746 AMNI:ConsultingAgreementMember 2013-10-17 2013-10-18 0000822746 AMNI:ConsultingAgreementMember 2013-01-01 2013-12-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2023-01-13 2023-01-13 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2021-03-16 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2021-03-15 2021-03-16 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2021-03-25 2021-03-26 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2021-03-26 0000822746 AMNI:SeriesAConvertiblePreferredStockMember AMNI:MarchTwoThousandTwentyOneIssuanceMember 2023-01-01 2023-03-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember AMNI:MarchTwoThousandTwentyOneIssuanceMember 2022-01-01 2022-03-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember AMNI:MarchTwoThousandTwentyOneIssuanceMember 2022-01-01 2022-12-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2021-01-01 2021-12-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2023-01-01 2023-03-31 0000822746 AMNI:OzarkCapitalLLCMember 2021-03-25 2021-03-26 0000822746 AMNI:OzarkCapitalLLCMember 2021-03-26 0000822746 AMNI:OzarkCapitalLLCMember 2022-12-31 0000822746 AMNI:OzarkCapitalLLCMember 2023-01-01 2023-03-31 0000822746 AMNI:OzarkCapitalLLCMember 2022-01-01 2022-03-31 0000822746 AMNI:OzarkCapitalLLCMember 2022-01-01 2022-12-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2022-06-12 2022-06-15 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2022-06-15 0000822746 AMNI:SeriesAConvertiblePreferredStockMember AMNI:JuneTwoThousandTwentyTwoIssuanceMember 2023-01-01 2023-03-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember AMNI:JuneTwoThousandTwentyTwoIssuanceMember 2022-01-01 2022-03-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember AMNI:JuneTwoThousandTwentyTwoIssuanceMember 2022-01-01 2022-12-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2022-08-01 2022-08-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2022-08-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember AMNI:AugustSeptemberTwoThousandTwentyTwoIssuanceMember 2023-01-01 2023-03-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember AMNI:AugustSeptemberTwoThousandTwentyTwoIssuanceMember 2022-01-01 2022-03-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember AMNI:AugustSeptemberTwoThousandTwentyTwoIssuanceMember 2022-01-01 2022-12-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2021-12-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2022-01-01 2022-03-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2022-03-31 0000822746 AMNI:ConvertiblePromissoryNoteMember AMNI:DebtSettlementAgreementMember 2021-03-30 2021-03-31 0000822746 AMNI:ConvertiblePromissoryNoteMember AMNI:DebtSettlementAgreementMember 2021-03-31 0000822746 AMNI:ConvertiblePromissoryNoteMember AMNI:DebtSettlementAgreementMember us-gaap:WarrantMember 2021-03-31 0000822746 AMNI:ConvertiblePromissoryNoteMember AMNI:DebtSettlementAgreementMember us-gaap:RelatedPartyMember 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNoteMember AMNI:DebtSettlementAgreementMember us-gaap:RelatedPartyMember 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNoteOneMember AMNI:DebtSettlementAgreementMember 2021-03-30 2021-03-31 0000822746 AMNI:ConvertiblePromissoryNoteOneMember AMNI:DebtSettlementAgreementMember 2021-03-31 0000822746 AMNI:ConvertiblePromissoryNoteOneMember AMNI:DebtSettlementAgreementMember 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNoteOneMember AMNI:DebtSettlementAgreementMember 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNoteTwoMember AMNI:DebtSettlementAgreementMember 2021-03-30 2021-03-31 0000822746 AMNI:ConvertiblePromissoryNoteTwoMember AMNI:DebtSettlementAgreementMember 2021-03-31 0000822746 AMNI:ConvertiblePromissoryNoteTwoMember AMNI:DebtSettlementAgreementMember us-gaap:RelatedPartyMember 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNoteTwoMember AMNI:DebtSettlementAgreementMember us-gaap:RelatedPartyMember 2022-12-31 0000822746 AMNI:SeriesBConvertiblePreferredStockMember us-gaap:SubsequentEventMember 2023-05-03 0000822746 us-gaap:SeriesBPreferredStockMember us-gaap:SubsequentEventMember 2023-05-03 0000822746 AMNI:SeriesBConvertiblePreferredStockMember us-gaap:SubsequentEventMember 2023-05-03 2023-05-04 0000822746 AMNI:SeriesBConvertiblePreferredStockMember us-gaap:SubsequentEventMember us-gaap:CommonStockMember 2023-05-03 2023-05-04 0000822746 AMNI:SeriesBConvertiblePreferredStockMember us-gaap:SubsequentEventMember us-gaap:CommonStockMember 2023-05-04 0000822746 AMNI:OzarkCapitalLLCMember us-gaap:SeriesBPreferredStockMember us-gaap:SubsequentEventMember 2023-05-05 2023-05-05 0000822746 AMNI:OzarkCapitalLLCMember us-gaap:ConvertibleCommonStockMember us-gaap:SubsequentEventMember 2023-05-05 2023-05-05 0000822746 AMNI:OzarkCapitalLLCMember us-gaap:SubsequentEventMember 2023-05-05 0000822746 AMNI:OzarkCapitalLLCMember us-gaap:SubsequentEventMember 2023-05-05 2023-05-05 0000822746 AMNI:OzarkCapitalLLCMember 2023-03-31 0000822746 AMNI:OzarkCapitalLLCMember 2022-12-31 0000822746 AMNI:OzarkCapitalLLCMember AMNI:ClassAConvertiblePreferredStockMember 2023-01-01 2023-03-31 0000822746 AMNI:OzarkCapitalLLCMember AMNI:ClassAConvertiblePreferredStockMember 2022-01-01 2022-03-31 0000822746 AMNI:OzarkCapitalLLCMember us-gaap:SeriesAPreferredStockMember 2023-01-01 2023-03-31 0000822746 AMNI:OzarkCapitalLLCMember us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-12-31 0000822746 AMNI:SeriesBConvertiblePreferredStockMember 2023-05-03 2023-05-04 0000822746 AMNI:ConvertiblePromissoryNotesPayableDueOnOctoberMember us-gaap:SubsequentEventMember 2023-05-05 0000822746 AMNI:ConvertiblePromissoryNotesPayableDueOnOctoberMember 2022-10-29 0000822746 AMNI:ConvertiblePromissoryNotesPayableDueOnOctoberMember 2022-09-15 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember us-gaap:SubsequentEventMember 2023-05-05 0000822746 AMNI:ConvertiblePromissoryNotesPayableDueOnOctoberMember 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableDueOnOctoberMember 2022-01-01 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableDueOnSeptemberMember 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableDueOnSeptemberMember 2022-01-01 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableDueOnJuneMember 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableDueOnJuneMember 2022-01-01 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableDueOnOctoberMember 2023-01-10 0000822746 AMNI:ConvertiblePromissoryNotesPayableDueOnOctoberMember 2023-05-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:acre utr:bbl

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~September~~March 3031, ~~2022.~~2023

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________.

Commission File Number: 000-17204

AMERICAN NOBLE GAS INC

(Exact name of registrant as specified in its charter)

Nevada

87-3574612

(State or other jurisdiction

of incorporation or organization)

(I.R.S. Employer

Identification No.)

15612 College Blvd, Lenexa, KS 66219

(Address of principal executive offices) (Zip Code)

(913) ~~948~~955-~~9512~~0532

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of exchange on which registered
—		—		—

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of Exchange Act.

	Large accelerated filer ☐		Accelerated filer ☐
	Non-accelerated filer ☒		Smaller reporting company ☒
			Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of ~~November~~June 168, ~~2022~~2023, the registrant had 2122,~~924~~424,515 shares of common stock, $0.0001 par value per share outstanding.

TABLE OF CONTENTS

	Page
PART I - Financial Information
Item 1. Financial Statements
Condensed Balance Sheets: September 30, 2022 (Unaudited) and December 31, 2021	3
Condensed Balance Sheets: March 31, 2023 (Unaudited) and December 31, 2022	3
Condensed Statements of Operations: Three and nine months ended September 30, 2022 and 2021 (Unaudited)	4
Condensed Statements of Operations: Three months ended March 31, 2023 and 2022 (Unaudited)	4
Condensed Statements of Changes in Stockholders’ Deficit: Three and nine months ended September 30, 2022 and 2021 (Unaudited)	5
Condensed Statements of Changes in Stockholders’ Deficit: Three months ended March 31, 2023 and 2022 (Unaudited)	5
Condensed Statements of Cash Flows: Nine months ended September 30, 2022 and 2021 (Unaudited)	6
Condensed Statements of Cash Flows: Three months ended March 31, 2023 and 2022 (Unaudited)	6
Notes to Condensed Financial Statements (Unaudited)	7
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	4039
Item 3. Quantitative and Qualitative Disclosures About Market Risk	6153
Item 4. Controls and Procedures	6153
PART II - Other Information
Item 1. Legal Proceedings	6254
Item 1A Risk Factors	6254
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	6254
Item 3. Defaults Upon Senior Securities	6354
Item 4. Mine Safety Disclosures	6355
Item 5. Other Information	6355
Item 6. Exhibits	6355
Signatures	6456

PART I - FINANCIAL INFORMATION

AMERICAN NOBLE GAS INC

Condensed Balance Sheets

	September 30, 2022			December 31, 2021
	March 31, 2023			December 31, 2022
		(Unaudited)
	(unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	172,~~096~~008		$	~~260~~10,~~590~~163
Accrued receivable		1655,~~608~~658			1047,~~998~~423
Prepaid expenses		169,~~172~~062			1312,~~090~~617
Total current assets		4966,~~876~~728			~~284~~70,~~678~~203
Oil and gas properties and equipment:
Oil and gas properties and equipment		1,~~243~~217,~~402~~016			~~913~~1,~~425~~217,016
Accumulated depreciation, depletion and impairment		(~~188~~1,~~463~~131,740	)		(921,~~502~~128,329	)
Property and equipment, net		185,~~054,939~~276			~~820~~88,~~923~~687
Investment in unconsolidated subsidiary – GMDOC, LLC		1,~~173~~141,~~633~~274			—1,101,461
Total assets	$	21,~~278~~293,~~448~~278		$	1,~~105~~260,~~601~~351
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable	$	1,~~195~~570,~~152~~855		$	~~975~~1,~~842~~387,893
Accrued liabilities		1,~~175~~159,~~464~~403			1,159,403
Accrued interest - related parties		1,284			643
Accrued interest - $1,713 and $1,501 to related parties as of March 31, 2023 and December 31, 2022, respectively		108,785			244,038
Convertible notes payable, net of unamortized discount		1,285,309			376,274
Accrued dividends		140,065			77,124
Total current liabilities		3,657,209			2,512,162
Warrant derivative liability		209,802			577,269
Asset retirement obligations		1,731,268			1,730,264
Convertible notes payable, net of unamortized discount		1,266,204			1,312,500
Total current liabilities		4,455,114			4,758,227
Asset retirement obligations		1,733,704			1,732,486
Convertible promissory notes, net of unamortized discount - related parties		28,665			28,665
Total liabilities		56,~~417~~217,~~142~~483			46,~~271~~519,~~091~~378
Commitments and contingencies (Note 11)		-			-
Commitments and contingencies (Note 12)		-			-
Stockholders’ deficit:
Preferred stock; par value $0.0001 per share, 10,000,000 shares authorized; Series A Convertible Preferred Stock – 27,778 shares authorized with stated/liquidation value of $100 per share, 25,526 and 22,076 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively		3			2
Preferred stock; par value $0.0001 per share, 10,000,000 shares authorized; Series A Convertible Preferred Stock – 27,778 shares authorized with stated/liquidation value of $100 per share, 25,526 and 25,526 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively		3			3
Common Stock, par value $0.0001 per share, 500,000,000 shares authorized, 21,924,515 shares issued and outstanding at September 30, 2022 and 19,012,015 shares issued and outstanding at December 31, 2021		2,192			1,901
Common Stock, par value $0.0001 per share, 500,000,000 shares authorized, 22,424,515 shares issued and outstanding at March 31, 2023 and 21,924,515 shares issued and outstanding at December 31, 2022		2,242			2,192
Additional paid-in capital		117,~~184~~602,~~170~~298			~~115~~117,~~522~~369,~~952~~198
Accumulated deficit		(~~120~~122,~~325~~528,~~059~~748	)		(~~118~~122,~~690~~630,~~345~~420	)
Total stockholders’ deficit		(34,~~138~~924,~~694~~205	)		(35,~~165~~259,~~490~~027	)
Total liabilities and stockholders’ deficit	$	21,~~278~~293,~~448~~278		$	1,~~105~~260,~~601~~351

The accompanying notes are an integral part of these unaudited condensed financial statements.

AMERICAN NOBLE GAS INC

Condensed Statements of Operations

(~~Unaudited~~unaudited)

	2022			2021			2022			2021
	2023			2022
	Three months ended September 30,						Nine months ended September 30,
	Three months ended March 31,
	2022			2021			2022			2021
	2023			2022
Revenues	$	438,~~034~~924		$	3525,~~392~~305		$	~~111,903~~		$	~~56,220~~
Operating expenses:
Oil and gas lease operating expense		5529,~~288~~605			~~220~~86,~~767~~536			~~198,003~~			~~446,849~~
Depreciation, depletion and amortization		34,292			30,834			95,961			61,668
Depreciation, depletion and impairment		3,411			30,834
Accretion of asset retirement obligation		~~424~~1,218			279			~~1,004~~			~~558~~
Oil and gas production related taxes		55—			~~1,626~~28			~~164~~			~~2,592~~
Other general and administrative expenses		~~283~~411,~~312~~848			~~294~~368,~~440~~706			~~1,131,456~~			~~738,419~~
Total operating expenses		~~373~~446,~~371~~082			~~547~~486,~~946~~383			~~1,426,588~~			~~1,250,086~~
Operating loss		(~~330~~437,~~337~~158	)		(~~512~~461,~~554~~078	)		~~(1,314,685~~	)		~~(1,193,866~~	)
Other income (expense):
Equity in earnings of unconsolidated subsidiary – GMDOC, LLC		~~209~~39,~~297~~813			—			~~323,633~~			—
Interest expense		(~~217~~37,~~872~~412	)		(593,~~724~~556	)		~~(643,662~~	)		~~(40,163~~	)
Gain on exchange and extinguishment of liabilities		—			—			—			86,602
Gain on extinguishment of convertible notes payable		168,962			—
Change in derivative fair value		—			—			—			199
Change in warrant derivative fair value		367,467			—
Total other income (expense)		(8538,~~575~~830	)		(593,~~724~~556	)		~~(320,029~~	)		~~46,638~~
Loss before income taxes		(338,912	)		(518,278	)		(1,634,714	)		(1,147,228	)
Income (loss) before income taxes		101,672			(554,634	)
Income tax (expense) benefit		—			—			—			—
Net loss		(338,912	)		(518,278	)		(1,634,714	)		(1,147,228	)
Net income (loss)		101,672			(554,634	)
Convertible preferred stock dividends		(6562,~~406~~941	)		(5752,~~408~~861	)		~~(170,556~~	)		~~(117,936~~	)
Net loss attributable to common stockholders	$	(404,318	)	$	(575,686	)	$	(1,805,270	)	$	(1,265,164	)
Net income (loss) attributable to common stockholders	$	38,731		$	(607,495	)
Basic and diluted net loss per share:
Basic	$	(0.0200	)	$	(0.03	)	$	~~(0.09~~	)	$	~~(0.07~~	)
Diluted	$	(0.0200	)	$	(0.03	)	$	~~(0.09~~	)	$	~~(0.07~~	)
Weighted average shares outstanding – basic and diluted		21,920,394			18,793,265			20,571,459			18,712,199
Weighted average shares outstanding – basic		22,357,099			19,213,560
Weighted average shares outstanding – diluted		22,357,099			19,213,560

The accompanying notes are an integral part of these unaudited condensed financial statements.

AMERICAN NOBLE GAS INC

Condensed Statements of Changes in Stockholders’ Deficit

(Unaudited)

	Shares			Amount		Shares		Amount		Capital			Deficit			Deficit
	Preferred Stock					Common Stock				Additional Paid-in			Accumulated			Stockholders’
	Shares			Amount		Shares		Amount		Capital			Deficit			Deficit
Balance, December 31, 2021		22,076		$	2		19,012,015	$	1,901	$	115,522,952		$	(118,690,345	)	$	(3,165,490	)

Stock-based compensation		—			—		—		—		229,906			—			229,906

Issuance of common stock pursuant to conversion of convertible preferred stock		(800	)		—		250,000		25		(25	)		—			—

Accrual of preferred stock dividends		—			—		—		—		(52,861	)		—			(52,861	)

Net loss		—			—		—		—		—			(554,634	)		(554,634	)

Balance, March 31, 2022		21,276		$	2		19,262,015	$	1,926	$	115,699,972		$	(119,244,979	)	$	(3,543,079	)
Balance		21,276		$	2		19,262,015	$	1,926	$	115,699,972		$	(119,244,979	)	$	(3,543,079	)

Balance, December 31, 2022		25,526		$	3		21,924,515	$	2,192	$	117,369,198		$	(122,630,420	)	$	(5,259,027	)
Balance		25,526		$	3		21,924,515	$	2,192	$	117,369,198		$	(122,630,420	)	$	(5,259,027	)

Stock-based compensation		—			—		—		—		246,091			—			246,091

Issuance of common stock upon conversion convertible notes payable and accrued interest		—			—		500,000		50		49,950			—			50,000

Accrual of preferred stock dividends		—			—		—		—		(62,941	)		—			(62,941	)

Net income		—			—		—		—		—			101,672			101,672
Net income(loss)		—			—		—		—		—			101,672			101,672

Balance, March 31, 2023		25,526		$	3		22,424,515	$	2,242	$	117,602,298		$	(122,528,748	)	$	(4,924,205	)
Balance		25,526		$	3		22,424,515	$	2,242	$	117,602,298		$	(122,528,748	)	$	(4,924,205	)

	Shares			Amount			Shares		Amount		Capital			Deficit			Deficit
	Preferred Stock						Common Stock				Additional Paid-in			Accumulated			Stockholders’
	Shares			Amount			Shares		Amount		Capital			Deficit			Deficit
Balance, December 31, 2020		—		$	—			18,548,265	$	1,855	$	110,352,302		$	(117,178,645	)	$	(6,824,488	)
Cumulative effect of adoption of ASU 2020-06		—			—			—		—		(252,961	)		92,061			(160,900	)
Stock-based compensation		—			—			—		—		81,250			—			81,250
Issuance of preferred stock with detachable warrants to purchase Common Stock		22,776			2			—		—		1,929,087			—			1,929,089
Issuance of warrants to purchase Common Stock pursuant to debt settlement agreements		—			—			—		—		1,605,178			—			1,605,178
Extinguishment of liabilities with related parties pursuant to debt settlement agreements		—			—			—		—		1,108,477			—			1,108,477
Accrual of Series A Convertible Preferred Stock dividends		—			—			—		—		(3,744	)		—			(3,744	)
Net loss		—			—			—		—		—			(203,624	)		(203,624	)
Balance, March 31, 2021		22,776			2			18,548,265		1,855		114,819,589			(117,290,208	)		(2,468,762	)
Stock-based compensation		—			—			—		—		106,750			—			106,750
Issuance of Common Stock pursuant to debt settlement agreements		—			—			245,000		24		68,576			—			68,600
Accrual of preferred stock dividends		—			—			—		—		(56,784	)		—			(56,784	)
Net loss		—			—			—		—		—			(425,326	)		(425,326	)
Balance, June 30, 2021		22,776			2			18,793,265		1,879		114,938,131			(117,715,534	)		(2,775,522	)
Stock-based compensation		—			—			—		—		157,749			—			157,749
Issuance of warrants to purchase Common Stock pursuant to issuance of debt		—			—			—		—		56,000			—			56,000
Accrual of preferred stock dividends		—			—			—		—		(57,408	)		—			(57,408	)
Net loss		—			—			—		—		—			(518,278	)		(518,278	)
Balance, September 30, 2021		22,776		$	2			18,793,265	$	1,879	$	115,094,472		$	(118,233,812	)	$	(3,137,459	)
Balance, December 31, 2021		22,076		$	2			19,012,015	$	1,901	$	115,522,952		$	(118,690,345	)	$	(3,165,490	)
Stock-based compensation -		—			—			—		—		229,906			—			229,906
Issuance of Common Stock pursuant to conversion of Series A Convertible Preferred Stock		(800	)		—			250,000		25		(25	)		—			—
Series A Convertible Preferred Stock dividends		—			—			—		—		(52,861	)		—			(52,861	)
Net loss		—			—			—		—		—			(554,634	)		(554,634	)
Balance, March 31, 2022		21,276			2			19,262,015		1,926		115,699,972			(119,244,979	)		(3,543,079	)
Stock-based compensation -		—			—			—		—		378,341			—			378,341
Issuance of Common Stock in association with the issuance of convertible bridge notes payable		—			—			425,000		42		196,112			—			196,154
Issuance of restricted Common Stock as compensation		—			—			1,550,000		155		(155	)		—			—
Issuance of detachable warrants to purchase Common Stock in association with issuance of convertible bridge note payable		—			—			—		—		136,574			—			136,574
Issuance of Series A Convertible preferred stock with detachable Common Stock purchase warrants		5,000			1			—		—		499,999			—			500,000
Issuance of Common Stock pursuant to conversion of Series A Preferred Stock		(1,900	)		(1	)		593,750		60		(59	)		—			—
Series A Convertible Preferred Stock dividends		—			—			—		—		(52,289	)		—			(52,289	)
Net loss		—			—			—		—		—			(741,168	)		(741,168	)
Balance, June 30, 2022		24,376			2			21,830,765		2,183		116,858,495			(119,986,147	)		(3,125,467	)
Balance		24,376			2			21,830,765		2,183		116,858,495			(119,986,147	)		(3,125,467	)
Stock-based compensation -		—			—			—		—		246,091			—			246,091
Issuance of Series A Convertible Preferred Stock with detachable Common Stock purchase warrants		1,450			2			—		—		144,998			—			145,000
Issuance of Common Stock pursuant to conversion of Series A Convertible Preferred Stock		(300	)		(1	)		93,750		9		(8	)		—			—
Series A Convertible Preferred Stock dividends		—			—			—		—		(65,406	)		—			(65,406	)
Net loss		—			—			—		—		—			(338,912	)		(338,912	)
Balance, September 30, 2022		25,526		$	3			21,924,515	$	2,192	$	117,184,170		$	(120,325,059	)	$	(3,138,694	)
Balance		25,526		$	3			21,924,515	$	2,192	$	117,184,170		$	(120,325,059	)	$	(3,138,694	)

The accompanying notes are an integral part of these unaudited co0ndensed financial statements.

The accompanying notes are an integral part of these unaudited condensed financial statements.

AMERICAN NOBLE GAS INC

~~Statements~~Condensed Statements of Cash Flows

(unaudited)

	2023			2022
	For the three months ended March 31,
	2023			2022
Cash flows from operating activities:
Net income (loss)	$	101,672		$	(554,634	)
Adjustments to reconcile net loss to net cash used in operating activities:
Equity in earnings of unconsolidated subsidiary – GMDOC, LLC		(39,813	)		—
Change in fair value of derivative liability		(367,467	)		—
Stock-based compensation		246,091			229,906
Gain on extinguishment of convertible notes payable		(168,962	)		—
Depreciation, depletion and amortization		3,411			30,834
Accretion of asset retirement obligations		1,218			279
Amortization of discount on convertible notes payable		—			80,667
Change in operating assets and liabilities:
Increase in accounts receivable		(8,235	)		(3,799	)
Decrease in prepaid expenses		3,555			3,500
Increase in accounts payable		182,962			162,826
Increase in accrued interest		37,413			210

Net cash used in operating activities		(8,155	)		(50,211	)

Cash flows from investing activities:
Investment in oil and gas properties and equipment		—			(9,134	)
Net cash used in investing activities		—			(9,134	)

Cash flows from financing activities:
Cash dividends paid on preferred stock		—			(52,861	)
Net cash provided by financing activities		—			(52,861	)

Net decrease in cash and cash equivalents		(8,155	)		(112,206	)

Cash and cash equivalents:
Beginning		10,163			260,590
Ending	$	2,008		$	148,384
Supplemental cash flow information:
Cash paid for interest	$	—		$	12,679
Cash paid for taxes	$	—		$	—

Supplemental disclosure of non-cash investing and financing activities:
Accrual of dividends on Series A Convertible Preferred Stock	$	62,941		$	—
Issuance of common stock upon conversion of convertible notes payable and accrued interest	$	50,000		$	—
Conversion of Series A Convertible Preferred Stock to Common Stock	$	—		$	25

	2022			2021
	For the Nine months Ended September 30,
	2022			2021
Cash flows from operating activities:
Net loss	$	(1,634,714	)	$	(1,147,228	)
Adjustments to reconcile net loss to net cash used in operating activities:
Equity in earnings of unconsolidated subsidiary – GMDOC, LLC		(323,633	)		—
Change in fair value of derivative liability		—			(199	)
Stock-based compensation		854,338			345,749
Depreciation, depletion and amortization		95,961			61,668
Accretion of asset retirement obligations		1,004			558
Gain on settlement of litigation		—			(23,000	)
Gain on exchange and extinguishment of liabilities		—			(179,407	)
Loss on retirement of convertible note payable		—			115,805
Expiration and charge-off of deposit to acquire oil and gas properties		—			75,000
Amortization of discount on convertible note payable		579,263			30,016
Change in operating assets and liabilities:
Increase in accounts receivable		(5,610	)		(25,545	)
Increase in prepaid expenses		(3,082	)		(16,590	)
Increase in accounts payable		219,310			194,645
Increase (decrease) in accrued liabilities		—			(112	)
Increase in accrued interest		641			10,146
Net cash used in operating activities		(216,522	)		(558,494	)
Cash flows from investing activities:
Investment in unconsolidated subsidiary – GMDOC, LLC		(850,000	)		—
Investment in Hugoton Gas Field participation agreement		(314,753	)		—
Investment in oil and gas properties and equipment		(15,224	)		(900,000	)
Net cash used in investing activities		(1,179,977	)		(900,000	)
Cash flows from financing activities:
Cash dividends paid on preferred stock		(154,495	)		(117,936	)
Net proceeds from issuance of convertible notes payable		1,200,000			100,000
Repayment of convertible note payable		(537,500	)		(453,539	)
Net proceeds from issuance of Series A Convertible Preferred Stock with detachable Common Stock purchase warrants		645,000			1,929,089
Net cash provided by financing activities		1,153,005			1,457,614
Net decrease in cash and cash equivalents		(243,494	)		(880	)
Cash and cash equivalents:
Beginning		260,590			11,042
Ending	$	17,096		$	10,162
Supplemental cash flow information:
Cash paid for interest	$	63,759		$	17,448
Cash paid for taxes	$	—		$	—
Supplemental disclosure of non-cash investing and financing activities:
Conversion of Series A Convertible Preferred Stock to Common Stock	$	94		$	—
Issuance of restricted Common Stock	$	155		$	—
Issuance of restricted Common Stock attributable to issuance of convertible notes payable	$	196,154		$	—
Issuance of detachable Common Stock warrants attributable to issuance of convertible notes payable	$	136,574		$	56,000
Cumulative effect of adoption of ASU 2020-06	$	—		$	160,900
Issuance of convertible promissory notes pursuant to debt settlement agreements	$	—		$	28,665
Issuance of detachable Common Stock purchase warrants pursuant to debt settlements agreements	$	—		$	1,605,178
Capital contribution attributable to related party debt extinguishment	$	—		$	1,108,477
Issuance of Common Stock pursuant to debt settlement agreements	$	—		$	68,600
Assumption of asset retirement obligation related to purchase of oil and gas properties	$	—		$	13,425

The accompanying notes are an integral part of these unaudited condensed financial statements.

AMERICAN NOBLE GAS, INC.

Notes to Unaudited Condensed Financial Statements

~~September~~March 3031, ~~2022~~2023

(Unaudited)

Note 1 – Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies

Unaudited Interim Financial Information

American Noble Gas, Inc. has prepared the accompanying condensed financial statements pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial reporting. These financial statements are unaudited and, in our opinion, include all adjustments consisting of normal recurring adjustments and accruals necessary for a fair presentation of our condensed balance sheets, statements of operations, statements of stockholders’ deficit and cash flows for the periods presented. Operating results for the periods presented are not necessarily indicative of the results that may be expected for the remainder of ~~2022~~2023 due to various factors. Certain information and footnote disclosures normally included in financial ~~statements~~ statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been omitted in in accordance with the rules and regulations of the SEC. These condensed financial statements should be read in conjunction with the audited financial statements and accompanying notes in Item 8, “Financial Statements and Supplementary Data,” of our ~~Annual~~ Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC.

Name change

At the Company’s Annual Meeting of Stockholders held on October 13, 2021 the stockholders approved an amendment to the Company’s Certificate of Incorporation, as amended, changing the Company’s name from Infinity Energy Resources, Inc. to American Noble Gas Inc. “AMGAS,” the “Company,” “we,” “us” and “our” refers collectively to American Noble Gas Inc, (formerly Infinity Energy Resources, Inc.), its predecessors and subsidiaries or one or more of them as the context may require.

Reincorporation in Nevada

On December 7, 2021, pursuant to an Agreement and Plan of Merger, American Noble Gas, Inc., a Delaware corporation, merged with and into its wholly owned subsidiary, American Noble Gas Inc., a Nevada corporation (“AMGAS-Nevada” and/or the “Company”) with AMGAS-Nevada continuing as the surviving corporation. In conjunction with the merger, AMGAS-Nevada succeeded to the assets, continued the business and assumed the rights and obligations of the predecessor Delaware corporation existing immediately prior to the merger. The merger was consummated by the filing of a certificate of merger on December 7, 2021 with the Secretary of State of the State of Delaware and Articles of Merger with the Secretary of State of the State of Nevada. The Agreement and Plan of Merger and transactions contemplated thereby were adopted by the holders of a majority of the outstanding shares of the predecessor company’s common stock, par value $0.0001 per share, and/or Series A Convertible Preferred Stock, par value $0.0001 per share, on an as-converted common stock basis, by written consent in lieu of a special meeting of stockholders, in accordance with the Delaware General Corporation Law.

Pursuant to the Agreement and Plan of Merger, (i) each outstanding share of predecessor’s common stock automatically converted into one share of common stock, par value $0.0001 per share, of AMGAS-Nevada (the “Common Stock”), (ii) each outstanding share of the predecessor’s Series A Convertible Preferred Stock automatically converted into one share of Series A Convertible Preferred Stock, par value $0.0001 per share of AMGAS-Nevada (the “Series A Convertible Preferred Stock”), and (iii) each outstanding option, right or warrant to acquire shares of predecessor common stock converted into an option, right or warrant to acquire an equal number of shares of AMGAS-Nevada Common Stock under the same terms and conditions as the original options, rights or warrants.

Similar to the shares of predecessor common stock prior to the merger, the shares of Common Stock are quoted on the OTCQB tier operated by the OTC Markets Group Inc. under the symbol “IFNY”. In accordance with the Agreement and Plan of Merger, each outstanding certificate previously representing shares of the predecessor’s common stock or Series A Convertible Preferred Stock automatically represents, without any action of the predecessor’s stockholders, the same number of shares of Common Stock or Series A Convertible Preferred Stock, as applicable.

Pursuant to the Agreement and Plan of Merger, the directors and officers of the predecessor company immediately prior to the merger became the directors and officers of AMGAS-Nevada and continued their respective directorship or services with the Company on the same terms as their respective directorship or service with the predecessor registrant immediately prior to the merger.

As a result of the merger, the internal affairs of the Company ceased to be subject to the Delaware General Corporation Law or governed by the predecessor’s Delaware Certificate of Incorporation, as amended, and its bylaws. As of December 7, 2021, the effective date of the merger, the Company is now subject to the Nevada Revised Statutes and is governed by the Company’s Articles of Incorporation as filed in the State of Nevada and the Company’s Bylaws.

Quotation of Common Stock on OTCQB

Effective July 13, 2021, the Company’s Common Stock was approved for quotation on the OTCQB® Venture Market under the symbol “IFNY.”

Nature of Operations

The Company has assessed various opportunities and strategic alternatives involving the acquisition, exploration and development of oil and gas oil producing properties in the United States, including the possibility of acquiring businesses or assets that provide support services for the production of oil and gas in the United States.

As a result, we are now involved with the following oil and gas producing properties:

Central Kansas Uplift - On April 1, 2021, we completed the acquisition of the Central Kansas Uplift Properties, for a purchase price of $900,000. The Central Kansas Uplift Properties include the production and mineral rights/leasehold for oil and gas properties, subject to overriding royalties to third parties, in the Central Kansas Uplift geological formation covering over 11,000 contiguous acres (the “Properties”). The purchase of the Properties included the existing production equipment, infrastructure and ownership of 11 square miles of existing 3-D seismic data on the acreage. The Properties include a horizontal producing well, horizontal saltwater injection well, conventional saltwater disposal well and two conventional vertical producing wells, which currently produce from the Reagan Sand Zone with an approximate depth of 3,600 feet.

We commenced rework of the existing production wells after completion of the acquisition of the Properties and have performed testing and evaluation of the existence of noble gas reserves on the Properties including helium, argon and other rare earth minerals/gases. Testing of the Properties for noble gas reserves has provided encouraging but not conclusive results and the Company has yet to determine the possibility of commercializing the noble gas reserves on the Properties. The Company plans to assess the Properties’ existing oil and gas reserves while continuing the evaluation of the existence of new oil and gas zones and other mineral reserves and specifically the noble gas reserves that the Properties may hold.

~~Hugoton~~During ~~Gas~~the ~~Field~~year ~~Farm-Out~~ended -December ~~On April 4~~31, 2022, the Company ~~acquired~~changed aits ~~40%~~strategy ~~participation~~regarding inthe aCentral ~~Farmout~~Kansas ~~Agreement~~Uplift byconsidering ~~and~~the ~~between~~reduced ~~Sunflower~~net cash ~~Exploration,~~flows ~~LLC~~from as the ~~Farmee~~sale ~~and~~of ~~Scout~~crude ~~Energy~~oil ~~Partners~~production. asThe ~~Farmor~~reduction ~~with~~in ~~regards~~net cash flows was attributable to ~~its~~lower spot crude oil prices during 2022 compared to 2021 and ~~gas~~higher ~~interests~~than inanticipated operating costs related to the ~~Hugoton~~operation ~~Gas~~of ~~Field,~~the horizontal wells on the Properties. The ~~located~~Company inhas ~~Haskell~~shut down the horizontal production wells as of March 31, 2023 and ~~Finney~~December ~~Counties~~31, ~~Kansas.~~2022 ~~The~~and ~~Company has~~is ~~joined~~considering ~~three~~the ~~other~~deepening ~~parties~~of the conventional wells on the property to explore for helium and ~~develop~~other ~~potential~~noble ~~oil,~~gases ~~natural~~that may be present in deeper producing zones. Accordingly, ~~gas~~the Company has recorded an impairment charge of $712,812 ~~noble~~to ~~gases~~reduce the capitalized tangible and ~~brine~~intangible ~~minerals~~costs onrelated ~~the~~to its Central Kansas Uplift properties ~~underlying~~to ~~the~~zero ~~Farmout~~as ~~Agreement~~of ~~(collectively~~March ~~the~~31, ~~“Hugoton~~2023 ~~JV”)~~and December 31, 2022.

Hugoton Gas Field Farm-Out - On April 4, 2022, the Company acquired a 40% participation in a Farmout Agreement by and between Sunflower Exploration, LLC as the Farmee and Scout Energy Partners as Farmor (“Scout”) with regards to its oil and gas interests in the Hugoton Gas Field, located in Haskell and Finney Counties, Kansas. The Company has joined three other parties to explore for and develop potential oil, natural gas, noble gases and brine minerals on the properties underlying the Farmout Agreement (collectively the “Hugoton JV”).

The Farmout Agreement covers drilling and completion of up to 50 wells, with the first exploratory well spudded on May 7, 2022. The Hugoton JV will utilize Scout’s existing infrastructure assets including water disposal, gas gathering and helium processing. The Farmout Agreement provides the Hugoton JV with rights to take in-kind and market its share of helium at the tailgate of Jayhawk Gas Plant, which will enable the Hugoton JV to market and sell the helium produced at prevailing market prices.

The Hugoton JV also acquired the right to all brine minerals subject to a ten percent (10%) royalty to Scout, across Finney and Haskell Counties. Brine minerals are harvested from the formation water produced from active, and to be drilled, oil and gas wells and may include a variety of dissolved minerals including bromine and iodine. The Hugoton JV plans to target brine minerals with commercial quantities of bromine and iodine. The Company through the Hugoton JV is currently developing proprietary technology to recover brine minerals, particularly with respect to bromine, which is well underway and has demonstrated recovery efficiency and is expected to be available for use in existing and future development wells.

The Hugoton JV believes that its unconventional theory has not previously been targeted for exploration by historical operations in the field. The initial exploratory well was spud on May 7, 2022 near Garden City, Kansas, with production casing set after testing and completion logs identified at least two potential zones with substantial gas and helium reserves. The initial well was completed upon the successful perforation across two lower intervals of the Chase group of formations. The fracture stimulation was completed in two stages during June 2022. The well was connected to the pipeline and commenced commercial production and sales of natural gas, natural gas liquids and helium on August 17, 2022. The Company is ~~evaluating~~continuing to evaluate the initial flows of both natural gas and helium to determine its plan for additional wells on the farmout.

9The Company performed the ceiling test to assess potential impairment of the capitalized costs relative to its Hugoton Gas Field Project. The ceiling test indicated an impairment charge of $192,762 was required to reduce the total capitalized costs to $88,687 as of December 31, 2022. Accordingly, the Company has recorded an impairment charge of $192,762 to reduce the capitalized tangible and intangible costs related to its Hugoton Gas Field properties to $88,687 as of December 31, 2022. The Company recorded an addition to depreciation and amortization expense of $3,411 during the three months ended March 31, 2023.

Investment in GMDOC, LLC - On May 3, 2022, the Company entered into an operating agreement (the “Operating Agreement”) pursuant to which the Company acquired 17 (or 60.7143%) of 28 limited liability membership interests (the “Interests”) in GMDOC, LLC, a Kansas limited liability company (“GMDOC”), for an aggregate purchase price of $4,037,500, and was subsequently admitted as a member of GMDOC.

~~With~~The ~~respect to its cash capital contribution, the~~ Company paid ~~a non-refundable cash deposit for~~ the ~~membership interests in the amount of $50,000 on May 3, 2022. The Company paid the remainder of the~~ cash contribution for the membership interests, orof $~~800~~850,000, onduring May ~~16,~~ 2022. The remainder of the Company’s capital contribution, or $3,187,500, was financed by the Bank Loan (as defined below).

GMDOC had previously acquired 70% of the working interests (the “Acquisition”) in certain oil and gas leases (the “GMDOC Leases”) from Castelli Energy, L.L.C., an Oklahoma limited liability company (“Castelli”). The GMDOC Leases cover approximately 10,000 acres located in Southern Kansas near the Oklahoma border. The GMDOC Leases currently produce approximately 100 barrels of oil per day and 1.5 million cubic feet of natural gas per day on a gross basis.

GMDOC is managed by two members: Darrah Oil Company, LLC, and Grand Mesa Operating Company, (collectively the “Managing Members”), which also serve as the operating companies under the GMDOC Leases.

COVID–19 Pandemic

The financial statements contained in this Quarterly Report on Form 10-Q as well as the description of our business contained herein, unless otherwise indicated, principally reflect the status of our business and the results of our operations as of and for the three and nine months ended September 30, 2022. Economies throughout the world continue to suffer disruptions by the effects of the quarantines, business closures and the reluctance of individuals to leave their homes as a result of the COVID-19 pandemic. In particular, the oil and gas market has been severely impacted by the negative effects of the COVID 19 pandemic because of the substantial and abrupt decrease in the demand for oil and gas globally followed by the recent resurgence in oil and natural gas prices. In addition, the capital markets have experienced periods of disruption and our efforts to raise necessary capital in the future may be adversely impacted by the continuing effects of the COVID-19 pandemic and investor sentiment and we cannot forecast with any certainty when the lingering uncertainty caused by the COVID-19 pandemic will cease to impact our business and the results of our operations. In reading this Quarterly Report on Form 10-Q, including our discussion of our ability to continue as a going concern set forth herein, in each case, consider the additional uncertainties caused by the COVID-19 pandemic.

Going Concern

The Company has incurred losses from operations, has a ~~net~~ stockholders’ deficit, incurred net cash used in operating activities and has a significant working capital deficit as of and for the ~~nine~~three months ended ~~September~~ 30March 31, ~~2022~~2023 and as of and for the ~~year~~years ended December 31, 2022 and 2021. The Company must raise substantial amounts of debt and equity capital from other sources in the future in order to fund (i) the development of the Properties acquired on April 1, 2021; (ii) our obligations for exploration and development under the Hugoton Farmout Agreement; (iii) normal day-to-day operations and corporate overhead; and (iv) outstanding debt and other financial obligations as they become due, as described below. ~~Some~~Most of the Company’s outstanding debt and other ~~financial~~ financial obligations are currently past due and the Company ~~anticipates~~must ~~that~~negotiate ~~other~~forbearance ~~debt~~ and/or ~~financial~~restructuring ~~obligations~~agreements ~~will~~with ~~become~~the holders ~~past~~of ~~due~~such ~~imminently~~debt. ~~See~~ ~~Note 4.~~ These are substantial operational and financial issues that must be successfully addressed during ~~2022~~2023 and beyond.

The Company has made substantial progress in resolving many of its existing financial obligations and acquiring oil and gas producing properties to deploy its new operational strategy during the nine months ended September 30, 2022 and for the year ended December 31, 2021.8

The Company will have significant financial commitments executing its planned exploration and development of the Properties and the Hugoton Gas Field. The Company may find it necessary to raise substantial amounts of debt or equity capital to fund such exploration and development activities and may seek offers from industry operators and other third parties for interests in the Properties in exchange for cash and a carried interest in exploration and development operations or other joint venture arrangement. There can be no assurance that it will be able to obtain such new funding or be able to reach agreements with industry operators and other third parties or on what terms.

Due to the uncertainties related to the foregoing matters, there exists substantial doubt about the Company’s ability to continue as a going concern within one year after the date the financials are issued. The unaudited condensed financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should the Company be unable to continue as a going concern.

Revenue Recognition

On January 1, 2018, the Company adopted Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” and the series of related accounting standard updates that followed, using the modified retrospective method of adoption. Adoption of the ASU did not require an adjustment to the opening balance of equity and did not change the Company’s amount and timing of revenues.

The Company’s revenues are primarily derived from its interests in the sale of oil and natural gas production. To date, such ~~revenues~~ revenues have only included the sale of oil and natural gas however the Company expects to begin generating more substantial revenues from the sale of ~~natural gas and~~ noble gases in the future. The Company recognizes revenue from its interests in the sales of oil and gas in the period that its performance obligations are satisfied. Performance obligations are satisfied when the customer obtains control of product, when the Company has no further obligations to perform related to the sale, when the transaction price has been determined and when collectability is probable. The sales of oil and gas are made under contracts which the third-party operators of the wells have negotiated with customers, which typically include variable consideration that is based on pricing tied to local indices and volumes delivered in the current month. The Company receives payment from the sale of oil and gas production from one to three months after delivery. At the end of each month when the performance obligation is satisfied, the variable consideration can be reasonably estimated and amounts due from customers are accrued in trade receivables, net in the balance sheets. Variances between the Company’s estimated revenue and actual payments are recorded in the month the payment is received, however, differences have been and are insignificant. The Company’s oil is typically sold at delivery points ~~under~~ under contracts terms that are common in our industry.

Cash and Cash Equivalents

For purposes of reporting cash flows, cash consists of cash on hand and demand deposits with financial institutions. The Company’s policy is that all highly liquid investments with an original maturity of three months or less when purchased would be cash equivalents and would be included along with cash as cash and equivalents.

The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation (FDIC) in accounts that at times may be in excess of the federally insured limit of $250,000 per bank. The Company minimizes this risk by placing its cash deposits with several financial institutions if necessary to remain below the federally insured limit of $250,000 per bank. At March 31, 2023 and December 31, 2022, the uninsured balance amounted to $-0- and $-0-, respectively.

Convertible Instruments

In August 2020, the Financial Accounting Standards Board (“FASB”) issued ASU 2020-06, “Debt – Debt with Conversion and Other Options (Subtopic 470- 20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40)” which is intended to reduce complexity in applying GAAP to certain financial instruments with characteristics of liabilities and equity. The guidance in ASU 2020-06 simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the existing guidance in Accounting Standards Codification (“ASC”) 470-20, Debt: Debt with Conversion and Other Options~~, that~~ that requires entities to account for beneficial conversion features and cash conversion features in equity, separately from the host ~~convertible~~ convertible debt or preferred stock. The guidance in ASC 470-20 applies to convertible instruments for which the embedded conversion features ~~are~~ are not required to be bifurcated from the host contract and accounted for as derivatives. In addition, the amendments revise the scope ~~exception~~ exception from derivative accounting in ASC 815-40 for freestanding financial instruments and embedded features that are both indexed to the issuer’s own stock and classified in stockholders’ equity, by removing certain criteria required for equity classification. These amendments are expected to result in more freestanding financial instruments qualifying for equity classification (and, therefore, not accounted for as derivatives), as well as fewer embedded features requiring separate accounting from the host contract. The amendments in ASU 2020-06 further revise the guidance in ASC 260, Earnings Per Share, to require entities to calculate diluted earnings per share (EPS) for convertible instruments by using the if-converted method. In addition, entities must presume share settlement for purposes of calculating diluted EPS when an instrument may be settled in cash or shares.

The ~~amendments~~Company inearly adopted ASU 2020-06 ~~are~~ effective ~~for~~January ~~public~~1, ~~entities~~2021 ~~that~~and ~~meet~~applied ~~the~~ASU ~~definition~~2020-06 ofto anall ~~SEC~~outstanding ~~filer,~~financial ~~excluding~~instruments ~~smaller reporting companies~~ as ~~defined~~of byJanuary ~~the SEC~~1, ~~for fiscal years beginning after December 15,~~ 2021. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020.

The Company early adopted ASU 2020-06 effective January 1, 2021 and has applied its effects to the 3% convertible notes payable issued on March 31, 2021 and the 8% convertible notes payable issued on August 30, 2021 (see Note 4). The Company elected to adopt ASU 2020-06 using the modified retrospective method which enables entities to apply the transition requirements in this ASU at the effective date of ASU 2020-06 (rather than as of the earliest comparative period presented) with the effect of initially adopting ASU 2020-06 recognized as a cumulative-effect adjustment to retained earnings (accumulated deficit) on the first day of the period adopted. Therefore, this transition method applies the amendments in ASU 2020-06 to outstanding financial instruments as of the beginning of the fiscal year of adoption (January 1, 2021), with the cumulative effect of the change recognized as an adjustment to the opening balance of retained earnings (accumulated deficit) as of the date of adoption. In accordance with the modified retrospective method, no adjustment was made to the comparative-period information including earnings (loss) per share.

The Company applied ASU-2020-06 to all outstanding financial instruments as of January 1, 2021, (the date of adoption of ASU 2020-06). The convertible notes payable issued on August 19, 2020 was the only outstanding financial instrument effected by this new accounting standard as of January 1, 2021. Therefore, the application of ASU-2020-06 to this convertible note payable was used to determine the cumulative effect of the adoption of the new accounting standard. The cumulative effect of the adoption of the new accounting standard was recognized as an adjustment to the opening balance of retained earnings (accumulated deficit) which resulted in an increase to the carrying value of convertible notes payable as of January 1, 2021 of $160,900, a decrease to additional paid in capital of $252,961 and a decrease to accumulated deficit of $92,061. See Note 4.

Prior to the adoption of ASU 2020-06, the Company applied the existing accounting standards for derivatives and hedging and for distinguishing liabilities from equity when accounting for hybrid contracts that feature conversion options. The accounting standards require companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments according to certain criteria. The criteria includes circumstances in which (i) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (ii) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (iii) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. The derivative is subsequently marked to market at each reporting date based on current fair value, with the changes in fair value reported in results of operations.

Conversion options that contain variable settlement features such as provisions to adjust the conversion price upon subsequent issuances of equity or equity linked securities at exercise prices more favorable than that featured in the hybrid contract generally result in their bifurcation from the host instrument.

Derivative Instruments

The Company accounts for derivative instruments or hedging activities under the provisions of ASC 815 Derivatives and Hedging. ASC 815 requires the Company to record derivative instruments at their fair value. If the derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings. If the derivative is designated as a cash flow hedge, the effective portions of changes in the fair value of the derivative are recorded in other comprehensive earnings (loss) and are recognized in the statement of earnings when the hedged item affects earnings. Ineffective portions of changes in the fair value of cash flow hedges, if any, are recognized in earnings. Changes in the fair value of derivatives that do not qualify for hedge treatment are recognized in earnings.

The purpose of hedging is to provide a measure of stability to the Company’s cash flows in an environment of volatile oil and gas prices and to manage the exposure to commodity price risk. As of March 31, 2023 and December 31, 2022 and during the periods then ended, the Company had no oil and natural gas derivative arrangements outstanding.

As a result of certain terms, conditions and features included in certain common stock purchase warrants issued by the Company (Notes 4 and 11), those warrants were required to be accounted for as derivatives at estimated fair value, with changes in fair value recognized in operations.

Fair Value of Financial Instruments

The carrying values of the Company’s accounts payable, accrued liabilities and short-term notes represent the estimated fair value due to the short-term nature of the accounts.

In accordance with ASC Topic 820 — Fair Value Measurements and Disclosures (“ASC 820”), the Company utilizes the market approach to measure fair value for its financial assets and liabilities. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets, liabilities or a group of assets or liabilities, such as a business.

ASC 820 utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:

●	Level 1 —	Quoted prices in active markets for identical assets and liabilities.

●	Level 2 —	Other significant observable inputs (including quoted prices in active markets for similar assets or liabilities).

●	Level 3 —	Significant unobservable inputs (including the Company’s own assumptions in determining the fair value.

The estimated fair value of warrant derivative liabilities, which are related to detachable warrants issued in connection with the Series A Convertible Preferred Stock, par value $0.001 per share (the “Series A Convertible Preferred Stock”) were estimated using a closed-ended option pricing model utilizing assumptions related to the contractual term of the instruments, estimated volatility of the price of the Company’s common stock, par value $0.001 per Share (the “Common Stock”) and current interest rates. The fair values for the warrant derivatives as of March 31, 2023 and December 31, 2022 were classified under the fair value hierarchy as Level 3.

The following table represents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2023 and December 31, 2022:

March 31, 2023	Level 1		Level 2		Level 3		Total
Liabilities:
Warrant derivative liabilities	$	—	$	—	$	209,802	$	209,802
	$	—	$	—	$	209,802	$	209,802

December 31, 2022	Level 1		Level 2		Level 3		Total
Liabilities:
Warrant derivative liabilities	$	—	$	—	$	577,269	$	577,269
	$	—	$	—	$	577,269	$	577,269

There were no changes in valuation techniques or reclassifications of fair value measurements between Levels 1, 2 or 3 during the three months ended March 31, 2023 and 2022.

Management Estimates

The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Significant estimates include, but are not limited to, oil and gas reserves; depreciation, depletion and amortization of proved oil and gas properties; future cash flows from oil and gas properties; impairment of long-lived assets; fair value of derivatives; asset retirement obligations, our control over equity method investments, fair value of equity compensation; warrants issued in connection with convertible debt; the realization of deferred tax assets; fair values of assets acquired and liabilities assumed in business combinations.

Oil and gas properties

Central Kansas Uplift Properties - On April 1, 2021, we completed the acquisition of the Properties, under the terms of the Asset Purchase Agreement, for a purchase price of $900,000. The purchase of the Properties included the existing production equipment, infrastructure and ownership of 11 square miles of existing 3-D seismic data on the acreage. The Properties include a horizontal producing well, horizontal saltwater injection well, conventional saltwater disposal well and two conventional vertical producing wells, which currently produce from the Reagan Sand Zone with an approximate depth of 3,600 feet.

1211

The Company has performed workovers of the wells subsequent to the Properties purchase which was necessary to put the lease back into production status. Therefore, these tangible and intangible workover costs were expensed as lease operating expenses rather than capitalized in the full cost pool through ~~September~~December 3031, 2022. In addition, the Company is currently evaluating the Properties for oil and gas reserves and specifically the potential for noble gas reserves such as helium, argon and krypton. Based on these evaluations, the Company may redirect its efforts to the production of noble gases rather than crude oil on the Properties. These noble gas evaluation costs have also been expensed as lease operating costs through ~~September~~March 3031, ~~2022~~2023.

Hugoton Gas Field Farm-Out -The first exploratory well commenced on May 7, 2022 near Garden City, Kansas with a goal to evaluate its unconventional theory of where substantial oil, natural gas and noble gases may be present in the Hugoton Gas Field. The initial well in which the Company has acquired a 40% participation together with three other venture partners was spud on May 7, 2022 with production casing set after testing and completion logs identified at least two potential zones with substantial gas and helium reserves.

The initial well was completed upon the successful perforation across two lower intervals of the Chase group of formations. The fracture stimulation was completed in two stages during June 2022. The well was connected to the pipeline and commenced commercial production on August 17, 2022. The Company is ~~evaluating~~continuing to evaluate the initial flows of both natural gas and helium to determine its plan for additional wells on the farmout.

Full Cost Accounting

The accounting for, and disclosure of, oil and gas producing activities require that we choose between two GAAP alternatives: the full cost method or the successful efforts method. We adopted and use the full cost method of accounting, which involves capitalizing all exploration, exploitation, development and acquisition costs. Once we incur costs, they are recorded in the depletable pool of proved properties or in unproved properties, collectively, the full cost pool. Our unproved property costs, which include unproved oil and gas properties, properties under development, and major development projects, were zero ~~through~~as ~~September~~of 30March 31, 2023 and December 31, 2022, and are not subject to depletion. We review our unproved oil and gas property costs on a quarterly basis to assess for impairment and transfer unproved costs to proved properties as a result of extensions or discoveries from drilling operations or determination that no proved reserves are attributable to such costs. We expect these costs to be evaluated in one to seven years and transferred to the depletable portion of the full cost pool during that time. The full cost pool is comprised of intangible drilling costs, lease and well equipment and exploration and development costs incurred plus acquired proved and unproved leaseholds.

When we acquire significant amounts of undeveloped acreage, we capitalize interest on the acquisition costs in accordance with FASB ASC Subtopic 835-20 for Capitalization of Interest. ~~We capitalize interest upon identification and development of shale resource opportunities in the Haynesville and Marcellus areas.~~ When the unproved property costs are moved to proved developed and undeveloped oil and gas properties, or the properties are sold, we cease capitalizing interest.

Capitalized costs to acquire oil and natural gas properties are depreciated and depleted on a units-of-production basis based on estimated proved reserves. Capitalized costs of exploratory wells and development costs are depreciated and depleted on a units-of-production basis based on estimated proved developed reserves. Under this method, the sum of the full cost pool, excluding the book value of unproved properties, and all estimated future development costs are divided by the total estimated quantities of proved reserves. This rate is applied to our total production for the quarter, and the appropriate expense is recorded. Support equipment and other property, plant and equipment related to oil and gas producing activities, as well as property, plant and equipment unrelated to oil and gas producing activities, are recorded at cost and depreciated on a straight-line basis over the estimated useful lives of the assets.

Sales, dispositions and other oil and gas property retirements are accounted for as adjustments to the full cost pool, with no recognition of gain or loss, unless the disposition would significantly alter the amortization rate and/or the relationship between capitalized costs and Proved Reserves.

Pursuant to Rule 4-10(c)(4) of Regulation S-X, at the end of each quarterly period, companies that use the full cost method of accounting for their oil and gas properties must compute a limitation on capitalized costs, or ceiling test. The ceiling test involves comparing the net book value of the full cost pool, after taxes, to the full cost ceiling limitation defined below. In the event the full cost ceiling is less than the full cost pool, we must record a ceiling test write-down of our oil and gas properties to the value of the full cost ceiling. The full cost ceiling limitation is computed as the sum of the present value of estimated future net revenues from our proved reserves by applying average prices as prescribed by the SEC Release No. 33-8995, less estimated future expenditures (based on current costs) to develop and produce the proved reserves, discounted at 10%, plus the cost of properties not being amortized and the lower of cost or estimated fair value of unproved properties included in the costs being amortized, net of income tax effects.

13The ceiling test is computed using the simple average spot price for the trailing twelve-month period using the first day of each month. The trailing twelve-month reference price was $94.14 per barrel for the West Texas Intermediate oil at Cushing, Oklahoma through December 31, 2022. This reference price for oil is further adjusted for quality factors and regional differentials to derive estimated future net revenues. Under full cost accounting rules, any ceiling test write-downs of oil and gas properties may not be reversed in subsequent periods. We recognized an impairment charge of $905,574 as of December 31, 2022 which is attributable to changing our strategy to exploring for noble gases and away from crude oil production at our Central Kansas Uplift properties which resulted in a large decrease in estimated future cash flows.

The ceiling test is computed using the simple average spot price for the trailing twelve-month period using the first day of each month. The trailing twelve-month reference price was $67.99 per barrel for the West Texas Intermediate oil at Cushing, Oklahoma through December 31, 2021. This reference price for oil is further adjusted for quality factors and regional differentials to derive estimated future net revenues. Under full cost accounting rules, any ceiling test write-downs of oil and gas properties may not be reversed in subsequent periods. There were no ceiling test write-downs through September 30, 2022.

The ceiling test calculation is based upon estimates of proved reserves. There are numerous uncertainties inherent in estimating quantities of proved reserves, in projecting the future rates of production and in the timing of development activities. The accuracy of any reserve estimate is a function of the quality of available data and of engineering and geological interpretation and judgment. Results of drilling, testing and production subsequent to the date of the estimate may justify revision of such estimate. Accordingly, reserve estimates are often different from the quantities of oil and gas that are ultimately recovered.

Equity Method Investments

The Company uses the equity method of accounting for equity investments if the investment provides the ability to exercise significant influence, but not control, over operating and financial policies of the investee. The Company’s proportionate share of the net income or loss of these investees is included in our ~~Condensed~~ Statements of Operations. Judgment regarding the level of influence over each equity ~~method~~ method investment includes considering key factors such as the Company’s ownership interest, legal form of the investee, representation on the board of directors, participation in policy-making decisions and material intra-entity transactions.

The Company evaluates equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amount of the investment might not be recoverable. Factors considered by the Company when reviewing an equity method investment for impairment include the length of time and the extent to which the fair value of the equity method investment has been less than cost, the investee’s financial condition and near-term prospects and the intent and ability to hold the investment for a period of time sufficient to allow for anticipated recovery. An impairment that is other-than temporary is recognized in the period identified.

The Company accounts for distributions received from equity method investees under the “nature of the distribution” approach. Under this approach, distributions received from equity method investees are classified on the basis of the nature of the activity or activities of the investee that generated the distribution as either a return on investment (classified as cash inflows from operating activities) or a return of investment (classified as cash inflows from investing activities).

Issuance of Debt Instruments With Detachable Stock Purchase Warrants

Proceeds from the issuance of a debt instrument with stock purchase warrants (detachable call options) are allocated to the two elements based on the relative fair values of the debt instrument without the warrants and of the warrants themselves at time of issuance. The portion of the proceeds allocated to the warrants are recorded as additional paid-in capital. The remainder of the proceeds are allocated to the debt instrument portion of the transaction. Such issuances generally result in a discount (or, occasionally, a reduced premium) relative to the debt instrument, which is amortized to interest expense using the effective interest rate method.

Asset Retirement Obligations

The Company records estimated future asset retirement obligations pursuant to the provisions of ASC 410. ASC 410 requires entities to record the fair value of a liability for an asset retirement obligation in the period in which it is incurred with a corresponding increase in the carrying amount of the related long-lived asset. Subsequent to its initial measurement, the asset retirement liability is required to be accreted each period. The Company’s asset retirement obligations consist of costs related to the plugging of wells, the removal of facilities and equipment, and site restoration on oil and gas properties.

During April 2021, the Company acquired the Properties and assumed the related asset retirement obligation existing at the date of acquisition. The asset retirement obligation assumed for the Properties relates to the plug and abandonment costs when the wells acquired are no longer useful. The Company determined the value of the liability by obtaining quotes for this service and estimated the increased costs that the Company will face in the future. We then discounted the future value based on an intrinsic interest rate that is appropriate for us. If costs rise more than what we have expected there could be additional charges in the future; however, we monitor the costs of the abandoned wells and we will adjust this liability if necessary.

As of December 31, 2012, the Company had divested all of its domestic oil properties that contained operating and abandoned wells in Texas, Colorado and Wyoming. The Company may have obligations related to the divestiture of certain abandoned non-producing domestic leasehold properties should the new owner not perform its obligations to reclaim abandoned wells in a timely manner. Management believes the Company has been relieved from asset retirement obligation related to Infinity-Texas because of the sale of its Texas oil and gas properties in 2011 and its sale of 100% of the stock in Infinity-Texas in 2012. The Company has recognized an additional liability of $734,897 related to its former Texas oil and gas producing properties (included in asset retirement obligations) to recognize the potential personal liability of the Company and its officers for the Infinity-Texas oil and gas properties should the new owner not perform its obligations to reclaim abandoned wells in a timely manner. In addition, management believes the Company has been relieved from asset retirement obligations related to Infinity-Wyoming because of the sale of its Wyoming and Colorado oil and gas properties in 2008; however, the Company has recognized since 2012 an additional liability of $981,106 related to its former Wyoming and Colorado oil and gas producing properties (included in asset retirement obligations) to recognize the potential liability of the Company and its officers should the new owner not perform its obligations to reclaim abandoned wells in a timely manner.

Income Taxes

The Company uses the asset and liability method of accounting for income taxes. This method requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of temporary differences between financial accounting bases and tax bases of assets and liabilities. The tax benefits of tax loss carryforwards and other deferred taxes are recorded as an asset to the extent that management assesses the utilization of such assets to be more likely than not. Management routinely assesses the realizability of the Company’s deferred income tax assets, and a valuation allowance is recognized if it is determined that deferred income tax assets may not be fully utilized in future periods. Management considers future taxable earnings in making such assessments. Numerous judgments and assumptions are inherent in the determination of future taxable earnings, including such factors as future operating conditions. When the future utilization of some portion of the deferred tax asset is determined not to be more likely than not, a valuation allowance is provided to reduce the recorded deferred tax asset. When the Company can project that a portion of the deferred tax asset can be realized through application of a portion of tax loss carryforward, the Company will record that utilization as a deferred tax benefit and recognize a deferred tax asset in the same amount. There can be no assurance that facts and circumstances will not materially change and require the Company to adjust its deferred income tax asset valuation allowance in a future period. The Company recognized a deferred tax asset, net of valuation allowance, of $-0- at March 31, 2023 and December 31, 2022.

The Company is potentially subject to taxation in many jurisdictions, and the calculation of income tax liabilities (if any) involves dealing with uncertainties in the application of complex income tax laws and regulations in various taxing jurisdictions. It recognizes certain income tax positions that meet a more-likely-than not recognition threshold. If the Company ultimately determines that the payment of these liabilities will be unnecessary, it will reverse the liability and recognize an income tax benefit. No liability for unrecognized tax benefit was recorded as of March 31, 2023 and December 31, 2022.

Stock-based compensation

The Company applies ASC 718, Stock Compensation, which requires companies to recognize compensation expense for share-based payments based on the estimated fair value of the awards. ASC 718 also requires tax benefits relating to the deductibility of increases in the value of equity instruments issued under share-based compensation arrangements to be presented as financing cash inflows in the statement of cash flows. Compensation cost is recognized based on the grant-date fair value for all share-based payments granted and is estimated in accordance with the provisions of ASC 718.

Related Party Transactions

The Company’s financial statements include disclosures of material related party transactions, other than compensation arrangements, expense allowances and similar items in the ordinary course of business. Disclosure of related party transactions include: 1) the nature of the relationships involved, 2) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements, 3) the dollar amounts of the transactions for each periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period, and 4) amounts due from or to related parties as of the date of each balance sheet presented and if not otherwise apparent,5) the terms of settlement.

Basic and Diluted Income (Loss) Per Share

Net income (loss) per share is calculated in accordance with FASB ASC 260, Earnings Per Share, for the periods presented. Basic net loss per share is based upon the weighted average number of shares of Common Stock outstanding. Diluted net earnings (loss) per share is based on the assumption that all dilutive convertible shares, warrants and stock options were converted or exercised or excluded from the calculations if their inclusion would be antidilutive. Dilution is computed by applying the if-converted/treasury stock method. Under this method, options and warrants are assumed exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase shares of Common Stock at the average market price during the period. The Company has outstanding convertible notes payable and Series A Convertible Preferred Stock both of which are potentially dilutive. Such potential dilutive effect is included in diluted earnings (loss) per share at the beginning of the period (or at the time of issuance, if later) if they have a dilutive effect or such potentially dilutive securities are excluded from the calculations if their inclusion would be antidilutive.

The adoption of ASU 2020-06 requires the Company to assume share settlement when an instrument can be settled in cash or shares at the entity’s option. This applies both to convertible instruments and freestanding arrangements that could result in cash or share settlement. ASU 2020-06 also stipulates that an average market price for the period should be used in the computation of the diluted earnings (loss) per share denominator in cases when the exercise price of an instrument may change based on an entity’s share price or changes in the entity’s share price may affect the number of shares that would be used to settle a financial instrument. Lastly, an entity should use the weighted-average share count from each quarter when calculating the year-to-date weighted average share count for all potentially dilutive securities.

During the three months ended March 31, 2023 and 2022, the Company had outstanding the following securities that were potentially dilutive: i) Series A Convertible Preferred Stock, ii) various convertible notes payable, iii) warrants to purchase Common Stock and iv) options to purchase Common Stock. All potentially dilutive securities were considered for inclusion or exclusion from the calculation of diluted income (loss) per share for the three months ended March 31, 2023 and 2022. Any potentially dilutive security that were considered anti-dilutive were excluded from the net income (loss) per share reported for the three months ended March 31, 2023 and 2022.

During the three and nine months ended September 30, 2022 and 2021, the Company had outstanding the following securities that were potentially dilutive: i) Series A Convertible Preferred Stock, ii) various convertible notes payable (see Note 4), iii) warrants to purchase Common Stock (see Note 7) and iv) options to purchase Common Stock. All potentially dilutive securities were excluded from the calculation of diluted income (loss) per share for the three and nine months ended September 30, 2022 and 2021 as all were considered anti-dilutive because of the net loss reported for the three and nine months ended September 30, 2022 and 2021.

Gain on Extinguishment of Liabilities / Troubled Debt Restructuring:

In accordance with ASC 470, the Company assesses restructuring of debt as troubled debt restructuring if the creditor for economic or legal reasons related to the debtor’s financial difficulties grant a concession to the debtor that it would not otherwise consider. The Company records a gain on restructuring of payables when it transfers its assets to a creditor to fully settle a payable. The gain is measured by the excess of the carrying amount of the payable over the fair value of the assets transferred or fair value of equity interest granted.

Recent Accounting Pronouncements

Business Combinations - In October 2021, FASB issued ASU 2021-08 Business Combinations (“Topic 805”): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The ASU requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers, as if it had originated the contracts. Under the current business combinations guidance, such assets and liabilities were recognized by the acquirer at fair value on the acquisition date. The ~~ASU~~Company isadopted ~~effective~~this ~~for~~ASU ~~fiscal~~on ~~years~~January 1, 2023 and ~~interim~~its ~~periods within those fiscal years, beginning after December 15, 2022, with early~~ adoption ~~permitted.~~did Wenot ~~are~~have ~~currently~~a ~~evaluating the~~material impact ~~of adopting this ASU~~ on our ~~condensed~~ financial statements.

Other accounting standards that have been issued by the FASB or other standards-setting bodies are not expected to have a material impact on the Company’s financial position, results of operations and cash flows.

Note 2 – Oil and Gas Properties and Equipment

Oil and gas properties and equipment is comprised of the following at ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022:

	September 30, 2022			December 31, 2021
	March 31, 2023			December 31, 2022
Oil and gas production equipment	$	913,425		$	913,425
Central Kansas Uplift - Oil and gas production equipment	$	913,425		$	913,425
Proven developed and undeveloped oil and gas properties		15,224			—
Hugoton Gas Field - Oil and gas production equipment		96,831			96,831
Hugoton Gas Field participation agreement initial well drilling and completion costs subject to adjustment to actual costs		314,753			—
Central Kansas Uplift – Leasehold costs		15,225			15,225
Subtotal		1,243,402			913,425
Hugoton Gas Field – Leasehold costs		191,535			191,535
Less: Accumulated depreciation, depletion and amortization		(188,463	)		(92,502	)
Subtotal		1,217,016			1,217,016
Oil and gas properties and equipment, net	$	1,054,939		$	820,923
Less: Accumulated impairment		(905,574	)		(905,574	)
Less: Accumulated depreciation, depletion and amortization		(226,166	)		(222,755	)
Oil and gas properties and equipment, net	$	85,276		$	88,687

Great Bend Properties - On April 1, 2021, the Company completed the previously announced acquisition of certain oil and gas properties and interests from Core Energy, LLC (“Core”), effective as of January 1, 2021 (the “Great Bend Properties Acquisition”). On December 14, 2020, the Company entered into an asset purchase and sale agreement (the “Agreement”) with Core Energy, as well as all of the members of Core, Mandalay LLC and Coal Creek Energy, LLC, to purchase certain oil and gas properties in the Central Kansas Uplift geological formation, covering over 11,000 contiguous acres, including, among other things, the production and mineral rights to and a leasehold interest in the Properties and all contracts, agreements and instruments. The Agreement provided for an aggregate purchase price consisting of $900,000 in cash at closing.

The following represents the purchase price allocation for the Great Bend Properties Acquisition for $900,000 in cash. The Great Bend Properties Acquisition qualifies as an asset acquisition. As such, the Company recognized the assets acquired and liabilities assumed at their fair values as of April 1, 2021, the date of closing. The fair value of the Properties acquired approximate the value of the consideration paid, and the asset retirement obligation to be assumed, which management has concluded approximates the fair value that would be paid by a typical market participant. As a result, neither goodwill nor a bargain purchase gain will be recognized related to the acquisition.

The Company determined the amount of the asset retirement obligation assumed to be $13,425 as of the date of acquisition. The obligation relates to legal requirements associated with the retirement of long-lived assets that result from the acquisitions, construction, development, or normal use of the asset. The obligation relates primarily to the requirement to plug and abandon oil and natural gas wells and support wells at the conclusion of their useful lives.

The following table summarizes the allocation of the assets acquired and the liabilities assumed related to the Properties:

Schedule of Assets and Liabilities Properties Acquired

	Amount
Properties, subject to depreciation, depletion and amortization	$	913,425
Asset retirement obligation assumed		(13,425	)
Total purchase price of the Properties	$	900,000

Hugoton Gas Field Participation Agreement - On April 4, 2022, the Company acquired a 40% participation in a Farmout Agreement by and between Sunflower Exploration, LLC as the Farmee and Scout Energy Partners as Farmor with regards to its oil and gas interests in the Hugoton Gas Field, located in Haskell and Finney Counties, Kansas. The Company has joined three other parties in the Hugoton JV to explore for and develop potential oil, natural gas, noble gases and brine minerals on the properties underlying the Farmout Agreement.

The Hugoton JV believes that its unconventional theory has not previously been targeted for exploration by historical operations in the field. The initial exploratory well was spud on May 7, 2022 near Garden City, Kansas with production casing set after testing and completion logs identified at least two potential zones with substantial gas and helium reserves. The initial well was completed upon the successful perforation across two lower intervals of the Chase group of formations. The fracture stimulation was completed in two stages during June 2022. The well was connected to the pipeline and commenced commercial production on August 17, 2022. The Company is evaluating the initial flows of both natural gas and helium.

The Company has paid a total of $314,753 for its participation in the drilling and completion of the initial exploratory well. Such amount was an estimate and will be adjusted to actual drilling and completion cost expenditures when the well is connected to the pipeline and the production of gas commences.

Note 3 – Investment in unconsolidated subsidiary – GMDOC

A summary of the Company’s investment in unconsolidated subsidiary-GMDOC during the three ~~and nine~~ months ended ~~September~~March 3031, ~~2022~~ 2023 follows:

	Three months ended		~~Nine months ended~~
	September 30, 2022		September 30, 2022
	March 31, 2023
Investment in unconsolidated subsidiary-GMDOC, at beginning of period	$	964,336	$	—
Investment in unconsolidated subsidiary-GMDOC, at December 31, 2022	$	1,101,461
Purchase of membership interests in GMDOC		—		850,000
Investment in unconsolidated subsidiary-GMDOC	$	1,101,461
Equity in earnings of GMDOC		~~209~~39,~~297~~813		~~323,633~~
Distributions during period		—		—
Impairment charges		—		—
Investment in unconsolidated subsidiary-GMDOC at end of period	$	1,173,633	$	1,173,633
Investment in unconsolidated subsidiary-GMDOC at March 31, 2023	$	1,141,274
Investment in unconsolidated subsidiary-GMDOC	$	1,141,274

~~The following table presents summarized balance sheet financial information of the Company’s unconsolidated subsidiary – GMDOC as of September 30, 2022 and December 31, 2021:~~16

~~Schedule~~The following table presents summarized balance sheet financial information of ~~Unconsolidated~~the ~~Subsidiary~~Company’s ~~Balance~~unconsolidated ~~Sheet~~subsidiary ~~Financial~~– ~~Information~~GMDOC as of March 31, 2023:

	September 30, 2022		December 31, 2021
Assets:
Cash	$	591,067	$	—
Accrued revenue & prepaid expenses		490,002		—
Oil and gas properties and equipment, net		7,439,743		—
Total assets	$	8,520,812	$	—
Liabilities and Member’s Equity:
Accounts payable and accrued liabilities	$	229,211	$	—
Mortgage note payable, net		5,493,214		—
Asset Retirement Obligations		865,344		—
Member’s equity		1,933,043		—
Total liabilities and member’s equity	$	8,520,812	$	—


	March 31, 2023
Assets:
Cash	$	215,466
Accrued revenue & prepaid expenses		275,493
Oil and gas properties and equipment, net		7,218,801

Total assets	$	7,709,760

Liabilities and Member’s Equity:
Accounts payable and accrued liabilities	$	124,314
General managing members advances		150,000
Mortgage note payable, net		4,656,429
Asset Retirement Obligations		899,271
Member’s equity		1,879,746

Total liabilities and member’s equity	$	7,709,760

The following table presents summarized income statement financial information of the Company’s unconsolidated subsidiary – GMDOC for the three ~~and nine~~ months ended ~~September~~March 3031, ~~2022~~2023:

	Three months ended			~~Nine months ended~~
	September 30, 2022			September 30, 2022
	March 31, 2023
Oil and gas revenues	$	~~929~~630,~~505~~215		$	~~1,718,468~~
Lease operating expenses		(~~300~~308,~~881~~092	)		~~(545,157~~	)
Production related taxes		(2715,~~830~~890	)		~~(50,743~~	)
Ad valorem taxes		(10,755	)		~~(21,510~~	)
Depreciation expense		(~~137~~134,~~644~~206	)		~~(269,157~~	)
Accretion of asset retirement obligation		(16,~~987~~940	)		~~(33,974~~	)
General and administrative expenses		(46,~~187~~682	)		~~(105,847~~	)
Interest expense		(8672,~~497~~075	)		~~(159,037~~	)
Net income		~~344~~65,~~724~~575			~~533,043~~
AMGAS member’s percentage		60.7143	%		~~60.7143~~	%
Equity in earnings of unconsolidated subsidiary – GMDOC	$	209,297		$	323,633
Equity in earnings of unconsolidated subsidiary – GMDOC for the three months ended March 31, 2023	$	39,813
Equity in earnings of unconsolidated subsidiary – GMDOC	$	39,813

The Company uses the equity method of accounting for equity investments if the investment provides the ability to exercise significant influence, but not control, over operating and financial policies of the investee, GMDOC. Management’s judgment regarding its level of influence over the operations of GMDOC included considering key factors such as the Company’s ownership interest, legal form of the investee, its’ lack of participation in policy-making decisions and its’ lack of control over the day-to-day operations of GMDOC.

~~On May 3, 2022, the Company entered into the Operating Agreement pursuant to which the Company acquired~~ 17 ~~(or 60.7143%) of 28 limited liability membership Interests in GMDOC, for an aggregate purchase price of $4,037,500, and was subsequently admitted as a member of GMDOC.~~

With respect to its cash capital contribution, the Company paid a non-refundable cash deposit for the membership interests in the amount of $50,000 on May 3, 2022. The Company paid the remainder of the cash contribution for the membership interests, or $800,000, on May 16, 2022. The remainder of the Company’s capital contribution, or $3,187,500, was financed by the Bank Loan (as defined below).

GMDOC is managed by two Managing Members, which also serve as the operating companies under the GMDOC Leases.

Pursuant to the terms of the Operating Agreement, each member agreed to pay GMDOC, as its capital contribution, $50,000 in cash per Interest, with the remainder to be financed, in part, by a loan to GMDOC from a commercial bank, secured by GMDOC’s property, in the aggregate amount of $6,045,000 (the “Bank Loan”). The principal of the Bank Loan is to be repaid in 84 varying monthly installments, ranging from $170,000 at the beginning to $40,500 at the end of the loan term, with the first installment on July 1, 2022. The Bank Loan bears a variable interest beginning at an initial rate of 6% per annum with one rate adjustment after 36 months subject to a 6% minimum interest rate. Initial working capital requirements was financed by a loan to GMDOC from the Managing Members, in the maximum aggregate amount of $400,000 (the “Member Loan”), which was repaid during the nine months ended September 30, 2022.

Note 4 – Debt Obligations

Debt obligations ~~are~~were comprised of the following at ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022:

Schedule of Debt Outstanding

	September 30, 2022		December 31, 2021
	March 31, 2023		December 31, 2022
Notes payable:
	$	28,665	$	28,665
3% convertible notes payable due March 30, 2026 (the 3% Notes)	$	28,665	$	28,665
8% convertible notes payable due October 29, 2022 (less discount of $27,191 and $273,726 as of September 30, 2022 and December 31, 2021, respectively) (the 8% Note and the October 8% Notes) (in default)		622,809		376,274
8% convertible notes payable due September 30, 2023 (the October 8% Notes)		500,000		500,000
8% Convertible promissory notes payable due September 15, 2022 (the June 2022 Note) (in default)		350,000		—
8% convertible note payable due October 29, 2022 (the 8% Note) (in default)		100,000		100,000
8% Convertible promissory notes payable due June 29, 2022 (the May 2022 Notes) (in default)		312,500		—
8% convertible note payable due October 29, 2022 (the Second 8% Note) (in default)		50,000		50000
Total notes payable		1,313,974		404,939
8% Convertible promissory notes payable due September 15, 2022 (the June 2022 Note) (in default)		350,000		350,000
8% Convertible promissory notes payable due September 30, 2023 (the May 2022 Notes)		266,204		312,500
Total notes payable		1,294,869		1,341,165
Less: Long-term portion		28,665		28,665
Notes payable, short-term	$	1,~~285~~266,~~309~~204	$	~~376~~1,~~274~~312,500

Debt obligations become due and payable as follows:

Schedule of Debt Obligations Maturities

Years ended	Principal balance due
2022 (October 1, 2022 through December 31, 2022)	$	1,285,309
2023	$	1,266,204
2023		—
2024		—
2025		—
2026		28,665
2027		—
Total	$	1,313,974
2028		—
Total	$	1,294,204

3% Convertible Notes Payable due March 30, 2026

On March 31, 2021, the Company entered into Debt Settlement Agreements with six creditors (five of which were related parties) which extinguished accounts payable and accrued liabilities totaling $2,866,497 in exchange for the issuance of $28,665 in principal balance of 3% convertible notes payable (the “3% Notes”) with detachable warrants to purchase 5,732,994 shares of Common Stock for fifty cents ($0.50) per share (the “3% Note Warrants”). The 3% Notes allow for prepayment at any time with all principal and accrued interest becoming due and payable at maturity on March 30, 2026 (the “Maturity Date”). The 3% Notes are convertible as to principal and any accrued interest, at the option of the holder, into shares of Common Stock at any time after the issue date and prior to the close of business on the business day preceding the Maturity Date at the rate of fifty cents ($0.50) per share, subject to normal and customary adjustment.

An8% ~~aggregate~~Convertible ~~of $2,577,727 of the total accounts payable and accrued liabilities that were extinguished were with five related parties. Such related parties were issued $25,777 principal balance of the 3%~~ Notes ~~and~~Payable ~~the~~due 3%September ~~Note Warrants to purchase 5~~30,~~155,454 shares~~ ~~of Common Stock in exchange for the extinguishment of their respective debt obligations. See Note 13.~~2023

~~The~~On October 329, 2021, the Company issued to two accredited investors (the “October 8% Note ~~Warrants~~Investors”) ~~were~~unsecured ~~valued~~convertible notes atpayable due October 29, 2022 (the “October 8% Notes”), with an aggregate principal face amount of approximately $500,000. The October 8% Notes are, subject to certain conditions, convertible into an aggregate of 1,~~605~~000,~~178~~000 ~~using~~shares of Common Stock, at a price ~~the~~of ~~Black~~fifty cents ($0.50) per share. The Company also issued five and one half-~~Scholes~~year ~~methodology~~Common Stock purchase warrants to purchase up to 1,500,000 shares of Common Stock at an exercise price of $0.50 per share, subject to customary adjustments (the “October 8% Note Warrants”) which are immediately exercisable. The ~~following~~October ~~assumptions~~8% Note Investors purchased the October 8% Notes and October 8% Note Warrants from the Company for an aggregate purchase price of $500,000 and the proceeds were used infor ~~calculating~~general working capital purposes. The Company also granted the ~~estimated~~October ~~fair~~8% ~~value~~Note Investors certain piggy-back registration rights whereby the Company has agreed to register for resale the shares underlying the October 8% Note Warrants and the conversion of the ~~warrants~~October as8% Notes unless the shares of ~~March~~the Company commences ~~31,~~to ~~2021~~trade on the NYSE American; the Nasdaq Capital Market; the Nasdaq Global Market; the Nasdaq Global Select Market; or the New York Stock Exchange, ~~their~~within ~~date~~one ofhundred ~~issuance:~~twenty (120) days after the closing date.

~~Schedule~~The October 8% Notes all bear interest at a rate of ~~Fair~~eight ~~Value~~percent (8%) per annum, may be voluntarily repaid in cash in full or in part by the Company at any time in an amount equal to 120% of ~~Warrants~~the ~~Estimated~~principal ~~Valuation~~amount ~~Assumptions~~of the underlying notes and any accrued and unpaid interest. Fifty percent (50%) of the 8% Note and the October 8% Notes shall be mandatorily repaid in cash in an amount equal to 120% of the principal amount of the underlying notes and any accrued and unpaid interest in the event of the consummation by the Company of any public or private offering or other financing pursuant to which the Company receives gross proceeds of at least $2,000,000 and one-hundred percent (100%) of the underlying notes plus accrued interest shall be mandatorily repaid in an amount equal to 120% of outstanding principal and interest in cases in which the Company receives gross proceeds of at least $3,000,000. In addition, pursuant to the October 8% Notes, so long as the underlying notes remain outstanding, the Company cannot enter into any financing transactions pursuant to which the Company sells its securities at a price lower than $0.50 cents per share without the written consent of the October 8% Note Investor.

	As of March 31, 2021
Volatility – range		374.0	%
Risk-free rate		0.92	%
Contractual term		5.0 years
Exercise price	$	0.50
Number of warrants in aggregate		5,732,994

20The conversion of the October 8% Notes and the exercise of the underlying warrants are each subject to beneficial ownership limitations such that the October 8% Note Investors may not convert the underlying notes or exercise the underlying warrants to the extent that such conversion or exercise would result in any of the investors being the beneficial owner in excess of 4.99% (or, upon election of the investors, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon such conversion or exercise, which beneficial ownership limitation may be increased or decreased up to 9.99% upon notice to the Company, provided that any increase in such limitation will not be effective until 61 days following notice to the Company.

The Company and the October 8% Note Investors have agreed that for so long as the underlying warrants remain outstanding, the investors have the right to participate in any issuance of Common Stock, conventional debt, or a combination of such securities and/or debt, up to an amount equal to thirty-five percent (35%) of such subsequent financing.

The Company did not pay the principal balance due on the October 8% Notes upon their original maturity on October 29, 2022 and the remaining balance remained due and payable and was therefore in technical default as of December 31, 2022. The Company reached an agreement with the two October 8% Note Investors on January 10, 2023. On January 10, 2023, the Company and the October 8% Note Holders amended each of the notes by entering into a Letter Agreement between the October 8% Note Investors and the Company. The Letter Agreement modifies the terms of the October 8% Notes by extending each note’s respective maturity date to September 30, 2023. In consideration for the extension, the Company amended the Fixed Conversion Price (as defined in each note) to $0.10, subject to any future adjustments as provided in each of the notes.

The Company evaluated the terms of the January 10, 2023 Letter Agreement which amended the October 8% Notes. This evaluation included analyzing whether there are significant and consequential changes to the economic substance of the October 8% Notes based on an analysis of the amended future cash flows. If the change was deemed insignificant (generally less than 10% difference in estimated net present value of future cash flows between the amended notes and the original notes) then the change is considered a debt modification in the financial statements, whereas if the change is considered substantial (generally over 10% difference in estimated net present value of future cash flows between the amended notes and the original notes) then the change is reflected as a debt extinguishment in the financial statements. A modification or an exchange that changes the substantive conversion option as of the conversion date would generally be considered substantial and require extinguishment accounting. The amendment of the Fixed Conversion Price to $0.10 from $0.50 per share, as provided for in the Letter Agreement, would be considered substantive based on the likelihood of the conversion option being exercised in the future. Accordingly, the Company accounted for the amendment of the Notes as an extinguishment of the original Bridge Notes.

Following is an analysis of estimated net present value of future cash flows of the amended notes as compared to the original notes as of January 10, 2023, the date of the amendment:

Schedule of Convertible Debt

	As of January 10, 2023
Carrying value of the original convertible notes payable
Principal balance	$	500,000
Accrued interest		120,753
Total carrying value of original convertible note payable		620,753

Less: Net present value of future cash flows on amended convertible notes payable		(516,776	)

Gain on extinguishment of convertible notes payable	$	103,977

The difference between estimated net present value of future cash flows of the amended notes as compared to the original notes as of January 10, 2023, the date of the amendment exceeded 10%. As a result, the Company recorded a gain on extinguishment of convertible notes payable totaling $103,977 during the three months ended March 31, 2023.

8% Convertible Notes Payable due October 29, 2022 (in default)

On August 30, 2021, the Company issued to an accredited investor (the “8% Note Investor”) an unsecured convertible note due October 29, 2022 (the “8% Note”), with an aggregate principal face amount of approximately $100,000. The 8% Note is, subject to certain conditions, convertible into an aggregate of 200,000 shares of Common Stock, at a price of fifty cents ($0.50) per share. The Company also issued a five and one half-year Common Stock purchase warrant to purchase up to 200,000 shares of Common Stock at an exercise price of fifty cents ($0.50) per share, subject to customary adjustments (the “8% Note Warrant”) which are immediately exercisable. The 8% Note Investor purchased the 8% Note and 8% Note Warrant from the Company for an aggregate purchase price of $100,000 and the proceeds were used for general working capital purposes. The Company also granted the 8% Note Investor certain piggy-back registration rights whereby the Company has agreed to register for resale the shares underlying the 8% Note Warrant and the conversion of the 8% Note unless the shares of the Company commences to trade on the NYSE American; the Nasdaq Capital Market; the Nasdaq Global Market; the Nasdaq Global Select Market; or the New York Stock Exchange, within one hundred twenty (120) days after the closing date.

OnThe ~~October~~8% ~~29,~~Note ~~2021,~~bears ~~the~~interest ~~Company~~at ~~issued~~a torate ~~three~~of ~~accredited~~eight ~~investors~~percent (~~the “October~~ 8% ~~Note Investors”~~) ~~unsecured convertible~~per ~~notes payable due October 29~~annum, ~~2022~~may ~~(the~~be ~~“October~~voluntarily 8%repaid ~~Notes”),~~in ~~with~~cash anin ~~aggregate~~full ~~principal~~or ~~face~~in ~~amount~~part ofby ~~approximately~~the ~~$550,000.~~Company ~~The~~at ~~October~~any 8%time ~~Notes~~in ~~are,~~an ~~subject~~amount equal to ~~certain~~120% ~~conditions,~~of ~~convertible~~the ~~into~~principal anamount ~~aggregate~~ of ~~1,100,000~~ ~~shares~~the ofunderlying ~~Common~~notes ~~Stock,~~and atany aaccrued ~~price~~and ofunpaid ~~fifty~~interest. ~~cents~~Fifty percent (~~$0.~~50%) ~~per~~ ~~share.~~of ~~The~~the ~~Company~~8% ~~also~~Note ~~issued~~shall ~~five~~be ~~and~~mandatorily ~~one~~repaid ~~half-year~~in ~~Common~~cash ~~Stock~~in ~~purchase~~an ~~warrants~~amount toequal ~~purchase up~~ to ~~1,650,000 shares~~120% of ~~Common~~the ~~Stock~~principal atamount anof ~~exercise~~the ~~price~~underlying ofnotes ~~$0.50~~and ~~per~~any ~~share,~~accrued ~~subject~~and tounpaid ~~customary~~interest ~~adjustments~~in (the ~~“October~~event 8%of ~~Note~~the ~~Warrants”)~~consummation ~~which~~by ~~are~~the ~~immediately~~Company ~~exercisable.~~of ~~The October~~any 8%public ~~Note~~or ~~Investors~~private ~~purchased~~offering ~~the~~or ~~October~~other 8%financing pursuant ~~Notes~~to ~~and~~which ~~October 8% Note Warrants from~~ the Company ~~for~~receives angross ~~aggregate~~proceeds ~~purchase price~~ of at least $~~550~~2,000 ,000 and ~~the~~one-hundred ~~proceeds~~percent ~~were~~(100%) ~~used~~of ~~for~~the ~~general~~underlying ~~working~~notes ~~capital purposes. The~~plus ~~Company~~accrued ~~also~~interest ~~granted~~shall ~~the~~be ~~October~~mandatorily 8%repaid ~~Note~~in ~~Investors~~an ~~certain~~amount ~~piggy-back~~equal ~~registration~~to ~~rights~~120% ~~whereby~~of ~~the~~outstanding ~~Company~~principal ~~has~~and ~~agreed~~interest toin ~~register for~~cases ~~resale~~in which the ~~shares~~Company receives ~~underlying~~gross ~~the~~proceeds ~~October~~of 8%at ~~Note~~least ~~Warrants~~$3,000,000. ~~and~~In ~~the~~addition, ~~conversion~~pursuant ofto the ~~October~~ 8% ~~Notes~~Note, ~~unless~~so ~~the~~long ~~shares~~as of the ~~Company~~ ~~commences~~underlying tonotes ~~trade~~remain on outstanding, the ~~NYSE~~Company ~~American;~~cannot ~~the~~enter ~~Nasdaq~~into ~~Capital~~any ~~Market;~~financing ~~the~~transactions ~~Nasdaq~~pursuant ~~Global~~to ~~Market;~~which the ~~Nasdaq~~Company ~~Global~~sells ~~Select Market;~~its orsecurities ~~the~~at ~~New~~a ~~York~~price ~~Stock~~lower ~~Exchange,~~than ~~within~~$0.50 cents ~~one~~per ~~hundred~~share ~~twenty~~without ~~(120)~~the ~~days~~written ~~after~~consent of the ~~closing~~8% ~~date~~Note Investor.

The 8%conversion ~~Note~~of ~~and~~ the ~~October~~ 8% ~~Notes~~Note ~~all~~and ~~bear~~the ~~interest~~exercise ~~at a rate~~ of ~~eight~~the ~~percent~~underlying ~~(8%)~~warrants ~~per~~are ~~annum,~~each ~~may~~subject beto ~~voluntarily~~beneficial ~~repaid~~ownership inlimitations ~~cash~~such ~~in full~~that ~~or in part by~~ the ~~Company at any time in an amount equal to 120~~8% ofNote ~~the~~Investor ~~principal~~may ~~amount~~not ofconvert the underlying notes ~~and~~or ~~any~~exercise ~~accrued and unpaid interest. Fifty percent (50%) of~~ the 8%underlying ~~Note~~warrants ~~and~~to the ~~October~~extent 8%that ~~Notes~~such ~~shall~~conversion beor ~~mandatorily~~exercise would ~~repaid~~result in ~~cash~~any ~~in an amount equal to 120%~~ of the ~~principal~~investors ~~amount~~being of the ~~underlying~~beneficial ~~notes~~owner ~~and any accrued and unpaid interest~~ in ~~the~~excess ~~event~~ of ~~the~~4.99% ~~consummation~~(or, byupon ~~the~~election ~~Company~~ of ~~any public or private offering or other financing pursuant to which~~ the ~~Company receives gross proceeds of at least $2~~investors,~~000,000~~ ~~and one-hundred percent (100~~9.99%) of the number ~~underlying~~of ~~notes~~shares ~~plus~~of ~~accrued~~the ~~interest~~Common ~~shall~~Stock beoutstanding ~~mandatorily~~immediately ~~repaid~~after ingiving aneffect ~~amount equal~~ to ~~120% of outstanding principal and interest in cases in which~~ the ~~Company~~issuance ~~receives~~of ~~gross~~shares ~~proceeds~~ of atCommon ~~least~~Stock ~~$3,000,000.~~issuable ~~In addition, pursuant to the 8%~~upon ~~Note~~such ~~and~~conversion ~~the~~or ~~October 8% Notes~~exercise, sowhich ~~long~~beneficial asownership ~~the~~limitation ~~underlying~~may ~~notes~~be ~~remain~~increased ~~outstanding,~~or ~~the~~decreased ~~Company~~up ~~cannot~~to ~~enter~~9.99% ~~into~~upon ~~any~~notice ~~financing transactions pursuant~~ to ~~which~~ the Company, provided ~~sells~~that ~~its~~any ~~securities~~increase atin asuch ~~price~~limitation ~~lower~~will ~~than~~not ~~$0.50~~be ~~cents~~effective ~~per~~until ~~share~~61 ~~without~~days ~~the~~following ~~written~~notice ~~consent~~to of the ~~8% Note Investor~~Company.

The ~~conversion~~Company ofand the 8% Note ~~and~~Investor ~~the~~have ~~October~~agreed 8%that ~~Notes~~for ~~and~~so ~~the~~long ~~exercise~~as of the underlying warrants ~~are~~remain ~~each~~outstanding, ~~subject to beneficial ownership limitations such that~~ the 8%investors ~~Note~~have ~~Investor and~~ the ~~October 8% Note Investors may not convert the underlying notes or exercise the underlying~~ ~~warrants~~right to ~~the~~participate ~~extent that such conversion or exercise would result~~ in any ofissuance ~~the investors being the beneficial owner in excess~~ of ~~4.99%~~ ~~(or, upon election of the investors, 9.99%) of the number of shares of the~~ Common Stock, ~~outstanding~~conventional ~~immediately~~debt, ~~after~~or ~~giving~~a ~~effect to~~combination ~~the issuance~~ of ~~shares of Common Stock issuable upon~~ such ~~conversion~~securities and/or ~~exercise~~debt, ~~which beneficial ownership limitation may be increased or decreased~~ up to ~~9.99%~~an amount ~~upon~~equal ~~notice~~ to ~~the~~thirty-five ~~Company,~~percent ~~provided~~(35%) ~~that~~of ~~any increase in~~ such ~~limitation~~subsequent ~~will not be effective until 61 days following notice to the Company~~financing.

The Company, the 8% Note Investor and the October 8% Note Investors have agreed that for so long as the underlying warrants remain outstanding, the investors have the right to participate in any issuance of Common Stock, conventional debt, or a combination of such securities and/or debt, up to an amount equal to thirty-five percent (35%) of such subsequent financing.

The underlying notes and warrants contain customary events of default, representations, warranties, agreements of the Company and the investors and customary indemnification rights and obligations of the parties thereto, as applicable.

On May 5, 2023, the Company reached an agreement with the holder of two separate convertible notes payable in the aggregate principal face amount of approximately $450,000 (including $100,000 outstanding principal balance of the 8% Note), which the Company did not pay by their maturity dates. The Company and the holder of the two convertible notes payable entered into a new convertible promissory note (the “New Note”), exchanging the outstanding principal amount of the old convertible notes payable into the New Note, with a maturity date of September 30, 2023. Upon issuance of the New Note, the old convertible notes payable were cancelled and the repayment defaults under the prior convertible notes payable were cured with the entry into the New Note. The conversion price of the New Note was reduced from $0.50 per share to $0.40 per share however, the interest rate and other significant terms of the New Note are the same as those of the prior convertible notes payable.

The Company has accrued default interest aggregating $23,471 and $21,335 as of March 31, 2023 and December 31, 2022, respectively related to the repayment default on this note.

8% Convertible Notes Payable due October 29, 2022 (in default)

On October 29, 2021, the Company issued to an accredited investor (the “Second 8% Note Investor”) an unsecured convertible note payable due October 29, 2022 (the “Second 8% Notes”), with an aggregate principal face amount of approximately $50,000. The Second 8% Note is, subject to certain conditions, convertible into an aggregate of 100,000 shares of Common Stock, at a price of fifty cents ($0.50) per share. The Company also issued five and one half-year Common Stock purchase warrants to purchase up to 150,000 shares of Common Stock at an exercise price of $0.50 per share, subject to customary adjustments (the “Second 8% Note Warrants”) which are immediately exercisable. The Second 8% Note Investor purchased the Second 8% Note and the Second 8% Warrants from the Company for an aggregate purchase price of $50,000 and the proceeds were used for general working capital purposes. The Company also granted the Second 8% Note Investor certain piggy-back registration rights whereby the Company has agreed to register for resale the shares underlying the Second 8% Note Warrants and the conversion of the Second 8% Note unless the shares of the Company commences to trade on the NYSE American; the Nasdaq Capital Market; the Nasdaq Global Market; the Nasdaq Global Select Market; or the New York Stock Exchange, within one hundred twenty (120) days after the closing date.

The Second 8% Note bears interest at a rate of eight percent (8%) per annum, may be voluntarily repaid in cash in full or in part by the Company at any time in an amount equal to 120% of the principal amount of the underlying notes and any accrued and unpaid interest. Fifty percent (50%) of the Second 8% Note shall be mandatorily repaid in cash in an amount equal to 120% of the principal amount of the underlying notes and any accrued and unpaid interest in the event of the consummation by the Company of any public or private offering or other financing pursuant to which the Company receives gross proceeds of at least $2,000,000 and one-hundred percent (100%) of the underlying notes plus accrued interest shall be mandatorily repaid in an amount equal to 120% of outstanding principal and interest in cases in which the Company receives gross proceeds of at least $3,000,000. In addition, pursuant to the Second 8% Note, so long as the underlying notes remain outstanding, the Company cannot enter into any financing transactions pursuant to which the Company sells its securities at a price lower than $0.50 cents per share without the written consent of the Second 8% Note Investor.

The conversion of the Second 8% Note and the exercise of the underlying warrants are each subject to beneficial ownership limitations such that the 8% Note Investor may not convert the underlying notes or exercise the underlying warrants to the extent that such conversion or exercise would result in any of the investors being the beneficial owner in excess of 4.99% (or, upon election of the investors, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon such conversion or exercise, which beneficial ownership limitation may be increased or decreased up to 9.99% upon notice to the Company, provided that any increase in such limitation will not be effective until 61 days following notice to the Company.

The Company, the Second 8% Note Investor have agreed that for so long as the underlying warrants remain outstanding, the investors have the right to participate in any issuance of Common Stock, conventional debt, or a combination of such securities and/or debt, up to an amount equal to thirty-five percent (35%) of such subsequent financing.

The Company has accrued default interest aggregating $11,736 and $10,668 as of March 31, 2023 and December 31, 2022, respectively related to the repayment default on this note.

As described in Note 1, the Company elected to early adopt ASU 2020-06 using the modified retrospective method which enables entities to apply the transition requirements in this ASU at the effective date of ASU 2020-06 (rather than as of the earliest comparative period presented) with the effect of initially adopting ASU 2020-06 recognized as a cumulative-effect adjustment to retained earnings (accumulated deficit) on the first day of the period adopted.

The Company has applied ASU-2020-06 to all outstanding financial instruments as of January 1, 2021, (the date of adoption of ASU 2020-06) and those entered into after January 1, 2021, including the 8% Note. As a result, the 8% Note and October 8% Notes were required to be separated into its debt and equity components based on their relative fair values because of the issuance of detachable warrants together with the 8% Note and the October 8% Notes. Accordingly, the Company allocated the proceeds of the 8% Note as follows:

Schedule of Proceeds from Debt Obligations

	Amount
Proceeds allocated to the 8% 8% Note and the October 8% Notes	$	314,104
Proceeds allocated to detachable warrants to purchase Common Stock		335,896
Total proceeds	$	650,000

The 8% Note and October 8% Notes were recorded at their par value less the discount established at its origination date. The note discount is amortized over the term of the convertible note utilizing the level-interest method. The following are the assumptions used in calculating the estimated grant-date fair value of the detachable warrants to purchase Common Stock granted in connection with the 8% Note and the October 8% Notes in August and October of 2021:

Schedule of Fair Value of Detachable Warrants to Purchase Common Stock Granted

	As of August 30, 2021 (issuance date)			As of October 30, 2021 (issuance date)
Volatility – range		369.4	%		367.7	%
Risk-free rate		0.77	%		1.18	%
Contractual term		5.5 years			5.5 years
Exercise price	$	0.50		$	0.50
Number of warrants in aggregate		200,000			1,650,000

The following is a summary of activity relative to the 8% Note and October 8% Notes for the nine months ended September 30, 2022:

Schedule of Convertible Debt

	Amount
Balance December 31, 2021 – 8% Note and October 8% Notes	$	376,274
Amortization of discount during the period to interest expense		246,535
Balance September 30, 2022 - 8% Note and October 8% Notes	$	622,809

The remaining unamortized discount relative to the 8% Notes and the October 8% Notes was $27,191 and $273,726 as of September 30, 2022 and December 31, 2021 respectively.

The Company did not pay the principal balance due on the 8% Notes and the October 8% Notes upon their maturity on October 29, 2022 and the remaining balance remains due and payable and is therefore in technical default. The parties are negotiating a resolution to such technical default including an extension and a roll-over of the principal into other Company securities, although there can be no assurance that the parties will reach a mutually agreeable resolution.

8% Convertible Notes Payable due September 15, 2022 (in default)

On June 8, 2022, the Company issued to an accredited investor an unsecured convertible note due September 15, 2022 (the “June 2022 Note”), with an aggregate principal face amount of $350,000. The June 2022 Note is, subject to certain conditions, convertible into an aggregate of 700,000 shares of Common Stock, at a price of fifty cents ($0.50) per share. The Company also issued a five-year Common Stock purchase warrant to purchase up to 700,000 shares of Common Stock at an exercise price of fifty cents ($0.50) per share, subject to customary adjustments (the “June 2022 Warrants”) which are immediately exercisable. The investor purchased the June 2022 Note and June 2022 Warrant from the Company for an aggregate purchase price of $350,000 and the proceeds were used for drilling and completion costs on the initial well drilled under the Hugoton Gas Field participation agreement and general working capital purposes. The Company also granted the investor certain piggy-back registration rights whereby the Company has agreed to register for resale the shares of Common Stock underlying the June 2022 Warrant and the conversion of the June 2022 Note unless the shares of the Company commence to trade on the NYSE American; the Nasdaq Capital Market; the Nasdaq Global Market; the Nasdaq Global Select Market; or the New York Stock Exchange, within one hundred twenty (120) days after the closing date.

The June 2022 Note bears interest at a rate of eight percent (8%) per annum, may be voluntarily repaid in cash in full or in part by the Company at any time in an amount equal to the remaining principal amount of the underlying note and any accrued and unpaid interest.

~~The~~On ~~Company~~May ~~has~~5, ~~applied~~2023, ~~ASU-2020-06~~the toCompany ~~all~~reached ~~outstanding~~an ~~financial~~agreement ~~instruments~~with asthe holder of ~~January~~two 1,separate ~~2021~~convertible (notes payable in the ~~date~~aggregate ofprincipal ~~adoption~~face amount of ~~ASU~~approximately ~~2020-06~~$450,000 (including the June 2022 Note) , which the Company did not pay by their maturity dates. The Company and the ~~those~~holder of the two convertible notes payable entered into ~~after~~a ~~January~~new 1convertible promissory note (the “New Note”), ~~2021~~exchanging the ~~including~~outstanding principal amount of the ~~June~~old ~~2022~~convertible notes payable into the New Note., Aswith a ~~result~~maturity date of September 30, ~~the~~2023. Upon ~~June~~issuance ~~2022~~of the New Note, ~~was~~the ~~required~~old toconvertible benotes ~~separated into~~payable ~~its~~were ~~debt~~cancelled and ~~equity~~the ~~components~~repayment ~~based~~defaults onunder ~~their~~the ~~relative~~prior ~~fair~~convertible notes ~~values~~payable ~~because~~were ofcured with the ~~issuance~~entry ofinto ~~detachable~~the ~~warrants~~New ~~together~~Note. ~~with the~~The ~~June~~conversion ~~2022~~price of the New Note was reduced from $0.50 ~~Accordingly~~per share to $0.40 per share however, the ~~Company~~interest ~~allocated~~rate ~~the~~and ~~proceeds~~other significant terms of the ~~June~~New 22 Note are the same as ~~follows:~~those of the prior convertible notes payable.

~~Schedule~~The Company has accrued default interest aggregating $15,112 and $8,208 as of ~~Proceeds~~March ~~from~~31, ~~Debt~~2023 ~~Obligations~~and December 31, 2022, respectively related to the repayment default on these notes.

	Amount
Proceeds allocated to 8% June 2022 Note	$	213,426
Proceeds allocated to detachable warrants to purchase Common Stock		136,574
Total proceeds	$	350,000

8% Convertible Notes Payable due September 30, 2023 (the “May 22 Notes”)

The Company entered into a securities purchase agreement with two accredited investors for the Company’s 8% convertible notes payable due June 29, 2022 ~~Note~~(the ~~was~~“May ~~recorded~~2022 atNotes”), ~~its~~with ~~par~~an ~~value~~aggregate ~~less~~principal ~~the~~amount ~~discount~~of ~~established~~$850,000. The May 2022 Notes are, subject to certain conditions, convertible into an aggregate of 2,125,000 shares of Common Stock, at ~~its~~a ~~origination~~price ~~date~~of forty cents ($0.40) per share. The ~~note~~Company ~~discount~~also isissued ~~amortized~~an ~~over~~aggregate of 425,000 shares of Common Stock as commitment shares (“Commitment Shares” and, together with the ~~term~~May of2022 Notes and Conversion Shares, the ~~convertible~~“Securities”) ~~note~~to ~~utilizing~~the investors as additional consideration for the ~~level-interest~~purchase of ~~method~~the May 2022 Notes. The ~~following~~closing ~~are~~of the ~~assumptions~~offering ~~used~~of inthe ~~calculating~~Securities occurred on May 13, 2022, when the ~~estimated~~investors purchased the Securities ~~grant-date~~for ~~fair~~an ~~value~~aggregate purchase price of $850,000. The Company has also granted the ~~detachable~~Investors ~~warrants~~certain automatic and piggy-back registration rights whereby the Company has agreed to ~~purchase~~register ~~Common~~the ~~Stock~~resale ~~granted~~by inthe ~~connection~~Investors ~~with~~of the ~~June~~Conversion ~~2022~~Shares. ~~Note:~~The proceeds of this offering of Securities were used to purchase the Company’s membership interests in GMDOC.

~~Schedule~~The May 2022 Notes bear interest at a rate of ~~Fair~~eight ~~Value~~percent (8%) per annum, may be voluntarily repaid in cash in full or in part by the Company at any time (subject to the occurrence of ~~Detachable~~an ~~Warrants~~event of default) in an amount equal to ~~Purchase~~120% ~~Common~~of ~~Stock~~the ~~Granted~~principal amount of each May 2022 Note and any accrued and unpaid interest, and shall be mandatorily repaid in cash in an amount equal to a) fifty percent (50%) of the then outstanding principal amount equal to 120% of the principal amount of each May 2022 Note and any accrued and unpaid interest in the event of the consummation by the Company of any public or private offering or other financing pursuant to which the Company receives gross proceeds of at least $2,000,000 but not greater than $3,000,000; or b) one hundred percent (100%) of the then outstanding principal amount equal to 120% of the principal amount of a May 2022 Note and any accrued and unpaid interest in the event of the consummation by the Company of any public or private offering or other financing pursuant to which the Company receives gross proceeds of in excess of $3,000,000. In addition, pursuant to the May 2022 Notes, so long as such May 2022 Notes remain outstanding, the Company shall not enter into any financing transactions pursuant to which the Company sells its securities at a price lower than the $0.40 per share conversion price, subject to certain adjustments, without the written consent of the investors.

	As of June 8, 2022 (issuance date)
Volatility – range		344.7	%
Risk-free rate		3.03	%
Contractual term		5.0 years
Exercise price	$	0.50
Number of warrants in aggregate		700,000

The ~~following~~ isconversion aof ~~summary~~the ofMay ~~activity~~2022 ~~relative~~Notes are each subject to beneficial ownership limitations such that the ~~June~~investors may not convert the May 2022 ~~Note~~Notes ~~for~~to the ~~nine~~extent ~~months~~that ~~ended~~such ~~September~~conversion 30or exercise would result in an investor being the beneficial owner in excess of 4.99% (or, upon ~~2022:~~election of the Investor, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon such conversion, which beneficial ownership limitation may be increased or decreased up to 9.99% upon notice to the Company, provided that any increase in such limitation will not be effective until 61 days following notice to the Company.

~~Schedule~~Pursuant to the purchase agreement for the Securities, for a period of ~~Convertible~~twelve ~~Debt~~(12) months after the closing date, the investors have a right to participate in any issuance of the Company’s Common Stock, Common Stock equivalents, conventional debt, or a combination of such securities and/or debt, up to an amount equal to thirty-five percent (35%) of the subsequent financing.

	Amount
Balance December 31, 2021 – June 2022 Note	$	—
Proceeds allocated to the May 2022 Notes (defined below)		213,426
Principal payments		—
Amortization of discount during the period to interest expense		136,574
Balance September 30, 2022 - June 2022 Notes	$	350,000

The note has matured and therefore the remaining unamortized discount relative to the June 2022 Notes was $-0- as of September 30, 2022. The parties are negotiating a resolution to such technical default including an extension and a roll-over of the principal into other Company securities, although there can be no assurance that the parties will reach a mutually agreeable resolution.

8% Convertible Notes Payable due June 29, 2022 (in default)

The Company entered into a securities purchase agreement with two accredited investors (the “Investors”) for the Company’s 8% convertible notes payable due June 29, 2022 (the “May 2022 Notes”), with an aggregate principal amount of $850,000. The May 2022 Notes are, subject to certain conditions, convertible into an aggregate of 2,125,000 shares of Common Stock, at a price of forty cents ($0.40) per share. The Company also issued an aggregate of 425,000 shares of Common Stock as commitment shares (“Commitment Shares” and, together with the May 2022 Notes and Conversion Shares, the “Securities”) to the Investors as additional consideration for the purchase of the May 2022 Notes. The closing of the offering of the Securities occurred on May 13, 2022, when the Investors purchased the Securities for an aggregate purchase price of $850,000. The Company has also granted the Investors certain automatic and piggy-back registration rights whereby the Company has agreed to register the resale by the Investors of the Conversion Shares. The proceeds of this offering of Securities were used to purchase the Company’s membership interests in GMDOC.

The May 2022 Notes bear interest at a rate of eight percent (8%) per annum, may be voluntarily repaid in cash in full or in part by the Company at any time (subject to the occurrence of an event of default) in an amount equal to 120% of the principal amount of each May 2022 Note and any accrued and unpaid interest, and shall be mandatorily repaid in cash in an amount equal to a) fifty percent (50%) of the then outstanding principal amount equal to 120% of the principal amount of each May 2022 Note and any accrued and unpaid interest in the event of the consummation by the Company of any public or private offering or other financing pursuant to which the Company receives gross proceeds of at least $2,000,000 but not greater than $3,000,000; or b) one hundred percent (100%) of the then outstanding principal amount equal to 120% of the principal amount of a May 2022 Note and any accrued and unpaid interest in the event of the consummation by the Company of any public or private offering or other financing pursuant to which the Company receives gross proceeds of in excess of $3,000,000. In addition, pursuant to the May 2022 Notes, so long as such May 2022 Notes remain outstanding, the Company shall not enter into any financing transactions pursuant to which the Company sells its securities at a price lower than the $0.40 per share conversion price, subject to certain adjustments, without the written consent of the Investors.

The conversion of the May 2022 Notes are each subject to beneficial ownership limitations such that the Investors may not convert the May 2022 Notes to the extent that such conversion or exercise would result in an Investor being the beneficial owner in excess of 4.99% (or, upon election of the Investor, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon such conversion, which beneficial ownership limitation may be increased or decreased up to 9.99% upon notice to the Company, provided that any increase in such limitation will not be effective until 61 days following notice to the Company.

Pursuant to the purchase agreement for the Securities, for a period of twelve (12) months after the closing date, the Investors have a right to participate in any issuance of the Company’s Common Stock, Common Stock equivalents, conventional debt, or a combination of such securities and/or debt, up to an amount equal to thirty-five percent (35%) of the subsequent financing.

The Company also entered into that certain registration rights side letter, pursuant to which, in the event the Company’s shares of Common Stock have not commenced trading on the NYSE American; the Nasdaq Capital Market; the Nasdaq Global Market; the Nasdaq Global Select Market; or the New York Stock Exchange, within one hundred twenty (120) days after the closing date, and, thereafter, the Company agreed to file a registration statement under the Securities Act to register the offer and sale, by the Company, of Common Stock underlying the May 2022 Notes in the event that such notes are not repaid prior to such 120-day period.

The Company paid half of the May 2022 Notes principal balance upon its maturity on June 29, 2022 and an additional $112,500 in September 2022 and the remaining balance remains due and payable and iswas therefore in technical default. ~~The~~as ~~parties are negotiating a resolution to such technical default including an extension and a roll-over~~ of ~~the~~December ~~principal into other Company securities~~31, ~~although there can be no assurance that the parties will reach a mutually agreeable resolution~~2022.

24The Company and the two May 2022 Note Holders reached an agreement on January 10, 2023. On January 10, 2023, the Company amended each of those notes by entering into a Letter Agreement between the investors and the Company. The Letter Agreement modifies the terms of the May 2022 Notes by extending each note’s respective maturity date to September 30, 2023. In consideration for the extension, the Company amended the Fixed Conversion Price (as defined in each note) to $0.10, subject to any future adjustments as provided in each of the notes.

The Company ~~has~~evaluated ~~applied~~the ~~ASU-2020-06~~terms toof ~~all~~the ~~outstanding~~January ~~financial~~10, ~~instruments~~2023 asLetter ofAgreement ~~January~~which 1,amended ~~2021, (~~the ~~date~~May of2022 ~~adoption~~Notes. ofThis ~~ASU~~evaluation ~~2020-06)~~included analyzing ~~and~~whether ~~those~~there ~~entered~~are ~~into~~significant ~~after~~and ~~January~~consequential 1,changes ~~2021~~to ~~including~~the economic substance of the May 2022 Notes based on an analysis of the amended future cash flows. AsIf the change was deemed insignificant (generally less than 10% difference in estimated future cash flows between the amended notes and the original notes) then the change is considered a ~~result~~debt modification in the financial statements, whereas if the change ~~May~~is ~~2022~~considered ~~Notes~~substantial ~~were~~(generally ~~required~~over to10% bedifference ~~separated~~in estimated net present value of future cash flows between the amended ~~into~~notes ~~its~~and the original notes) then the change is reflected as a debt ~~and~~extinguishment ~~equity~~in ~~components~~the ~~based~~financial onstatements. ~~their~~A ~~relative~~modification ~~fair~~or ~~values~~an exchange ~~because~~that changes the substantive conversion option as of the ~~issuance~~conversion date would generally be considered substantial and require extinguishment accounting. The amendment of ~~commitment~~the ~~shares~~Fixed ~~together~~Conversion ~~with~~Price to $0.10 from $0.50 per share, as provided for in the ~~May~~Letter ~~2022~~Agreement, would ~~Notes~~be considered substantive based on the likelihood of the conversion option being exercised in the future. Accordingly, the Company accounted ~~allocated~~for the ~~proceeds~~amendment of the ~~May 2022~~ Notes as ~~follows:~~an extinguishment of the original Bridge Notes.

~~Schedule~~Following is an analysis of ~~Proceeds~~estimated ~~from~~net ~~Debt~~present ~~Obligations~~value of future cash flows of the amended notes as compared to the original notes as of January 10, 2023, the date of the amendment:

	Amount
Proceeds allocated to the May 2022 Notes	$	653,846
Proceeds allocated to Commitment Shares		196,154
Total proceeds	$	850,000

Schedule of Future Cash Flow

The May 2022 Notes were recorded at their par value less the discount established at its origination date. The note discount is amortized over the term of each May 2022 Note (June 29, 2022) utilizing the level-interest method. The following is a summary of activity relative to the May 2022 Notes for the nine months ended September 30, 2022:

	As of January 10, 2023
Carrying value of the original convertible notes payable
Principal balance	$	312,500
Accrued interest		75,471
Total carrying value of original convertible note payable		387,971

Less: Net present value of future cash flows on amended convertible notes payable		(322,986	)

Gain on extinguishment of convertible notes payable	$	64,985

~~Schedule of Convertible Debt~~23

	Amount
Balance December 31, 2021 – May 2022 Notes	$	—
Proceeds allocated to the May 2022 Notes		653,846
Principal payments		(537,500	)
Amortization of discount during the period to interest expense		196,154
Balance September 30, 2022 - May 2022 Notes	$	312,500

The difference between estimated net present value of future cash flows of the amended notes as compared to the original notes as of January 10, 2023, the date of the amendment exceeded 10%. As a result, the Company recorded a gain on extinguishment of convertible notes payable totaling $64,985 during the three months ended March 31, 2023.

~~The~~On ~~remaining~~January ~~unamortized~~13, ~~discount~~2023, ~~relative~~one of the May 22 Note holders exercised its right to convert $46,296 of principal and $3,704 accrued interest into 500,000 shares of common stock. The remaining outstanding principal balance on the two May 2022 Notes ~~were~~totaled $~~-0-~~266,204 asand $312,500 as of ~~September~~March 3031, 2023 and December 31, 2022, respectively.

Note 5 – Accrued liabilities

Accrued liabilities consisted of the following at ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022:

Schedule of Accrued Liabilities

	September 30, 2022		December 31, 2021
	March 31, 2023		December 31, 2022
Accrued rent	$	614,918	$	614,918
Accrued Nicaragua Concession fees		544,485		544,485
Accrued preferred stock dividends payable (see Note 12)		16,061		—
Total accrued liabilities	$	1,159,403	$	1,159,403
Total accrued liabilities	$	1,175,464	$	1,159,403

The accrued rent balances relate to unpaid rent for the Company’s previous headquarters in Denver, Colorado and represents unpaid rents and related costs for the period June 2006 through November 2008. The Company has not had any correspondence with the landlord for several years and will seek to settle and/or negotiate the matter when it has the financial resources to do so.

~~The~~From ~~accrued~~2009 to 2020, the Company had pursued the exploration of potential oil and gas resources in the United States and in the Perlas and Tyra concession blocks in offshore Nicaragua in the Caribbean Sea (the “Concessions”), which contain a total of approximately 1.4 million acres. In January 2020, the Company decided to cease its activities, exploration and production in the Concessions. The accrued Nicaraguan Concession fees were accrued during the time the Concessions had lapsed and the Company was attempting to negotiate ~~extensions~~ extensions to the underlying concessions with the Nicaraguan government which were unsuccessful. The Company abandoned all efforts to ~~negotiate~~ negotiate an extension to the Concessions effective January 1, 2020 and ceased the accrual of all related fees at that time.

Note 6 – Stock Options

Total stock-based compensation is comprised of the following for the three ~~and nine~~ months ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022:

Schedule of Stock-~~based~~Based Compensation

	Three months ended September 30,				Nine months ended September 30,
	Three Months ended March 31,
	2022		2021		2022		2021
	2023		2022
Stock-based compensation – stock option grants	$	—	$	76,~~499~~500	$	~~127,499~~	$	~~101,999~~
Stock-based compensation – restricted stock grants		174,375		81,250		~~511,250~~		~~243,750~~
Stock-based compensation – warrants issued for services pursuant to USNG Letter Agreement (defined below)		71,716		—72,156		~~215,589~~	$	—
Total stock-based compensation	$	246,091	$	~~157~~229,~~749~~906	$	~~854,338~~	$	~~345,749~~

At the Company’s Annual Meeting of Stockholders held on September 25, 2015, the stockholders approved the 2015 Stock Option and Restricted Stock Plan (the “2015 Plan”) and the Company reserved 500,000 shares for issuance under the 2015 Plan. At the Company’s Annual Meeting of Stockholders held on October 13, 2021, the stockholders approved the 2021 Stock Option and Restricted Stock Plan (the “2021 Plan”) and the Company reserved 5,000,000 shares for issuance under the 2021 Plan.

The 2021 Plan and the 2015 Plan provide for under which both incentive and non-statutory stock options may be granted to employees, officers, non-employee directors and consultants. An aggregate of 5,500,000 shares of the Company’s Common Stock is reserved for issuance under the 2021 Plan and the 2015 Plan. Options granted under the 2021 Plan and 2015 Plan allow for the purchase of shares of Common Stock at prices not less than the fair market value of such stock at the date of grant, become exercisable immediately or as directed by the Company’s Board of Directors and generally expire ten years after the date of grant. The Company has issued stock options and restricted stock awards that are not pursuant to a formal plan with terms similar to the 2021 and 2015 Plans.

As of ~~September~~March 3031, ~~2022~~2023, 5,500,000 shares were available for future grants under the 2021 Plan and the 2015 Plan.

The fair value of each option award is estimated on the date of grant using the Black-Scholes option-pricing model, which requires the input of subjective assumptions, including the expected term of the option award, expected stock price volatility and expected dividends. These estimates involve inherent uncertainties and the application of management judgment. For purposes of estimating the expected term of options granted, the Company aggregates option recipients into groups that have similar option exercise behavioral traits. Expected volatilities used in the valuation model are based on the expected volatility based on historical volatility. The risk-free rate for the expected term of the option is based on the U.S. Treasury yield curve in effect at the time of grant. The Company’s forfeiture rate assumption used in determining its stock-based compensation expense is estimated based on historical data. The actual forfeiture rate could differ from these estimates. ~~There were 1,800,000 options granted during June 2021.~~

Stock option grants

The following table summarizes stock option activity for the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022:

Summary of Stock Option Activity

	Number of Options			Weighted Average Exercise Price Per Share			Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value
Outstanding at December 31, 2020		332,000		$	41.86			1.28 years	$	—
Granted		1,800,000			0.50
Exercised		—			—
Forfeited		(115,000	)		(64.24	)
Outstanding at September 30, 2021		2,017,000		$	3.67			8.75 years	$	—
Outstanding and exercisable at September 30, 2021		217,000		$	30.00			1.03 years	$	—
Outstanding at December 31, 2021		1,892,000		$	1.93			9.07 years	$	—
Granted		—			—
Exercised		—			—
Forfeited		~~(450,000~~—	)		~~0.50~~—
Outstanding at September 30, 2022		1,442,000		$	2.38			8.21 years	$	—
Outstanding at March 31, 2022		1,892,000		$	1.93			8.82 years	$	—
Outstanding and exercisable at September 30, 2022		1,442,000		$	2.38			8.21 years	$	—
Outstanding and exercisable at March 31, 2022		92,000		$	30.00			1.79 years	$	—
Outstanding at December 31, 2022		1,442,000		$	2.38			7.96 years	$	—
Granted		—			—
Exercised		—			—
Forfeited		—			—
Outstanding at March 31, 2023		1,442,000		$	2.38			7.71 years	$	—
Outstanding and exercisable at March 31, 2023		1,442,000		$	2.38			7.71 years	$	—

The following table summarizes the range of exercise prices and weighted average remaining contractual life for outstanding and exercisable options under the Company’s option plans as of September 30, 2022:25

~~Summary~~The following table summarizes the range of ~~Exercise~~exercise ~~Prices~~prices and ~~Weighted~~weighted ~~Average~~average ~~Remaining~~remaining ~~Contractual~~contractual ~~Life~~ life for outstanding and exercisable options under the Company’s option plans as of March 31, 2023:

		Outstanding options				Exercisable options
Exercise price per share		Number of options		Weighted average remaining contractual life		Number of options		Weighted average remaining contractual life
$	0.50		1,350,000		8.68 years		1,350,000		8.68 years
$	30.00		92,000		1.28 years		92,000		1.28 years
	Total		1,442,000		8.21 years		1,442,000		8.21 years

The following is the assumptions used in calculating the estimated grant-date fair value of the stock options granted during 2021:

		Outstanding options				Exercisable options
Exercise price per share		Number of options		Weighted average remaining contractual life		Number of options		Weighted average remaining contractual life

$	0.50		1,350,000		8.18 years		1,350,000		8.18 years
$	30.00		92,000		0.79 years		92,000		0.79 years

	Total		1,442,000		7.71 years		1,442,000		7.71 years

~~Schedule~~There were no stock options granted during the three months ended March 31, 2023 and 2022. The Company recorded stock-based compensation expense in connection with the vesting of ~~Stock~~stock ~~Option~~options ~~Valuation~~granted ~~Assumption~~aggregating $-0- and $76,500 for the three months ended March 31, 2023 and 2022, respectively.

	As of June 4, 2021 (issuance date)
Volatility – range		286.6	%
Risk-free rate		1.56	%
Contractual term		10.0 years
Exercise price	$	0.50
Number of options in aggregate		1,800,000

The intrinsic value as of March 31, 2023 and December 31, 2022 related to the vested and unvested stock options as of that date was $-0-. There is no unrecognized compensation cost as of March 31, 2023 related to the unvested stock options as of that date.

The Company recorded stock-based compensation expense in connection with the vesting of stock options granted aggregating $-0- and $76,499 for the three months ended September 30, 2022 and 2021, respectively, and $127,499 and $101,999 for the nine months ended September 30, 2022 and 2021, respectively.

The total grant date fair value of the 1,800,000 stock options issued during 2021 was $305,997 in total or $0.17 per share and there were no stock options granted during the nine months ended September 30, 2022.

The intrinsic value as of September 30, 2022 related to the vested and unvested stock options as of that date was $-0-. There is no unrecognized compensation cost as of September 30, 2022 related to the unvested stock options as of that date.

Restricted stock grants.

During May 2022, the Board of Directors granted 1,550,000 shares of restricted stock awards to our officers, directors and consultants. In addition, during August 2020 the Board of Directors granted 5,000,000 shares of restricted stock awards to our officers, directors and a consultant. Restricted stock awards are valued on the date of grant and have no purchase price for the recipient. Restricted stock awards typically vest over a period of time generally corresponding to yearly anniversaries of the grant date. Unvested shares of restricted stock awards may be forfeited upon the termination of service of employment with the Company, depending upon the circumstances of termination. Except for restrictions placed on the transferability of restricted stock, holders of unvested restricted stock have full stockholder’s rights, including voting rights and the right to receive cash dividends.

A summary of all restricted stock activity under the equity compensation plans for the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022 is as as follows:

	Number of restricted shares			Weighted average grant date fair value
Nonvested balance, December 31, 2020		3,750,000		$	0.13
Nonvested balance, December 31, 2021		1,250,000		$	0.13
Granted		—			—
Vested		(1625,~~875,~~000	)		(0.13	)
Forfeited		—			—
Nonvested balance, September 30, 2021		1,875,000		$	0.13
Nonvested balance, March 31, 2022		625,000		$	0.13
Nonvested balance, December 31, 2021		1,250,000		$	0.13
Nonvested balance, December 31, 2022		387,500		$	0.45
Granted		~~1,550,000~~—			~~0.45~~—
Vested		(2387,~~025,000~~500	)		(0.2545	)
Forfeited		—			—
Nonvested balance, September 30, 2022		775,000		$	0.45
Nonvested balance, March 31, 2023		—		$	—

The Company recorded stock-based compensation expense in connection with the issuance/vesting of restricted stock grants aggregating $174,375 and $81,250 during the three months ended September 30, 2022 and 2021, respectively, and $511,250 and $243,750 during the nine months ended September 30, 2022 and 2021, respectively.26

The Company ~~estimated~~recorded ~~the fair market value of these restricted~~ stock ~~grants~~ -based oncompensation ~~the~~expense ~~closing~~in ~~market~~connection ~~price~~with on the ~~date~~issuance/vesting of ~~grant.~~restricted Asstock ~~of September~~grants ~~30,~~aggregating ~~2022~~$174,375 and ~~there were~~ $~~348~~81,~~750~~250 ofduring ~~total unrecognized compensation costs related to all remaining non-vested restricted stock grants, which will be amortized over~~ the ~~next~~three ~~six~~ months inended ~~accordance~~March ~~with~~31, ~~the~~2023 ~~respective~~and ~~vesting~~2022, ~~scale~~respectively.

The ~~nonvested~~Company ~~balance~~estimated the fair market value of these restricted stock ~~vests~~grants based on the closing market price on the date of grant. As of March 31, 2023, there were $-0- of total unrecognized compensation costs related to all remaining non-vested restricted stock grants as ~~follows:~~all restricted stock granted to date have fully vested.

Schedule of Nonvested Restricted Stock Unit Activity

Years ended	Number of Shares
2022		387,500
2023		387,500

Note 7 – Warrants

The following table summarizes warrant activity for the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022:

Summary of Warrant Activity

	Number of Warrants			Weighted Average Exercise Price Per Share
Outstanding and exercisable at December 31, 2020		1,528,380		$	0.65
Issued in connection with issuance of Series A Convertible Preferred Stock (see Note 12)		5,256,410			0.39
Issued in connection with issuance of 3% Notes (see Note 4)		5,732,994			0.50
Issued in connection with issuance of 8% convertible promissory Note and the October 8% Notes (see Note 4)		200,000			0.50
Forfeited/expired		(47,000	)		(5.22	)
Outstanding and exercisable at September 30, 2021		12,670,784		$	0.45
Outstanding and exercisable at December 31, 2021		17,580,784		$	0.47
Issued in connection with issuance of Series A Convertible Preferred Stock (see Note 12)		2,149,999			0.30
Issued in connection with issuance of 8% Note and October 8% Notes (see Note 4)		700,000			0.50
Forfeited/expired		—			—
Outstanding and exercisable at September 30, 2022		20,430,783		$	0.45
Outstanding and exercisable at March 31, 2022		17,580,784		$	0.47
Outstanding and exercisable at December 31, 2022		20,430,783		$	0.45
Forfeited/expired		—			—
Outstanding and exercisable at March 31, 2023		20,430,783		$	0.45

29The weighted average term of all outstanding Common Stock purchase warrants was 3.5 years as of March 31, 2023. The intrinsic value of all outstanding Common Stock purchase warrants and the intrinsic value of all vested Common Stock purchase warrants was zero as of March 31, 2023 and 2022.

The ~~weighted~~following ~~average~~table ~~term~~summarizes ofthe ~~all~~range ~~outstanding~~of ~~Common~~exercise ~~Stock~~prices ~~purchase~~and ~~warrants~~weighted ~~was~~average ~~4.0~~remaining ~~years~~contractual aslife offor ~~September 30, 2022. The intrinsic value of all~~ outstanding ~~Common~~and ~~Stock purchase~~ exercisable warrants ~~and~~to ~~the intrinsic value of all vested Common Stock~~ purchase ~~warrants~~common ~~was~~shares ~~zero~~ as of ~~September 30,~~March ~~2022 and December~~ 31, ~~2021.~~2023:

~~The~~Summary ~~following~~of ~~table~~Warrant ~~summarizes the~~ range of ~~exercise~~Exercise ~~prices~~Prices and ~~weighted~~Weighted ~~average~~Average ~~remaining~~Remaining ~~contractual~~Contractual ~~life for outstanding and exercisable warrants to purchase common shares as of September 30, 2022:~~Life

Summary of Warrant Range of Exercise Prices and Weighted Average Remaining Contractual Life

		Outstanding and exercisable warrants
Exercise price per share		Number of warrants		Weighted average remaining contractual life
$	0.30		2,149,999		4.8 years
$	0.39		5,256,410		3.5 years
$	0.50		13,024,374		3.3 years

	Total		20,430,783		3.5 years

		Outstanding and exercisable warrants
Exercise price per share		Number of warrants		Weighted average remaining contractual life
$	0.30		2,149,999		5.2 years
$	0.39		5,256,410		4.0 years
$	0.50		13,024,374		3.8 years
	Total		20,430,783		4.0 years

Warrants issued pursuant to USNG Letter Agreement

On November 9, 2021, the Company entered into a letter agreement (the “USNG Letter Agreement”) with U.S. Noble Gas, LLC (“USNG”), pursuant to which USNG provides consulting services to the Company for exploration, testing, refining, production, marketing and distribution of various potential reserves of noble gases and rare earth element/minerals on the Company’s recently acquired 11,000-acre oil and gas properties in the Otis Albert Field located on the Properties. The USNG Letter Agreement would cover all of the noble gases, specifically including helium, and rare earth elements/minerals potentially existing on Properties and the Company’s future acquisitions, if any, including the Hugoton Gas Field.

The USNG Letter Agreement also provides that USNG will supply a large vessel designed for flows up to 5,000 barrels of water per day at low pressures, known as a gas extraction/separator unit. The gas extraction/separator unit is a dewatering vessel that the Company may use for multiple wells in the future.

The USNG Letter Agreement requires the Company to establish a four-member board of advisors (the “Board of Advisors”) comprised of various experts involved in noble gas and rare earth elements/minerals. The Board of Advisors will help attract both industry partners and financial partners for developing a large helium, noble gas and/or rare earth element/mineral resources that may exist in the region where the Company currently operates. The industry partners would include helium, noble gas and/or rare earth element/mineral purchasers and exploration and development companies from the energy industry. The financial partners may include large family offices or small institutions.

Pursuant to the USNG Letter Agreement, the Company will pay USNG a monthly cash fee equal to $8,000 per month beginning at the onset of commercial helium or minerals production and sales, subject to certain thresholds. Such monthly fees will become due and payable for any month that the Company receives cash receipts in excess of $25,000 derived from the sale of noble gases and/or rare earth elements/minerals. The Company has not yet achieved the $25,000 cash receipts threshold, therefore, there has been no payment or accrual liability relative to this cash fee provision as of ~~September~~March 3031, 2023 and December 31, 2022.

The USNG Letter Agreement has an initial term of 5 years, which shall thereafter continue for successive one-year periods, provided that there is no uncured breach, unless otherwise terminated by either party upon a written notice of intent to non-renew.

In consideration for the consulting services to be rendered and pursuant to the terms of the USNG Letter Agreement, the Company issued warrants to purchase, in the aggregate, 2,060,000 shares of its Common Stock at an exercise price of fifty cents ($0.50) to three of USNG’s principal consultants and four third-party service providers. The Company issued warrants to purchase, in the aggregate, 1,200,000 shares of Common Stock at fifty cents ($0.50) per share exercise price to three members of the Board of Advisors. The Company granted a total of 3,260,000 warrants to purchase its Common Stock with an exercise price of fifty cents ($0.50) per share in connection with the USNG Letter Agreement and the arrangements described therein. The warrants expire five years after the date of the USNG Letter Agreement.

The fair value of the warrants to purchase Common Stock in consideration for services to be rendered under the USNG Letter Agreement with USNG is estimated on the date of grant using the Black-Scholes option-pricing model, which requires the input of subjective assumptions, including the expected term of the warrant, expected stock price volatility and expected dividends. These estimates involve inherent uncertainties and the application of management judgment. For purposes of estimating the expected term of warrants granted, the Company considered the historical pattern of warrant exercises behavioral traits and determined that the expected term should be 5 years. Expected volatilities used in the valuation model are based on the expected volatility based on historical volatility. The risk-free rate for the expected term of the option is based on the U.S. Treasury yield curve in effect at the time of grant. The Company’s forfeiture rate assumption used in determining its stock-based compensation expense is estimated based on historical data. The actual forfeiture rate could differ from these estimates.

The following are the assumptions used in calculating the estimated grant-date fair value of the warrants issued pursuant to the USNG Letter Agreement granted on November 9, 2021:

Schedule of ~~Warrants~~Warrant Valuation Assumption

	As of November 9, 2021 (issuance date)

Volatility – range		359.3	%
Risk-free rate		1.08	%
Expected term		5.0 years
Exercise price	$	0.50
Number of warrants in aggregate		3,260,000

The Company recognized $71,716 and $~~215~~72,~~589~~156 of compensation expense relative to the 3,260,000 warrants to purchase Common Stock issued pursuant to the USNG Letter Agreement during the three ~~and nine~~ months ended ~~September~~March 3031, 2023 and 2022, respectively. There have been no exercises or ~~forfeitures~~ forfeitures of the warrants to purchase Common Stock relative to the USNG Letter during the ~~nine~~three months ended ~~September~~March 3031, ~~2022.~~2023 ~~The USNG warrants were not outstanding during the three~~ and ~~nine months ended September 30, 2021~~2022.

The total grant date fair value of the 3,260,000 warrants to purchase Common Stock issued pursuant to the USNG Letter Agreement on November 9, 2021 was $1,434,313 in total or $0.44 per share. Total unrecognized compensation costs related to the 3,260,000 warrants to purchase Common Stock issued pursuant to the USNG Letter Agreement, as of ~~September~~March 3031, ~~2022~~2023 was $1,~~171~~027,~~354~~923 which will be amortized over the next forty-~~nine~~three months.

Note 8 – Income Taxes

The effective income tax rate on income (loss) before income tax benefit varies from the statutory federal income tax rate primarily due to the net operating loss history of the Company maintaining a full reserve on all net deferred tax assets during the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022.

The Company has incurred operating losses in recent years, and it continues to be in a three-year cumulative loss position at March 31, 2023. Accordingly, the Company determined there was not sufficient positive evidence regarding its potential for future profits to outweigh the negative evidence of our three-year cumulative loss position under the guidance provided in ASC 740. Therefore, it determined to continue to provide a 100% valuation allowance on its net deferred tax assets. The Company expects to continue to maintain a full valuation allowance until it determines that it can sustain a level of profitability that demonstrates its ability to realize these assets. To the extent the Company determines that the realization of some or all of these benefits is more likely than not based upon expected future taxable income, a portion or all of the valuation allowance will be reversed.

~~The~~For ~~Company~~income ~~has~~tax ~~incurred operating losses in recent years~~purposes, ~~and~~the itCompany ~~continues~~has tonet beoperating inloss ~~a three~~carry-~~year~~forwards ~~cumulative~~of ~~loss~~approximately ~~position at September 30~~$64, ~~2022. Accordingly~~710,000 ~~the~~in ~~Company~~accordance ~~determined~~with ~~there was not sufficient positive evidence regarding~~ its ~~potential~~2021 ~~for~~Federal Income ~~future~~tax ~~profits~~return toas ~~outweigh the~~filed. ~~negative~~Approximately ~~evidence~~$61,045,000 of ~~our~~such ~~three-year~~net ~~cumulative~~operating loss ~~position~~carry-forwards ~~under~~expire ~~the~~from ~~guidance~~2028 ~~provided~~through in2037 ~~ASC~~while ~~740. Therefore~~$1, ~~it determined to~~935,000 ~~continue~~of tosuch ~~provide~~net aoperating ~~100%~~loss ~~valuation~~carry-forwards ~~allowance~~have onan ~~its~~indefinite ~~net~~carryforward ~~deferred~~period ~~tax~~in ~~assets.~~accordance ~~The~~with ~~Company~~the ~~expects~~Tax toCuts ~~continue~~and toJobs ~~maintain~~Act. aIn ~~full valuation~~addition, ~~allowance~~the ~~until~~Tax itCuts ~~determines~~and ~~that~~Jobs itAct ~~can~~limits ~~sustain~~the ausage ~~level~~ of ~~profitability~~net ~~that~~operating ~~demonstrates~~loss ~~its~~carryforwards ~~ability~~ to ~~realize~~80% ~~these assets. To the extent the Company determines that the realization~~ of ~~some or all of these benefits is more likely than not based upon expected future~~ taxable income, aper ~~portion or all of the valuation allowance will be reversed~~year.

~~For~~The ~~income tax purposes, the~~ Company has ~~net~~recently ~~operating~~completed ~~loss~~the ~~carry-forwards~~filing of ~~approximately $62,980,000 in accordance with~~ its ~~2021 federal income~~ tax ~~return~~returns asfor ~~filed.~~the ~~Approximately~~tax ~~$61,045,000 of~~years ~~such~~2012 ~~net operating loss carry-forwards expire from 2028~~ through ~~2037~~2021. ~~while $1~~Therefore,~~935,000 of~~ all such ~~net~~tax ~~operating~~returns ~~loss carry-forwards have an indefinite carryforward period in accordance with the Tax Cuts and Jobs Act of 2017, as amended (the “Tax Cuts and Jobs Act”). In~~are ~~addition,~~open ~~the~~to ~~Tax~~examination ~~Cuts~~by ~~and Jobs Act limits~~ the ~~usage~~Internal ofRevenue ~~net operating loss carryforwards to 80% of taxable income per year~~Service.

The Internal ~~Company~~Revenue ~~has~~Code ~~completed~~contains ~~the~~provisions ~~filing~~under ofSection ~~its~~382 ~~federal~~which ~~income~~limit ~~tax~~a ~~returns~~company’s ability to utilize net operating loss carry-forwards ~~for~~in ~~all~~the ~~tax~~event ~~years~~that ~~through~~it ~~2021~~has experienced a more than 50% change in ownership over a three-year period. ~~The~~Management ~~Federal~~has ~~income~~completed ~~tax~~its ~~returns~~review of ~~for~~whether ~~the~~such ~~years~~ownership ~~2012~~changes ~~through~~have ~~2021~~occurred, ~~remain~~and ~~open~~based upon such review, management believes that the Company is not currently subject to ~~examination~~an byannual limitation or the Upossibility of the complete elimination of the net operating loss carry- forwards.S. ~~Internal~~In ~~Revenue~~addition, ~~Service~~the Company may be limited by additional ownership changes which may occur in the future.

The Internal Revenue Code of 1986, as amended, contains provisions under Section 382 which limit a company’s ability to utilize net operating loss carry-forwards in the event that it has experienced a more than 50% change in ownership over a three-year period. Management has completed its review of whether such ownership changes have occurred, and based upon such review, management believes that the Company is not currently subject to an annual limitation or the possibility of the complete elimination of the net operating loss carry-forwards. In addition, the Company may be limited by additional ownership changes which may occur in the future.29

Note 9 – Gain on ~~Exchange and~~ Extinguishment of ~~Liabilities~~Convertible Notes Payable

During the three ~~and nine~~ months ended ~~September~~March 3031, ~~2021~~2023 and 2022, the Company recorded gains on the extinguishment of ~~liabilities~~convertible ~~through~~notes ~~the~~payable ~~negotiation~~through ofnegotiation and settlements with certain creditors ~~and through the operation of law~~ as follows:

	2022		2021		2022		2021
	Three months ended March 31,
	Three months ended September 30,				Nine months ended September 30,
	2023		2022
	2022		2021		2022		2021
Gain on extinguishment of convertible notes payable:
Gain (loss) on exchange and extinguishment of liabilities:
Gain on extinguishment of convertible notes payable – the October 8% Notes (See Note 4)	$	103,977	$	—
Gain on exchange and extinguishment of notes payable	$	—	$	—	$	—	$	55,230
Gain on extinguishment of convertible notes payable – the May 22 Notes (see Note 4)		64,985		—
Gain on exchange and extinguishment of liabilities		—		—		—		124,177
Total gain on extinguishment of convertible notes payable	$	168,962	$	—
Gain from settlement of litigation (see Note 12)		—		—		—		23,000
Loss from retirement of convertible note payable (see Note 4)		—		—		—		(115,805	)
Total gain on exchange and extinguishment of liabilities	$	—	$	—	$	—	$	86,602

Gain on exchange and extinguishment of notes payable – On April 1, 2021, the Company and the holders of two notes payable aggregating $85,000 that were in default reached a settlement whereby the Company issued a total of 245,000 shares of Common Stock in exchange for the extinguishment of the outstanding principal, accrued interest and associated Common Stock purchase warrants which totaled $123,830, as of April 1, 2021. The 245,000 shares issued to extinguish the debt obligations resulted in a gain of $55,230 which was recorded in the nine months ended September 30, 2021.

Gain on exchange and extinguishment of liabilities - On March 31, 2021, the Company entered into Debt Settlement Agreements with six creditors (five of which were related parties), which extinguished accounts payable and accrued liabilities totaling $2,866,497 in exchange for the issuance of $28,665 in principal balance of the 3% Notes with the 3% Note Warrants. The 3% Notes allows for prepayment at any time with all principal and accrued interest becoming due and payable at maturity on the Maturity Date. The 3% Notes are convertible as to principal and any accrued interest, at the option of holder, into shares of the Company’s Common Stock at any time after the issue date and prior to the close of business on the business day preceding the Maturity Date at the rate of fifty cents ($0.50) per share, subject to normal and customary adjustment.

An aggregate of $2,577,727 of the total accounts payable and accrued liabilities that were extinguished were with five related parties. Such related parties were issued $25,777 principal balance of the 3% Notes and the 3% Note Warrants in exchange for the extinguishment of their respective debt obligations. The Company recognized a gain on extinguishment of liabilities for the portion of the extinguishment with non-related parties. Furthermore, it recognized the portion of the gain on extinguishment of liabilities with related parties as a contribution of capital.

The gain on extinguishment of liabilities from the Debt Settlement Agreements was determined as follows:

Schedule of Gain on Extinguishment of Liabilities

	Amount
Total accounts payable and accrued liabilities extinguished	$	2,866,497
Less: Principal balance of 3% Notes issued		(28,665	)
Less: Fair value of 3% Note Warrants		(1,605,178	)
Total gain on extinguishment of liabilities	$	1,232,654
Less: Related party amounts reported as a capital contribution		(1,108,477	)
Gain on extinguishment of liabilities	$	124,177

Loss from retirement of convertible note payable - On March 26, 2021, the Company exercised its right to retire a convertible note payable originally issued in August 2020 (the “August 2020 Note”) in conjunction with the issuance of March 2021 Series A Convertible Preferred Stock (see Note 12). In accordance with the prepayment provisions contained in the August 2020 Note, the Company paid all principal, accrued interest and the 15% prepayment premium as follows:

Schedule of Prepayment of Note

	Amount
Principal balance at par	$	365,169
Remaining discount included in principal balance		(44,883	)
Accrued interest		17,448
Prepayment premium (including remaining discount due to early retirement)		115,805
Total payment to retire the August Note	$	453,539

The prepayment premium was charged to non-operating expense as a loss from retirement of convertible note payable during the nine months ended September 30, 2021.

Note 10 – Asset Retirement Obligations

The Company’s asset retirement obligations primarily relate to the Company’s portion of future plugging and abandonment costs for wells and related facilities. The following table presents the changes in the asset retirement obligations for the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022:

	Amount
Asset retirement obligation at December 31, 2020	$	1,716,003
Additions		13,425
Accretion expense during the period		558
Asset retirement obligation at September 30, 2021	$	1,729,986
Asset retirement obligation at December 31, 2021	$	1,730,264
Additions		—
Accretion expense during the period		~~1,004~~279
Asset retirement obligation at September 30, 2022	$	1,731,268
Asset retirement obligation at March 31, 2022	$	1,730,543
Asset retirement obligation at December 31, 2022	$	1,732,486
Additions		—
Accretion expense during the period		1,218
Asset retirement obligation at March 31, 2023	$	1,733,704

~~The~~Approximately $1,716,003 of the total asset retirement obligation existing at ~~December~~March 31, ~~2020~~2023 and inDecember ~~years~~31, ~~prior~~2022 torepresent ~~2020 represented~~ the remaining potential ~~liability~~ liability for oil and gas wells the Company had owned in Texas and Wyoming prior to their sales/disposal in 2012. The Company was not in compliance with then existing federal, state and local laws, rules and regulations for its previously owned Texas and Wyoming domestic oil and gas properties. All domestic oil and gas properties held by Infinity – -Wyoming and Infinity-Texas were disposed of in 2012 and in years prior to 2012; however, the Company may remain liable for certain asset retirement costs should the new owners not complete their asset retirement obligations. Management believes the total asset retirement obligations recorded relative to all the Company wells including these Texas and Wyoming wells of $1,~~716~~733,~~003~~704 and $1,732,486 as of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022, respectively are sufficient to cover any potential noncompliance liabilities relative to the plugging of abandoned wells, the removal of facilities and equipment, and site restoration on oil and gas properties for its current and former oil and gas properties.

The Company assumed a $13,425 asset retirement obligation pursuant to an acquisition on April 1, 2021 and recorded $302 and $882 of accretion expense during the three and nine months ended September 30, 2022, respectively, related to the acquisition of the Properties as further described in Note ~~1. In addition, the Company drilled and completed its first Hugoton Gas Field well which was placed in service~~ in11 ~~August~~– ~~2022.~~Warrant ~~The~~Derivative ~~Company recorded $122 and $122 of accretion expense during the three and nine months ended September 30, 2022, respectively related to the new Hugoton Gas Field well.~~Liability

The estimated fair value of the Company’s derivative liabilities, all of which were related to the detachable warrants issued in connection with Series A Convertible Preferred Stock, were estimated using a closed-ended option pricing model utilizing assumptions related to the contractual term of the instruments, estimated volatility of the price of the Company’s common stock and current interest rates. The detachable warrants issued in connection with the issuance of certain Series A Convertible Preferred Stock (See Note 13 - March 2021 11Issuance) –contained ~~Commitments~~a provision allowing the holder to require cash settlement in certain situations were fundamental transaction, as defined in the warrant agreements have occurred. An event occurred on December 31, 2022 that activated the Holder’s ability to utilize such provisions therefore the related derivative liability was recognized on December 31, 2022 and ~~Contingencies~~also at March 31, 2023.

The following is a summary of the assumptions used in calculating estimated fair value of such derivative liabilities as of the March 31, 2023 and December 31, 2022:

Summary of Warrant Valuation Assumption

	As of March 31, 2023			As of December 31, 2022

Volatility – range		347.7	%		342.2	%
Risk-free rate		3.58	%		3.99	%
Contractual term		3.49 years			3.74 years
Exercise price	$	0.39		$	0.39
Number of warrants in aggregate		5,256,410			5,256,410

The following table provides a summary of the changes in fair value, including net transfers in and/or out, of the derivative financial instruments, measured at fair value on a recurring basis using significant unobservable inputs for both open and closed derivatives:

	Amount
Balance at December 31, 2021	$	—
Unrealized derivative gains included in other income/expense for the period		—
Balance at March 31, 2022	$	—
Balance at December 31, 2022	$	577,269
Unrealized derivative gains included in other income/expense for the period		(367,467	)

Balance at March 31, 2023	$	209,802

Note 12 – Commitments and Contingencies

Lack of Compliance with Law Regarding Domestic Properties

The ~~Company~~ Company was not in compliance with then existing federal, state and local laws, rules and regulations for domestic oil and gas properties ~~owned~~ owned and disposed of in 2012 and in years prior to 2012 and could have a material or significantly adverse effect upon the liquidity, ~~capital~~ capital expenditures, earnings or competitive position of the Company. All domestic oil and gas properties held by Infinity – -Wyoming and Infinity-Texas were disposed of in 2012 and in years prior to 2012; however, the Company may remain liable for certain asset retirement costs should the new owners not complete their obligations. Management believes the total asset retirement obligations recorded for these prior matters of $1,716,003 as of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022 are sufficient to cover any potential noncompliance liabilities relative to the plugging of abandoned wells, the removal of facilities and equipment, and site restoration on oil and gas properties for its former oil and gas properties.

USNG Letter Agreement commitment

Pursuant to the USNG Letter Agreement (see Note 7), the Company will pay USNG a monthly cash fee equal to $8,000 per month beginning at the onset of commercial helium or minerals production and sales, subject to certain thresholds. Such monthly fees will become due and payable for any month that the Company receives cash receipts in excess of $25,000 derived from the sale of noble gases and/or rare earth elements/minerals. The Company has not yet achieved the $25,000 cash receipts threshold, therefore there has been no payment or accrual liability relative to this cash fee provision as of ~~September~~ 30March 31, 2023 and December 31, 2022.

Litigation

The Company is subject to various claims and legal actions in which vendors are claiming breach of contract due to the Company’s failure to pay amounts due. The Company believes that it has made adequate provision for these claims in the accompanying financial statements.

The Company is currently involved in litigation as follows:

● In October 2012, the State of Texas filed a lawsuit naming Infinity-Texas, the Company and the corporate officers of Infinity-Texas, seeking $30,000 of reclamation costs associated with a single well, in addition to administrative expenses and penalties. The Company engaged in negotiations with the State of Texas in late 2012 and early 2013 and reached a settlement agreement that would reduce the aggregate liability, in this action and any extension of this action to other Texas wells, to $45,103, which amount has been paid. Certain performance obligations remain which must be satisfied in order to finally settle and dismiss the matter. Pending satisfactory performance of the performance obligations and their acceptance by the State of Texas, the Company’s officers have potential liability regarding the above matter, and the Company’s officers are held personally harmless by indemnification provisions of the Company. Therefore, to the extent they might actually occur, these liabilities are the obligations of the Company. Management estimates that the liabilities associated with this matter will not exceed $780,000, calculated as $30,000 for each of the 26 Infinity-Texas operated wells. This related liability, less the payment made to the State of Texas in 2012 in the amount of $45,103, is included in the asset retirement obligation on the accompanying balance sheets, which management believes is sufficient to provide for the ultimate resolution of this dispute. ● Cambrian Consultants America, Inc. (“Cambrian”) filed an action in the District Court of Harris County, Texas, number CV2014-55719, on September 26, 2014 against the Company resulting from certain professional consulting services provided for quality control and management of seismic operations during November and December 2013 on the Nicaraguan Concessions. Cambrian provided these services pursuant to a Master Consulting Agreement with the Company, dated November 20, 2013, and has claimed breach of contract for failure to pay amounts due. On December 8, 2014, a default judgment was entered against the Company in the amount of $96,877 plus interest and attorney fees. The Company has included the impact of this litigation as a liability in its accounts payable, which management believes is sufficient to provide for the ultimate resolution of this dispute. ● Torrey Hills Capital, Inc. (“Torrey”) notified the Company by letter, dated August 15, 2014, of its demand for the payment of $56,000, which it alleged was unpaid and owed under a consulting agreement dated October 18, 2013. The parties entered into a consulting agreement under which Torrey agreed to provide investor relations services in exchange for payment of $7,000 per month and the issuance of 15,000 shares of Common Stock. The agreement was for an initial three month-term with automatic renewals unless terminated upon 30 days’ written notice by either party. The Company made payments totaling $14,000 and issued 15,000 shares of Common Stock during 2013. The Company contends that Torrey breached the agreement by not performing the required services and that it had provided proper notice of termination to Torrey. Furthermore, the Company contends that the parties agreed to settle the dispute on or about June 19, 2014 under which it would issue 2,800 shares of Common Stock in full settlement of any balance then owed and final termination of the agreement. Torrey disputed the Company’s contentions and submitted the dispute to binding arbitration. The Company was unable to defend itself and the arbitration panel awarded Torrey a total of $79,594 in damages. The Company has accrued this amount in accounts payable as of September 30, 2022 and December 31, 2021, which management believes is sufficient to provide for the ultimate resolution of this dispute. ● Joseph Ryan (“Ryan”) filed an action in the District Court of Johnson County, Kansas, number 20CV01493, on March 20, 2020 against the Company resulting from certain professional consulting services Ryan alleges he performed for Social, Environmental and Economic Impact Assessments during July 2012 through September 2015 on the Nicaraguan Concessions. Ryan alleges that such services were provided pursuant to oral agreements with the Company. Ryan claims breach of contract for failure to pay $12,000 amounts invoiced and due. On December 23, 2020, Ryan filed a Motion for Default Judgment for $12,000 in unpaid invoices plus legal, fees, statutory interest and any expert testimony fees.

●	Cambrian Consultants America, Inc. (“Cambrian”) filed an action in the District Court of Harris County, Texas, number CV2014-55719, on September 26, 2014 against the Company resulting from certain professional consulting services provided for quality control and management of seismic operations during November and December 2013 on the Nicaraguan Concessions. Cambrian provided these services pursuant to a Master Consulting Agreement with the Company, dated November 20, 2013, and has claimed breach of contract for failure to pay amounts due. On December 8, 2014, a default judgment was entered against the Company in the amount of $96,877 plus interest and attorney fees. The Company has included the impact of this litigation as a liability in its accounts payable, which management believes is sufficient to provide for the ultimate resolution of this dispute.

●	Torrey Hills Capital, Inc. (“Torrey”) notified the Company by letter, dated August 15, 2014, of its demand for the payment of $56,000, which it alleged was unpaid and owed under a consulting agreement dated October 18, 2013. The parties entered into a consulting agreement under which Torrey agreed to provide investor relations services in exchange for payment of $7,000 per month and the issuance of 15,000 shares of Common Stock. The agreement was for an initial three month-term with automatic renewals unless terminated upon 30 days’ written notice by either party. The Company made payments totaling $14,000 and issued 15,000 shares of Common Stock during 2013. The Company contends that Torrey breached the agreement by not performing the required services and that it had provided proper notice of termination to Torrey. Furthermore, the Company contends that the parties agreed to settle the dispute on or about June 19, 2014 under which it would issue 2,800 shares of Common Stock in full settlement of any balance then owed and final termination of the agreement. Torrey disputed the Company’s contentions and submitted the dispute to binding arbitration. The Company was unable to defend itself and the arbitration panel awarded Torrey a total of $79,594 in damages. The Company has accrued this amount in accounts payable as of March 31, 2023 and December 31, 2022, which management believes is sufficient to provide for the ultimate resolution of this dispute.

On February 10, 2021, the parties agreed to a full and complete settlement of the matter with prejudice. The terms of the settlement required the Company to pay a total of $10,000 to extinguish accounts payable to Ryan totaling $33,000. As a result, the Company recorded a $23,000 gain from settlement of litigation during the nine months ended December 31, 2021 (see Note 9).32

Note 1213 – Stockholder’s Deficit

Conversion of 8% Convertible Notes Payable to Common Stock.

On January 13, 2023, a holder of 8% Convertible Notes Payable exercised its right to convert $46,296 of principal and $3,704 of accrued interest into 500,000 shares of common stock.

Series A Convertible Preferred Stock

As of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022, the Company is authorized to issue up to 10,000,000 shares of preferred stock, par value $0.0001 per share.

The following summarizes the activity in Series A Convertible Preferred Stock for the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022:

	Number of Shares
Outstanding at December 31, 2020		—
Issued		22,776
Converted to Common Stock		—
Outstanding at September 30, 2021		22,776
Outstanding at December 31, 2021		22,076
Issued		~~6,450~~—
Converted to Common Stock		(~~3,000~~800	)
Outstanding at September 30, 2022		25,526
Outstanding at March 31, 2022		21,276
Outstanding at December 31, 2022		25,526
Issued		—
Converted to Common Stock		—
Outstanding at March 31, 2023		25,526

On March 16, 2021, the Company approved and filed a Certificate of Designation of Preferences, Rights and Limitations of the Series A Convertible Preferred Stock (“COD”) with the Secretary of State of the State of Delaware. The COD provides for the issuance of up to 27,778 shares of Series A Convertible Preferred Stock with a stated/liquidation value of $100 per share. Pursuant to the provisions of the COD, the Series A Convertible Preferred Stock is convertible, at the option of the holders thereof, at any time, subject to certain beneficial ownership limitations, into shares of Common Stock determined on a per share basis by dividing the $100 stated/liquidation value of such share of Series A Convertible Preferred Stock by the $0.32 per share conversion price, which conversion price is subject to certain adjustments. In addition, the COD provides for the payment of 10% per annum cumulative dividends, in (i) cash, or (ii) shares of Common Stock, to the holders of the Series A Convertible Preferred Stock based on the stated/liquidation value, until the earlier of (i) the date on which the shares of Series A Convertible Preferred Stock are converted to Common Stock or (ii) date the Company’s obligations under the COD have been satisfied in full. The shares of Series A Convertible Preferred Stock also (i) vote on an as-converted to Common Stock basis, subject to certain beneficial ownership limitations, (ii) are subject to mandatory conversion into Common Stock upon the closing of any equity financing transaction consummated after the original issue date, pursuant to which the Company raises gross proceeds of not less than $5,000,000, (iii) rank senior to the Common Stock and any class or series of capital stock created after the Series A Convertible Preferred Stock and (iv) have a special preference upon the liquidation of the Company.

March 2021 Issuance - On March 26, 2021, the Company entered into a securities purchase agreement with five (5) accredited investors providing for an aggregate investment of $2,050,000 by the investors for the issuance by the Company to them of (i) 22,776 shares of Series A Convertible Preferred Stock with a stated/liquidation value of $100 per share (the “March 2021 Series A Convertible Preferred Stock”); and (ii) warrants, with a term of five and a half (5.5) years, exercisable six (6) months after issuance, to purchase an aggregate of up to 5,256,410 shares of Common Stock at an exercise price of thirty-nine ($0.39) per share, subject to customary adjustments thereunder. The March 2021 Series A Convertible Preferred Stock is convertible into an aggregate of up to 7,117,500 shares of Common Stock. Holders of the warrants may exercise them by paying the applicable cash exercise price or, if there is not an effective registration statement for the sale of the shares of Common Stock underlying the warrants within six (6) months following the closing date, as defined in the warrants, by exercising on a cashless basis pursuant to the formula provided in the warrants. Net proceeds from the issuance of March 2021 Series A Convertible Preferred Stock totaled $1,929,089 after deducting the placement agent fee and other expenses of the offering. The Company used the proceeds of the March 2021 Series A Convertible Preferred Stock offering to complete the acquisition and development of the Properties, to pay-off certain outstanding convertible notes payable (see Note 4) and for general working capital purposes.

The Company also entered into that certain registration rights agreement, pursuant to which the Company agreed to file a registration statement within forty-five (45) days following the closing of the acquisition of the Properties, which occurred on April 1, 2021, to register the shares of Common Stock underlying the warrants. The Company is to use its best efforts to cause such registration statement to be declared effective within forty-five (45) days after the filing thereof, but in any event no later than the ninetieth (90^th) calendar day following the closing of the acquisition of the Properties, which occurred on April 1, 2021. The Company completed the required registration of these shares on Form S-1, which the Securities and Exchange Commission declared effective on August 4, 2021.

The holders of the March 2021 Series A Convertible Preferred Stock agreed to a 4.99% beneficial ownership cap that limits the investors’ ability to convert its March 2021 Series A Convertible Preferred Stock and/or exercise its Common Stock purchase warrants. Such limitation can be raised to 9.99% upon 60 days advance notice to the Company.

The Company has accrued ~~and paid~~ preferred dividends totaling $~~154~~47,~~495~~037 and $~~117~~52,~~936~~861 relative to the March 2021 Series A Convertible Preferred ~~Stock~~ Stock which was charged to additional paid in capital during the ~~nine~~three months ended ~~September~~March 3031, 2023 and 2022, respectively. The Company has outstanding accrued and unpaid preferred dividends totaling $91,842 and $44,805 relative to the March 2021 Series A Convertible Preferred Stock as of March 31, 2023 and December 31, 2022, respectively.

The holders of March 2021 Series A Convertible Preferred Stock ~~exercised~~did not exercise their rights to convert aany ~~total~~ of ~~3,000 shares~~the of March 2021 Series A Convertible Preferred Stock into ~~937,500~~ shares of Common Stock during the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023. ~~There~~The ~~were~~holders noexercised ~~conversions~~their rights to convert a total of 800 shares of March 2021 Series A Convertible Preferred Stock into 250,000 shares of Common Stock during the ~~nine~~three months ~~ended~~ ~~September~~ended 30March 31, ~~2021~~2022.

On March 26, 2021, Ozark Capital, LLC (“Ozark”) acquired 1,111 shares of March 2021 Series A Convertible Preferred Stock (convertible into 347,188 shares of Common Stock), together with warrants to acquire 256,410 shares of Common Stock at fifty cents ($0.50) per share for a total cash of $100,000. Ozark ~~Capital, LLC~~ and its affiliates hold over 10% of the shares of the Company’s Common Stock as of ~~September~~March 3031, 2023 and December 31, 2022. ~~Dividends~~Accrued ~~paid~~dividends attributable to Ozark ~~Capital, LLC~~ were $2,~~800~~ 739 and $2,~~800~~ 740 for the three months ended ~~September~~March 3031, ~~2022~~ 2023 and ~~2021,~~2022 respectively. The Company has outstanding accrued and unpaid preferred dividends totaling $85,~~279~~ 540 and $52,~~753 for~~800 relative to the Ozark’s ~~nine~~Series ~~months~~A ~~ended~~Convertible ~~September~~Preferred 30Stock as of March 31, ~~2022~~2023 and ~~2021~~December 31, 2022, respectively.

37All holders of the March 2021 Series A Convertible Preferred Stock, including Ozark, have agreed to a 4.99% beneficial ownership cap that limits the investors’ ability to convert its Series A Convertible Preferred Stock and/or exercise its Common Stock purchase warrants. Such limitation can be raised to 9.99% upon 60 days’ advance notice to the Company.

All holders of the March 2021 Series A Convertible Preferred Stock, including Ozark Capital, LLC, have agreed to a 4.99% beneficial ownership cap that limits the investors’ ability to convert its Series A Convertible Preferred Stock and/or exercise its Common Stock purchase warrants. Such limitation can be raised to 9.99% upon 60 days’ advance notice to the Company.

June 2022 Issuance - On June 15, 2022, the Company entered into a securities purchase agreement with an accredited investor providing for an aggregate investment of $500,000 by the investor for the issuance by the Company of (i) 5,000 shares of Series A Convertible Preferred Stock with a stated/liquidation value of $100 per share (the “June 2022 Series A Convertible Preferred Stock”); and (ii) warrants, with a term of five and a half (5.5) years, exercisable six (6) months after issuance, to purchase an aggregate of up to 1,666,667 shares of Common Stock at an exercise price of thirty cents ($0.30) per share, subject to customary adjustments thereunder. The June 2022 Series A Convertible Preferred Stock is convertible into an aggregate of up to 1,562,500 shares of Common Stock. The holder of the warrants may exercise them by paying the applicable cash exercise price or, if there is not an effective registration statement for the sale of the shares of Common Stock underlying the warrants within six (6) months following the closing date, as defined in the warrants, by exercising on a cashless basis pursuant to the formula provided in the warrant. Net proceeds from the issuance of the June 2022 Series A Convertible Preferred Stock totaled $500,000. The Company used the proceeds of the June 2022 Series A Convertible Preferred Stock offering to pay-off certain outstanding convertible notes payable (see Note 4) and for general working capital purposes.

The Company also entered into that certain registration rights agreement, pursuant to which the Company agreed to file a registration statement within forty-five (45) days following the closing of the of the June 2022 Series A Preferred Stock, which occurred on June 15, 2022, to register the shares of Common Stock underlying the warrants. The Company is to use its best efforts to cause such registration statement to be declared effective within forty-five (45) days after the filing thereof, but in any event no later than the ninetieth (90^th) calendar day following the closing of the offering, which occurred on June 15, 2022.

The holder of the June 2022 Series A Convertible Preferred Stock agreed to a 4.99% beneficial ownership cap that limits the investors’ ability to convert its June 2022 Series A Convertible Preferred Stock and/or exercise its Common Stock purchase warrants. Such limitation can be raised to 9.99% upon 60 days advance notice to the Company.

The Company has accrued preferred dividends totaling $1412,~~658~~329 and $-0- relative to the June 2022 Series A Convertible Preferred Stock which was charged to additional paid in capital during the ~~nine~~three months ended ~~September~~March 3031, 2023 and 2022, respectively. The Company has outstanding accrued and ~~2021~~unpaid preferred dividends totaling $39,589 and $27,260 relative to the June 2022 Series A Convertible Preferred Stock as of March 31, 2023 and December 31, 2022, respectively.

August/September 2022 Issuances – During August and September 2022, the Company entered into a securities purchase ~~agreements~~agreement with three ~~accredited~~ accredited investors providing for an aggregate investment of $145,000 by the investors for the issuance by the Company of (i) 1,450 shares of Series A Convertible Preferred Stock with a stated/liquidation value of $100 per share (the “August/September 2022 Series A Convertible Preferred Stock”); and (ii) warrants, with a term of five and a half (5.5) years, exercisable six (6) months after issuance, to purchase an aggregate of up to 483,332 shares of Common Stock at an exercise price of thirty ($0.30) per share, subject to customary adjustments thereunder. The August/September 2022 Series A Convertible Preferred Stock is convertible into an aggregate of up to 453,125 ~~shares~~ shares of Common Stock. The holders of the warrants may exercise them by paying the applicable cash exercise price or, if there is not an an effective registration statement for the sale of the shares of Common Stock underlying the warrants within six (6) months following the closing date, as defined in the warrants, by exercising on a cashless basis pursuant to the formula provided in the warrant. Net proceeds from the issuance of the August/September 2022 Series A Convertible Preferred Stock totaled $145,000. The Company used the proceeds of the August/September 2022 Series A Convertible Preferred Stock offering to pay-off certain outstanding convertible notes payable (see Note 4) and for general working capital purposes.

The holders of the August/September 2022 Series A Convertible Preferred Stock agreed to a 4.99% beneficial ownership cap that limits the investors’ ability to convert its August/September 2022 Series A Convertible Preferred Stock and/or exercise its Common Stock purchase warrants. Such limitation can be raised to 9.99% upon 60 days advance notice to the Company.

The Company has accrued preferred dividends totaling $13,~~403~~575 and $-0- relative to the August/September 2022 Series A Convertible Preferred Stock which was charged to additional paid in capital during the ~~nine~~three months ended ~~September~~March 3031, 2023 and 2022, respectively. The Company has outstanding accrued and ~~2021~~unpaid preferred dividends totaling $8,634 and $5,059 relative to the August/September 2022 Series A Convertible Preferred Stock as of March 31, 2023 and December 31, 2022, respectively.

38Note 14 – Related Party Transactions

The Company does not have any employees other than its Chief Executive Officer, Chief Operating Officer and Chief Financial Officer. In previous years, certain general and administrative services (for which payment is deferred) had been provided by the Company’s Chief Financial Officer’s accounting firm at its standard billing rates plus out-of-pocket expenses consisting primarily of accounting, tax and other administrative fees. The Company no longer utilizes its Chief Financial Officer’s accounting firm for such support services and was not billed for any such services during the years ended December 31, 2022 and 2021. On March 31, 2021, the parties entered into a Debt Settlement Agreement whereby all amounts due to such firm for services totaling $762,407 were extinguished upon the issuance of $7,624 principal balance of the 3% Notes and the issuance of the 3% Note Warrants as further described in Note 4. Total amounts due to 13the –related ~~Related~~party ~~Party~~was ~~Transactions~~$-0- as of March 31, 2023 and December 31, 2022.

The Company’s Previous Chief Operating Officer was a non-controlling member of Core. On April 1, 2021, we completed the acquisition of the Properties, under the same terms of the Agreement which provided a purchase price of $900,000. The Company raised approximately $2.05 million on March 26, 2021, through the issuance of the March 2021 Series A Convertible Preferred Stock with detachable Common Stock purchase warrants. The funds raised pursuant to the March 2021 Series A Convertible Preferred Stock issuance were used to complete the acquisition of the Properties on April 1, 2021, to retire the outstanding convertible note payable and for working capital purposes.35

The Company ~~does~~had ~~not~~accrued ~~have~~compensation ~~any~~to ~~employees other than~~ its ~~Chief~~officers ~~Executive Officer, Chief Operating Officer~~ and ~~Chief~~directors ~~Financial~~in ~~Officer. In previous~~ years, ~~certain~~prior ~~general~~to ~~and~~2018. ~~administrative~~The ~~services~~Board ~~(for~~of ~~which~~Directors ~~payment~~authorized ~~is deferred) had been provided by~~ the Company’s ~~Chief~~to ~~Financial~~cease ~~Officer’s~~the ~~accounting~~accrual ~~firm at its standard billing rates plus out-~~of~~-pocket~~ ~~expenses~~compensation ~~consisting~~for ~~primarily of accounting, tax and other administrative fees. The Company no longer utilizes~~ its ~~Chief~~officers ~~Financial Officer’s accounting firm for such support services~~ and ~~was~~directors, ~~not~~effective ~~billed~~January ~~for any such services during the years ended December 31~~1, ~~2021 and 2020~~2018. On March 31, 2021, the parties entered into a Debt Settlement ~~Agreement~~Agreements whereby all accrued amounts due tofor such ~~firm for~~ services totaling $~~762~~1,~~407~~789,208 were extinguished upon the issuance of $717,~~624~~892 principal balance of the 3% Notes and the issuance of the 3% Note Warrants as further described in ~~Notes~~Note 4~~, 10 and 14~~. Total amounts due to the officers and directors related ~~party~~to accrued compensation was $-0- as of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022.

~~The~~Offshore ~~Company~~Finance, ~~had~~LLC ~~accrued~~was ~~compensation~~owed tofinancing ~~its~~costs ~~officers~~in ~~and~~connection ~~directors~~with ina ~~years~~subordinated ~~prior~~loan to ~~2018.~~the Company which was converted to common shares in 2014. The ~~Board~~managing partner of ~~Directors~~Offshore ~~authorized~~and the Company to’s ~~cease~~Chief Financial Officer are partners in the ~~accrual~~accounting offirm ~~compensation~~which ~~for~~the ~~its~~Company used ~~officers~~for ~~and~~general ~~directors,~~corporate ~~effective~~purposes ~~January~~in 1,the ~~2018~~past. On March 31, 2021, the parties entered into a Debt Settlement ~~Agreements~~Agreement whereby all ~~accrued~~ amounts due for such services totaling $126,~~789,208~~113 were extinguished upon the issuance of $~~17,892~~261 principal balance of the 3% Notes and the issuance of the 3% Note Warrants as further described in ~~Notes~~Note 4~~, 7 and 9~~. Total amounts due to ~~the officers~~this ~~and directors~~ related toparty ~~accrued compensation~~ was $-0- as of ~~September~~March 3031, ~~2022~~ 2023 and December 31, ~~2021~~2022.

Offshore Finance, LLC was owed financing costs in connection with a subordinated loan to the Company which was converted to common shares in 2014. The managing partner of Offshore and the Company’s Chief Financial Officer are partners in the accounting firm which the Company used for general corporate purposes in the past. On March 31, 2021, the parties entered into a Debt Settlement Agreement whereby all amounts due for such services totaling $26,113 were extinguished upon the issuance of $261 principal balance of the 3% Notes and the issuance of the 3% Note Warrants as further described in Notes 4, 7 and 9. Total amounts due to this related party was $-0- as of September 30, 2022 and December 31, 2021.

In connection with the Hugoton Gas Field Farmout Agreement, John Loeffelbein, the Company’s previous Chief Operating Officer, was granted a 3% carried interest through drilling in the Hugoton JV. Such carried interest was burdened only to the three other partners in the Hugoton JV and not the Company’s interest. On April 18, 2022, John Loeffelbein resigned from his position as Chief Operating Officer with the Company.

Note 1415 –Net ~~Subsequent~~Income ~~Events~~(Loss) Per Share

AsThe ~~further~~calculation ~~described~~of ~~in Note 4~~ the ~~Company~~weighted ~~has~~average ~~certain~~number ~~convertible~~of ~~notes~~shares ~~payable~~outstanding ~~that have matured~~ and ~~are~~income in(loss) ~~default~~per asshare ofoutstanding ~~September 30,~~for ~~2022.~~the Inthree ~~addition,~~months ~~certain~~ended ~~notes matured on October 29~~March 31, ~~2022~~2023 and ~~were~~2022 ~~not repaid and therefore~~ are ~~currently~~as ~~in default status. Following is the outstanding principal balance on matured convertible notes that are currently in default~~follows:

Schedule of Net Earnings Per Share


	Three Months Ended March 31,
	2023			2022
Numerator:
Net income (loss)	$	101,672		$	(554,634	)

Less- Convertible preferred stock dividends		(62,941	)		(52,861	)

Numerator for basic income (loss) per share - Net income (loss) attributable to common stockholders	$	38,731		$	(607,495	)

Add: Convertible preferred stock dividends		—			—

Add: Interest expense on convertible debt		—			—

Adjusted numerator for diluted income (loss) per share – Net income (loss) attributable to common stockholders	$	38,731		$	(607,495	)

Denominator:
Denominator for basic (loss) income per share – weighted average shares outstanding		22,357,099			19,213,560

Dilutive effect of convertible preferred stock outstanding		—			—

Dilutive effect of convertible debt outstanding		—			—

Dilutive effect of shares issuable under stock options and warrants outstanding		—			—

Denominator for diluted income (loss) per share – adjusted weighted average shares outstanding		22,357,099			19,213,560

Net income (loss) income per share:
Basic	$	0.00		$	(0.03	)
Diluted	$	0.00		$	(0.03	)

Basic income (loss) per share is based upon the weighted average number of shares of Common Stock outstanding during the period. For the three months ended March 31, 2023 the shares issuable upon the conversion of all convertible debt, all convertible preferred stock and the exercise of outstanding all stock options and warrants were considered antidilutive, and, therefore, not included in the computation of diluted income (loss) per share for the three months ended March 31, 2023.

During the three months ended March 31, 2022, all shares issuable upon conversion of convertible debt, convertible preferred stock and the exercise of outstanding stock options and warrants were considered antidilutive due to the loss incurred, and, therefore, not included in the computation of diluted income (loss) per share.

Note 16 – Subsequent Events

Designation of Series B Convertible Preferred Stock

On May 3, 2023, the Company filed the Certificate of Designation (the “Certificate of Designation”) with the Secretary of State of the State of Nevada (the “Nevada Secretary of State”), establishing the rights, preferences, privileges, qualifications, restrictions, and limitations relating to the Series B Convertible Preferred Stock, par value $0.0001 per share (the “Series B Convertible Preferred Stock”). The Certificate of Designation became effective upon filing with the Nevada Secretary of State.

Pursuant to the provisions of the Certificate of Designation of Preferences, Rights and Limitations of the Series B Preferred Stock (the “Certificate of Designation”) the Company is authorized to issue up to 50,000 shares of Series B Preferred from time to time with a Stated Value/Liquidation Value of $100 per share. Each share of Series B Preferred Stock is convertible, at the option of the holders thereof, at any time, subject to certain beneficial ownership limitations, into shares of Common Stock determined on a per share basis by dividing the Stated Value of such share of Preferred Stock (as such term is defined in the Certificate of Designation) by the Conversion Price (as such term is defined in the Certificate of Designation), which Conversion Price is subject to certain adjustments. In addition, the Certificate of Designation also provides for the payment of dividends, in (I) cash, or (ii) shares of Common Stock, to the holders of the Series B Preferred Stock, of 8% per annum, based on the Stated Value, until the earlier of (i) the date on which the shares of Series B Preferred Stock are converted to Common Stock or (ii) date the Company’s obligations under the Certificate of Designation have been satisfied in full. The shares of Series B Preferred Stock also (i) vote on an as-converted to Common Stock basis, subject to certain beneficial ownership limitations, (ii) are redeemable at the option of the Company at any time, (iii) rank senior to the Common Stock and any class or series of capital stock created after the Series B Preferred Stock and (iv) have a special preference upon the liquidation of the Company.

Issuance of Series B Convertible Preferred Stock

May 2023 Issuance - On May 4, 2023, the Company entered into a securities purchase agreement with three (3) accredited investors providing for an aggregate investment of $750,000 by the investors for the issuance by the Company to them of (i) 7,500 shares of Series B Convertible Preferred Stock with a stated/liquidation value of $100 per share (the “May 2023 Series B Convertible Preferred Stock”); and (ii) warrants, with a term of five and a half (5.5) years, exercisable six (6) months after issuance, to purchase an aggregate of up to 15,000,000 shares of Common Stock at an exercise price of five ($0.05) cents per share, subject to customary adjustments thereunder. The 7,500 shares of May 2023 Series B Convertible Preferred Stock are convertible into an aggregate of up to 15,000,000 shares of Common Stock. Holders of the warrants may exercise the warrants by paying the applicable cash exercise price or, if there is not an effective registration statement for the sale of the shares of Common Stock underlying the warrants within six (6) months following the closing date, as defined in the warrants, by exercising on a cashless basis pursuant to the formula provided in the warrants. The Company intends to use the proceeds of the May 2023 Series B Convertible Preferred Stock offering for development of Hugoton Gas Field and Central Kansas Uplift Properties and for general working capital purposes.

The Company also entered into that certain registration rights agreement, pursuant to which the Company agreed to file a registration statement within forty-five (45) days following the closing of the May 2023 Series B Convertible Preferred Stock transaction, to register the shares of Common Stock issuable upon the conversion of the May 2023 Series B Convertible Preferred Stock and the common stock underlying the warrants. The Company is to use its best efforts to cause such registration statement to be declared effective within forty-five (45) days after the filing thereof, but in any event no later than the ninetieth (90^th) calendar day following the issuance of the May 2023 Series B Convertible Preferred Stock.

On May 5, 2023, Ozark Capital, LLC (“Ozark”) acquired 2,500 shares of Series B Preferred Stock (convertible into 5,000,000 shares of Common Stock), together with warrants to acquire 5,000,000 shares of Common Stock at five cents ($0.05) per share for a total cash contribution of $250,000. Ozark and its affiliates hold over 10% of the shares of the Company’s Common Stock as of March 31, 2023 and December 31, 2022. Accrued dividends on the Class A Convertible Preferred Stock attributable to Ozark were $2,739 and $2,739 for the three months ended March 31, 2023 and 2022, respectively. The Company has outstanding accrued and unpaid preferred dividends totaling $5,540 and $ 2,800 relative to Ozark’s Series A Preferred Stock as of March 31, 2023 and December 31, 2022, respectively.

The holders of the May 2023 Series B Convertible Preferred Stock agreed to a 4.99% beneficial ownership cap that limits the investors’ ability to convert its May 2023 Series B Convertible Preferred Stock and/or exercise its Common Stock purchase warrants. Such limitation can be raised to 9.99% upon 60 days advance notice to the Company.

The Securities Purchase Agreement also contains customary representations, warranties and agreements of the Company and the Investors and customary indemnification rights and obligations of the parties thereto.

Appointment of Officers

Resignation of Stanton E. Ross- On May 5, 2023, in connection with the closing of the May 2023 Series B Convertible Preferred Stock, Stanton E. Ross, the Company’s Chief Executive Officer and President, resigned from his positions as Chief Executive Officer and President with the Company. Mr. Ross remains as Chairman of the Board of Directors.

Resignation of Daniel F. Hutchins- On May 5, 2023, in connection with the closing of the May 2023 Series B Convertible Preferred Stock, Daniel F. Hutchins, the Company’s Chief Financial Officer, resigned from his positions as Chief Financial Officer, Treasurer and Secretary with the Company. Mr. Hutchins remains as a member of the Board of Directors.

Appointment of Thomas J. Heckman as Chief Executive Officer and Chief Financial Officer- On May 2, 2023, in connection with the anticipated closing of the May 2023 Series B Convertible Preferred Stock the Company’s Board of Directors appointed Thomas J. Heckman to the positions of Chief Executive Office and Chief Financial Officer of the Company to replace Mr. Ross and Mr. Hutchins, effective May 5, 2023.

Status of 8% Convertible Notes Payable in Default as of March 31, 2023.

As further described in Note 4 the Company has certain convertible notes payable that have matured and are in default as of December 31, 2022. Following is the outstanding principal balance on matured convertible notes that are currently in default:

	Amounts
Notes payable, in default:
Notes payable, in default	$	1,312,500
8% Convertible notes payable due October 29, 2022 (the 8% Note)	$	100,000
8% convertible notes payable due October 29, 2022	$	650,000
8% Convertible notes payable due October 29, 2022 (the Second 8% Note)		50,000
8% Convertible promissory notes payable due September 15, 2022		350,000
8% Convertible promissory notes payable due June 29, 2022		312,500
Notes payable, in default	$	500,000
Notes payable, in default	$	1,312,500

The Company did not pay the principal balance due on these Convertible Notes upon their maturity, therefore the remaining balance remains due and payable and is therefore in technical default. ~~The~~as ~~parties are negotiating a forbearance/resolution to such technical defaults which include several alternatives. Such negotiations include i) a reduction in the conversion price~~ of ~~the~~March ~~underlying convertible notes~~31, ~~ii)~~ ~~an extension and a roll-over of the principal into other Company securities, and iii) a combination of the alternatives~~2023. ~~The Company can provide no assurance that the parties will reach a mutually agreeable resolution.~~

On May 5, 2023, the Company reached an agreement with the holder of two separate convertible notes payable in the aggregate principal face amount of approximately $450,000 (including $100,000 principal balance of the notes payable due October 29, 2022 and $350,000 principal balance of the note payable due September 15, 2022), which the Company did not pay by their maturity dates. The Company and the holder of the two convertible notes payable entered into a new convertible promissory note (the “New Note”), exchanging the outstanding principal amount of the old convertible notes payable into the New Note, with a maturity date of September 30, 2023. Upon issuance of the New Note, the old convertible notes payable were cancelled and the repayment defaults under the prior convertible notes payable were cured with the entry into the New Note. The conversion price of the New Note was reduced from $0.50 per share to $0.40 per share however, the interest rate and other significant terms of the New Note are the same as those of the prior convertible notes payable.

With respect to the Second 8% Note that was not amended or exchanged on January 10, 2023 and May 5, 2023, the parties are negotiating a forbearance/resolution to such technical defaults which include several alternatives. Such negotiations include i) a reduction in the conversion price of the underlying convertible notes, ii) an extension and a roll-over of the principal into other Company securities, and iii) a combination of the alternatives. The Company can provide no assurance that the parties will reach a mutually agreeable resolution.

**********************

3938

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Note Regarding Forward Looking Statements

This ~~quarterly~~Quarterly ~~report~~Report on Form 10-Q contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which are intended to be covered by the safe harbors created thereby. In some cases, you can identify forward-looking statements by by terminology such as “may,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue,” “intends,” and other variations of these words or comparable words. These statements include statements relating to trends in or expectations relating to the effects of our existing and any future initiatives, strategies, investments, outlooks and plans.

Actual results or events may differ materially from those anticipated and as reflected in forward-looking statements included in this report. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others: our ability to successfully develop and operate our properties; changes in the competitive environment in our industry and the markets we serve, and our ability to compete effectively; our cash needs and the adequacy of our cash flows and earnings; our ability to service our debt obligations; our ability to attract and retain qualified personnel; changes in applicable laws or regulations; litigation; public health epidemics or outbreaks (such as the novel strain of COVID-19 and related variants); accidents, equipment failures or mechanical problems; and other risks.

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this report. Except as required by law, we do not undertake to update or revise any of the forward-looking statements to conform these statements to actual results, whether as a result of new information, future events or otherwise.

As used in this quarterly report, “AMGAS,” the “Company,” “we,” “us” and “our” refer collectively to American Noble Gas Inc., its predecessors and subsidiaries or one or more of them as the context may require.

Overview

As a result, we are now involved with the following oil and gas producing properties:

We commenced rework of the existing production wells after completion of the acquisition of the Properties and have performed testing and evaluation of the existence of noble gas reserves on the Properties including helium, argon and other rare earth minerals/gases. Testing of the Properties for noble gas reserves has provided encouraging but not conclusive results and ~~the~~we ~~Company~~have ~~has~~ yet to determine the ~~possibility~~ possibility of commercializing the noble gas reserves on the Properties. The Company plans to assess the Properties’ existing oil and gas reserves, including ~~while continuing~~ the ~~evaluation~~exploration offor the existence of new oil and gas zones and other mineral reserves, ~~and~~in ~~specifically~~ particular, the noble gas reserves that the Properties may hold.

During the year ended December 31, 2022, the Company changed its strategy regarding the Central Kansas Uplift considering the reduced net cash flows from the sale of crude oil production. The reduction in net cash flows was attributable to lower spot crude oil prices during 2022 compared to 2021 and higher than anticipated operating costs related to the operation of the horizontal wells on the Properties. The Company has shut down the horizontal production wells as of March 31, 2023 and December 31, 2022 and is considering the deepening of the conventional wells on the property to explore for helium and other noble gases that may be present in deeper producing zones. Accordingly, the Company has recorded an impairment charge of $712,812 to reduce the capitalized tangible and intangible costs related to its Central Kansas Uplift properties to zero as of December 31, 2022 and it remains at a zero carrying cost as of March 31, 2023.

Hugoton Gas Field Farm-Out - On April 4, 2022, the Company acquired a 40% participation in a Farmout Agreement by and between Sunflower Exploration, LLC as the Farmee and Scout Energy Partners as Farmor with regards to its oil and gas interests in the Hugoton Gas Field, located in Haskell and Finney Counties, Kansas. The Company has joined three other parties to explore for and develop potential oil, natural gas, noble gases and brine minerals on the properties underlying the Farmout Agreement (collectively the “Hugoton JV”).

The Hugoton JV believes that its unconventional theory has not previously been targeted for exploration by historical operations in the field. The initial exploratory well was spud on May 7, 2022 near Garden City, Kansas, with production casing set after testing and completion logs identified at least two potential zones with substantial gas and helium reserves. The initial well was completed upon the successful perforation across two lower intervals of the Chase group of formations. The fracture stimulation was completed in two stages during June 2022. The well was connected to the pipeline and commenced commercial production on August 17, 2022. The Company is evaluating the initial flows of both natural gas and helium.40

41The Hugoton JV believes that its unconventional theory has not previously been targeted for exploration by historical operations in the field. The initial exploratory well was spud on May 7, 2022 near Garden City, Kansas, with production casing set after testing and completion logs identified at least two potential zones with substantial gas and helium reserves. The initial well was completed upon the successful perforation across two lower intervals of the Chase group of formations. The fracture stimulation was completed in two stages during June 2022. The well was connected to the pipeline and commenced commercial production and sales of natural gas, natural gas liquids and helium on August 17, 2022. The Company is continuing to evaluate the initial flows of both natural gas, natural gas liquids and helium to determine its plan for additional wells on the farmout.

The Company performed the ceiling test to assess potential impairment of the capitalized costs relative to its Hugoton Gas Field Project as of December 31, 2022. The ceiling test indicated an impairment charge of $192,762 was required to reduce the total capitalized costs to $88,687 as of December 31, 2022. Accordingly, the Company has recorded an impairment charge of $192,762 to reduce the capitalized tangible and intangible costs related to its Hugoton Gas Field properties to $88,687 as of December 31, 2022 and $85,276 as of March 31, 2023.

GMDOC had previously acquired 70% of the working interests (the “Acquisition”) in certain oil and gas leases (the “GMDOC Leases”) from Castelli Energy, L.L.C., an Oklahoma limited liability company. The GMDOC Leases cover approximately 10,000 acres located in Southern Kansas near the Oklahoma border. The GMDOC Leases currently produce approximately 100 barrels of oil per day and 1.5 million cubic feet of natural gas per day on a gross basis.

~~Name~~2023 ~~Change~~Operational and ~~Reincorporation~~Financial ~~Matters~~Objectives

At the Company’s Annual Meeting of Stockholders held on October 13, 2021, the stockholders approved an amendment to the Company’s Certificate of Incorporation, changing the Company’s name to American Noble Gas Inc. The stockholders also approved an amendment to the Company’s Certificate of Incorporation, removing the provision providing that any action taken by the stockholders by written consent in lieu of a meeting requires that all of the Company’s stockholders entitled to vote on such action consent in writing thereto. Finally, the stockholders approved the 2021 Stock Option and Restricted Stock Plan (the “2021 Plan”) and we reserved 5,000,000 shares of the Company’s Common Stock, par value $0.0001 per share (the “Common Stock”) for issuance under the 2021 Plan.

Reincorporation in Nevada

On December 7, 2021, pursuant to the Agreement and Plan of Merger, American Noble Gas, Inc., a Delaware corporation, merged with and into its wholly owned subsidiary, American Noble Gas Inc., a Nevada corporation (“AMGAS-Nevada” and/or the “Company”) with AMGAS-Nevada continuing as the surviving corporation. In conjunction with the merger, AMGAS-Nevada succeeded to the assets, continued the business and assumed the rights and obligations of the predecessor Delaware corporation existing immediately prior to the merger. The merger was consummated by the filing of a Certificate of Merger on December 7, 2021 with the Secretary of State of the State of Delaware and Articles of Merger with the Secretary of State of the State of Nevada. The Agreement and Plan of Merger and transactions contemplated thereby were adopted by the holders of a majority of the outstanding shares of the predecessor’s common stock, par value $0.0001 per share, and/or Series A Convertible Preferred Stock, par value $0.0001 per share, on an as-converted common stock basis, by written consent in lieu of a special meeting of stockholders, in accordance with the Delaware General Corporation Law.

Pursuant to the Agreement and Plan of Merger, (i) each outstanding share of the Predecessor’s common stock automatically converted into one share of Common Stock of AMGAS-Nevada, (ii) each outstanding share of the predecessor’s Series A Convertible Preferred Stock automatically converted into one share of Series A Convertible Preferred Stock, par value $0.0001 per share, of AMGAS-Nevada (the “Series A Convertible Preferred Stock”), and (iii) each outstanding option, right or warrant to acquire shares of predecessor common stock converted into an option, right or warrant to acquire an equal number of shares of AMGAS-Nevada Common Stock under the same terms and conditions as the original options, rights or warrants.

Similar to the shares of common stock of the Predecessor prior to the merger, the shares of Common Stock are quoted on the OTCQB tier operated by the OTC Markets Group Inc. under the symbol “IFNY”. In accordance with the Agreement and Plan of Merger, each outstanding certificate previously representing shares of the predecessor’s common stock or Series A Convertible Preferred Stock automatically represents, without any action of the predecessor’s stockholders, the same number of shares of Common Stock or Series A Convertible Preferred Stock, as applicable.

Pursuant to the Agreement and Plan of Merger, the directors and officers of the predecessor immediately prior to the merger became the directors and officers of AMGAS-Nevada and continued their respective directorship or services with the Company on the same terms as their respective directorship or services with the predecessor immediately prior to the merger.

As a result of the merger, the internal affairs of the Company ceased to be subject to the Delaware General Corporation Law or governed by the predecessor’s Certificate of Incorporation, as amended, and its bylaws. As of December 7, 2021, effective date of the merger, the Company is now subject to the Nevada Revised Statutes and is governed by the Company’s Articles of Incorporation as filed in the State of Nevada and the Company’s Bylaws.

All references to the Company in this Quarterly Report on Form 10-Q refer to the predecessor prior to the merger, and AMGAS-Nevada subsequent to the merger.

2022 Operational and Financial Objectives

COVID–19 PANDEMIC

The financial statements contained in this Quarterly Report on Form 10-Q as well as the description of our business contained herein, unless otherwise indicated, principally reflect the status of our business and the results of our operations as of and for the three and nine months ended September 30, 2022. Economies throughout the world have been and continue to suffer disruptions by the effects of the quarantines, business closures and the reluctance of individuals to leave their homes as a result of the COVID-19 pandemic. In particular, the oil and gas market has been severely adversely impacted by the effects of the COVID-19 pandemic because of the substantial and abrupt decrease in the demand for oil and gas globally followed by the recent resurgence in oil and natural gas prices. In addition, the capital markets have experienced periods of disruption and our efforts to raise necessary capital in the future may be adversely impacted by the continuing effects of the COVID-19 pandemic and investor sentiment and we cannot forecast with any certainty when the lingering uncertainty caused by the COVID-19 pandemic will cease to impact our business and the results of our operations. In reading this Quarterly Report on Form 10-Q, including our discussion of our ability to continue as a going concern set forth herein, in each case, consider the additional uncertainties caused by the COVID-19 pandemic.

Corporate Activities

The Company’s ~~2022~~2023 operating objectives are focused on: 1) raising the necessary funds to finance exploration and development of the Hugoton Gas Field ~~Farm-Out~~through ~~Venture~~the Hugoton JV, 2) raising the necessary funds ~~to purchase~~for ~~our~~repayment ~~membership~~of ~~interest~~obligations that become due, or are in ~~GMDOC~~default and/or past due, 3) raising the funds necessary to explore and develop the Properties, including testing and evaluation of noble gas reserves in additional to the oil and gas producing zones, 4) raising the funds necessary to allow the Company to compete for new oil and gas properties that become available for acquisition purposes, and 5) funding our daily operations and the repayment of ~~obligations~~other obligations that become due, or are in default and/or past due.

Recent financings –

~~Issuances~~Issuance of Series AB Convertible Preferred Stock

~~March~~May ~~2021~~2023 Issuance - On ~~March~~May 264, ~~2021~~2023, the Company entered into a securities purchase agreement with ~~five~~three (53) accredited investors providing for an aggregate investment of $2750,~~050,~~000 by the investors for the issuance by the Company to them of (i) 227,~~776~~500 shares of Series AB Convertible Preferred Stock, with a stated/liquidation value of $100 per share (the “~~March 2021~~May 2023 Series AB Convertible Preferred Stock”); and (ii) warrants, with a term of five and a half (5.5) years, exercisable six (6) months after issuance, to purchase an aggregate of up to 515,~~256~~000,~~410~~000 shares of Common Stock at an exercise price of ~~thirty-nine~~five ~~cents~~ ($0.3905) cents per share, subject to customary adjustments thereunder. The ~~March~~7,500 ~~2021~~shares of May 2023 Series AB Convertible Preferred Stock isare convertible into an aggregate of up to 715,~~117~~000,~~500~~000 shares of Common Stock. Holders of the warrants may exercise ~~them~~the warrants by paying the applicable cash exercise price or, if there is not an effective registration statement for the sale of the shares of Common Stock underlying the warrants within six (6) months following the closing date, as defined in the warrants, by exercising on a cashless basis pursuant to the formula provided in the warrants. ~~Net~~The ~~proceeds~~Company ~~from the issuance of March 2021 Series A Convertible Preferred Stock totaled $1,929,089 after deducting the placement~~intends ~~agent~~to ~~fee~~use ~~and other expenses of~~ the ~~offering. The Company used the~~ proceeds of the ~~March~~May ~~2021~~2023 Series AB Convertible Preferred Stock offering to ~~complete~~for ~~the acquisition and~~ development of ~~the~~Hugoton ~~Properties,~~Gas toField ~~pay-off~~and ~~certain~~Central ~~outstanding~~Kansas Uplift ~~convertible~~Properties ~~notes payable~~ and for general working capital purposes.

43The Company also entered into that certain registration rights agreement, pursuant to which the Company agreed to file a registration statement within forty-five (45) days following the closing of the May 2023 Series B Convertible Preferred Stock transaction, to register the shares of Common Stock issuable upon the conversion of the May 2023 Series B Convertible Preferred Stock and the common stock underlying the warrants. The Company is to use its best efforts to cause such registration statement to be declared effective within forty-five (45) days after the filing thereof, but in any event no later than the ninetieth (90th) calendar day following the closing of the issuance of the May 2023 Series B Convertible Preferred Stock.

~~The~~On May ~~Company~~5, ~~also~~2023, ~~entered~~Ozark ~~into~~Capital, ~~that~~LLC ~~certain~~(“Ozark”) ~~registration~~acquired ~~rights agreement~~2, ~~pursuant~~500 toshares ~~which~~of ~~the~~Series ~~Company~~B ~~agreed~~Preferred toStock ~~file a registration statement within forty-five~~ (~~45)~~convertible ~~days~~into ~~following~~5,000,000 ~~the closing of the acquisition~~shares of ~~the~~Common ~~Properties~~Stock), ~~which~~together ~~occurred~~with onwarrants ~~April~~to 1,acquire ~~2021~~5,000,000 ~~to register~~ shares of Common Stock ~~underlying~~at ~~the~~five ~~warrants~~cents ($0.05) ~~The~~per ~~Company~~share isfor toa ~~use~~total cash ~~its~~contribution ~~best~~of ~~efforts~~$250,000. toOzark ~~cause~~and ~~such~~its ~~registration~~affiliates ~~statement~~hold toover be10% ~~declared~~of ~~effective~~the ~~within~~shares ~~forty-five~~of ~~(45)~~the ~~days~~Company’s ~~after~~Common ~~the~~Stock ~~filing~~as ~~thereof~~of March 31, ~~but~~2023 inand ~~any~~December ~~event~~31, no2022. ~~later~~Accrued ~~than~~dividends ~~the~~attributable ~~ninetieth~~to ~~(90th)~~Ozark ~~calendar~~were ~~day~~$2,739 ~~following~~and ~~the~~$2,740 ~~closing~~for of the ~~acquisition~~three ofmonths ~~the~~ended ~~Properties~~March 31, ~~which occurred~~2023 onand ~~April 1, 2021~~2022 respectively. The Company ~~completed~~has ~~the~~outstanding ~~required~~accrued ~~registration~~and ofunpaid ~~these~~preferred ~~shares~~dividends ontotaling ~~Form~~$5,540 ~~S-1~~and $2,800 ~~which~~relative to the ~~U.S.~~Ozark’s Series ~~Securities~~A ~~and Exchange~~Convertible ~~Commission~~Preferred ~~(the~~Stock ~~“SEC”)~~as ~~declared~~of ~~effective~~March on31, ~~August~~2023 4and December 31, ~~2021~~2022, respectively.

~~The~~Refinancing and ~~holders~~extensions of ~~the March 2021 Series A~~ Convertible ~~Preferred~~Notes Stock agreed to a 4.99% beneficial ownership cap that limits the investors’ ability to convert its March 2021 Series A Convertible Preferred Stock and/or exercise its Common Stock purchase warrants. Such limitation can be raised to 9.99% upon 60 days advance notice to the Company.Payable

8% Convertible Notes Payable due September 30, 2023 - The ~~holders~~Company ofdid ~~March~~not ~~2022~~pay ~~Series~~the A$500,000 ~~Convertible~~principal ~~Preferred~~balances ~~Stock~~due ~~exercised~~on the October 8% Notes upon their ~~rights~~original tomaturity ~~convert~~on aOctober ~~total~~29, 2022 and the remaining balance remained due and payable and was therefore in technical default as of 3December 31,~~000~~ ~~shares~~2022. ofThe ~~March~~Company ~~2021~~reached ~~Series~~an Aagreement ~~Convertible~~with ~~Preferred~~the ~~Stock~~two ~~into~~October ~~937~~8% Note Investors on January 10,~~500~~ ~~shares~~2023. On January 10, 2023, the Company and the October 8% Note Holders amended each of ~~Common~~the ~~Stock~~notes by entering into a Letter Agreement between the October ~~during~~8% Note Investors and the ~~nine~~Company. ~~months~~The ~~ended~~Letter Agreement modifies the terms of the October 8% Notes by extending each note’s respective maturity date to September 30, ~~2022~~2023. ~~There~~In ~~were~~consideration nofor ~~conversions~~the ~~during~~extension, the ~~nine~~Company ~~months~~amended ~~ended~~the ~~September~~Fixed 30Conversion Price (as defined in each note) to $0.10, ~~2021~~subject to any future adjustments as provided in each of the notes.

On8% Convertible ~~March~~Notes ~~26,~~Payable ~~2021~~due October 29, ~~Ozark~~2022 ~~Capital~~and 8% Convertible Notes Payable due September 15, ~~LLC~~2022 ~~acquired~~(in default) - On May 15,~~111~~ ~~shares~~2023, ofthe ~~March~~Company ~~2021~~reached ~~Series~~an Aagreement ~~Convertible~~with ~~Preferred~~the ~~Stock~~holder (of two separate convertible ~~into~~notes ~~347~~payable in the aggregate principal face amount of approximately $450,~~188~~000 ~~shares~~(including $100,000 outstanding principal balance of ~~Common~~the ~~Stock~~8% Note), ~~together~~which ~~with~~the ~~warrants~~Company did not pay by their respective tomaturity ~~acquire~~dates. ~~256,410~~The ~~common~~Company ~~shares~~and ofthe ~~Common~~holder ~~Stock~~of atthe ~~fifty~~two ~~cents~~convertible ~~($0.50)~~notes ~~per~~payable ~~share~~entered ~~for~~into a ~~total~~new ~~cash~~convertible ofpromissory ~~$100,000.~~note ~~Ozark~~(the ~~Capital~~“New Note”), ~~LLC~~exchanging ~~and its~~the ~~affiliates~~outstanding ~~hold~~principal ~~over~~amount ~~10%~~ of the ~~shares~~old ofconvertible notes payable into the ~~Company’s~~New ~~Common~~Note, ~~Stock~~with asa maturity date of September 30, ~~2022~~2023. ~~Dividends~~Upon ~~paid~~issuance toof ~~Ozark~~the ~~Capital~~New Note, ~~LLC~~ the old convertible notes payable were ~~$2,800~~cancelled and ~~$2,800~~the ~~for~~repayment defaults under the ~~three~~prior ~~months~~convertible ~~ended~~notes ~~September~~payable ~~30,~~were ~~2022~~cured ~~and~~with ~~2021,~~the ~~respectively~~entry ~~and~~into ~~$8,279~~the ~~and~~New ~~$5,753~~Note. ~~for~~The conversion price of the ~~nine~~New ~~months~~Note was reduced from ~~ended~~$0.50 ~~September~~per 30share to $0.40 per share however, ~~2022~~the interest rate and ~~2021,~~other ~~respectively~~significant terms of the New Note are the same as those of the prior convertible notes payable.

~~All~~8% Convertible ~~holders~~Notes ofPayable due September 30, 2023 (the ~~March~~“May ~~2021~~22 ~~Series~~Notes”) A- ~~Convertible~~The ~~Preferred~~Company ~~Stock,~~and ~~including~~the two May 2022 Note Holders ~~Ozark~~reached ~~Capital~~an agreement on January 10, ~~LLC~~2023. On January 10, ~~have~~2023, ~~agreed~~the toCompany amended each of those notes by entering into a 4Letter Agreement between the investors and the Company.~~99%~~ ~~beneficial~~The ~~ownership~~Letter ~~cap~~Agreement ~~that~~modifies ~~limits~~the terms of the ~~investors~~May 2022 Notes by extending each note’s ~~ability~~respective maturity date to ~~convert~~September ~~its~~30, ~~Series~~2023. AIn ~~Convertible Preferred~~consideration ~~Stock~~for ~~and/or~~the ~~exercise~~extension, ~~its~~the ~~Common~~Company ~~Stock~~amended ~~purchase~~the ~~warrants.~~Fixed ~~Such~~Conversion ~~limitation~~Price ~~can~~(as bedefined ~~raised~~in each note) to 9$0.~~99%~~10, ~~upon~~subject 60to ~~days’~~any ~~advance notice~~future toadjustments as provided in each of the ~~Company~~notes.

June 2022 Issuance - On June 15, 2022 the Company entered into a securities purchase agreement with an accredited investor providing for an aggregate investment of $500,000 by the investor for the issuance by the Company of (i) 5,000 shares of Series A Convertible Preferred Stock with a stated/liquidation value of $100 per share (the “June 2022 Series A Convertible Preferred Stock”); and (ii) warrants, with a term of five and a half (5.5) years, exercisable six (6) months after issuance, to purchase an aggregate of up to 1,666,667 shares of Common Stock at an exercise price of thirty cents ($0.30) per share, subject to customary adjustments thereunder. The June 2022 Series A Convertible Preferred stock is convertible into an aggregate of up to 1,562,500 shares of Common Stock. The holder of the warrants may exercise them by paying the applicable cash exercise price or, if there is not an effective registration statement for the sale of the shares of Common Stock underlying the warrants within six (6) months following the closing date, as defined in the warrants, by exercising on a cashless basis pursuant to the formula provided in the warrant. Net proceeds from the issuance of the June 2022 Series A Convertible Preferred Stock totaled $500,000. The Company used the proceeds of the June 2022 Series A Convertible Preferred Stock offering to pay-off certain outstanding convertible notes payable and for general working capital purposes.42

The Company also entered into that certain registration rights agreement, pursuant to which the Company agreed to file a registration statement within forty-five (45) days following the closing of the offering of the June 2022 Series A Convertible Preferred Stock, which occurred on June 15, 2022, to register the shares of Common Stock underlying the warrants. The Company is to use its best efforts to cause such registration statement to be declared effective within forty-five (45) days after the filing thereof, but in any event no later than the ninetieth (90th) calendar day following the closing of the offering, which occurred on June 15, 2022.

There were no conversions during the nine months ended September 30, 2022 and 2021.

August/September 2022 Issuances – During August and September 2022, the Company entered into a securities purchase agreements with three accredited investors providing for an aggregate investment of $145,000 by the investors for the issuance by the Company of (i) 1,450 shares of Series A Convertible Preferred Stock with a stated/liquidation value of $100 per share (the “August/September 2022 Series A Convertible Preferred Stock”); and (ii) warrants, with a term of five and a half (5.5) years, exercisable six (6) months after issuance, to purchase an aggregate of up to 483,332 shares of Common Stock at an exercise price of thirty cents ($0.30) per share, subject to customary adjustments thereunder. The August/September 2022 Series A Convertible Preferred Stock is convertible into an aggregate of up to 453,125 shares of Common Stock. The holders of the warrants may exercise them by paying the applicable cash exercise price or, if there is not an effective registration statement for the sale of the shares of Common Stock underlying the warrants within six (6) months following the closing date, as defined in the warrants, by exercising on a cashless basis pursuant to the formula provided in the warrant. Net proceeds from the issuance of the August/September 2022 Series A Convertible Preferred Stock totaled $145,000. The Company used the proceeds of the August/September 2022 Series A Convertible Preferred Stock offering to pay-off certain outstanding convertible notes payable and for general working capital purposes.

There were no conversions during the nine months ended September 30, 2022 and 2021.

Issuances of Convertible Notes Payable

8% Convertible Notes Payable due September 15, 2022 (in default) - On June 8, 2022, the Company issued to an accredited investor an unsecured convertible note payable due September 15, 2022 (the “June 2022 Note”), with an aggregate principal face amount of approximately $350,000. The June 2022 Note is, subject to certain conditions, convertible into an aggregate of 700,000 shares of Common Stock, at a price of fifty cents ($0.50) per share. The Company also issued a five-year Common Stock purchase warrant to purchase up to 700,000 shares of Common Stock at an exercise price of fifty cents ($0.50) per share, subject to customary adjustments (the “June 2022 Warrants”) which are immediately exercisable. The investor purchased the June 2022 Note and June 2022 Warrant from the Company for an aggregate purchase price of $350,000 and the proceeds were used for drilling and completion costs on the initial well drilled under the Hugoton Gas Field participation agreement and general working capital purposes. The Company also granted the investor certain piggy-back registration rights whereby the Company has agreed to register for resale the shares of Common Stock underlying the June 2022 Warrant and the conversion of the June 2022 Note unless the shares of the Company commence to trade on the NYSE American; the Nasdaq Capital Market; the Nasdaq Global Market; the Nasdaq Global Select Market; or the New York Stock Exchange, within one hundred twenty (120) days after the closing date.

The Company did not pay the principal balance due on the June 2022 Note upon its maturity on September 15, 2022 and the remaining balance remains due and payable and is therefore in technical default. The parties are negotiating a resolution to such technical default including an extension and a roll-over of the principal into other Company securities, although there can be no assurance that the parties will reach a mutually agreeable resolution.

8% Convertible Notes Payable due June 29, 2022 (in default) - The Company entered into a securities purchase agreement with two accredited investors (the “Investors”) for the Company’s 8% convertible notes payable due June 29, 2022 (the “May 2022 Notes”), with an aggregate principal amount of $850,000. The May 2022 Notes are, subject to certain conditions, convertible into an aggregate of 2,125,000 shares of Common Stock, at a price of forty cents ($0.40) per share. The Company also issued an aggregate of 425,000 shares of Common Stock as commitment shares (“Commitment Shares” and, together with the May 2022 Notes and Conversion Shares, the “Securities”) to the Investors as additional consideration for the purchase of the May 2022 Notes. The closing of the offering of the Securities occurred on May 13, 2022, when the Investors purchased the Securities for an aggregate purchase price of $850,000. The Company has also granted the Investors certain automatic and piggy-back registration rights whereby the Company has agreed to register the resale by the Investors of the Conversion Shares. The proceeds of this offering of Securities was used to purchase the Company’s membership interests in GMDOC.

The Company paid half of the May 2022 Notes principal balance upon its maturity on June 29, 2022 and an additional $112,500 in September 2022 the remaining balance remains due and payable and is therefore in technical default. The parties are negotiating a resolution to such technical default including an extension and a roll-over of the principal into other Company securities, although there can be no assurance that the parties will reach a mutually agreeable resolution.

8% Convertible Notes Payable due October 29, 2022 (in default) - On August 30, 2021, 2021, the Company issued to an accredited investor (the “8% Note Investor”) an unsecured convertible note payable due October 29, 2022 (the “8% Note”), with an aggregate principal face amount of approximately $100,000. The 8% Note is, subject to certain conditions, convertible into an aggregate of 200,000 shares of Common Stock, at a price of fifty cents ($0.50) per share. The Company also issued a five and one half-year Common Stock purchase warrant to purchase up to 200,000 shares of Common Stock at an exercise price of fifty cents ($0.50) per share, subject to customary adjustments (the “8% Note Warrant”) which are immediately exercisable. The 8% Note Investor purchased the 8% Note and 8% Note Warrant from the Company for an aggregate purchase price of $100,000 and the proceeds were used for general working capital purposes. The Company also granted the 8% Note Investor certain piggy-back registration rights whereby the Company has agreed to register for resale the shares underlying the 8% Note Warrant and the conversion of the 8% Note unless the shares of the Company commences to trade on the NYSE American; the Nasdaq Capital Market; the Nasdaq Global Market; the Nasdaq Global Select Market; or the New York Stock Exchange, within one hundred twenty (120) days after the closing date.

On October 29, 2021, the Company issued to three accredited investors (the “October 8% Note Investors”) unsecured convertible notes payable due October 29, 2022 (the “October 8% Notes”), with an aggregate principal face amount of approximately $550,000. The October 8% Notes are, subject to certain conditions, convertible into an aggregate of 1,100,000 shares of Common Stock, at a price of fifty cents ($0.50) per share. The Company also issued five and one half-year Common Stock purchase warrants to purchase up to 1,650,000 shares of Common Stock at an exercise price of $0.50 per share, subject to customary adjustments (the “October 8% Note Warrants”) which are immediately exercisable. The October 8% Note Investors purchased the October 8% Notes and October 8% Note Warrants from the Company for an aggregate purchase price of $550,000 and the proceeds were used for general working capital purposes. The Company also granted the October 8% Note Investors certain piggy-back registration rights whereby the Company has agreed to register for resale the shares underlying the October 8% Note Warrants and the conversion of the October 8% Notes unless the shares of the Company commences to trade on the NYSE American; the Nasdaq Capital Market; the Nasdaq Global Market; the Nasdaq Global Select Market; or the New York Stock Exchange, within one hundred twenty (120) days after the closing date.

The 8% Note and the October 8% Notes all bear interest at a rate of eight percent (8%) per annum, may be voluntarily repaid in cash in full or in part by the Company at any time in an amount equal to 120% of the principal amount of the underlying notes and any accrued and unpaid interest. Fifty percent (50%) of the 8% Note and the October 8% Notes shall be mandatorily repaid in cash in an amount equal to 120% of the principal amount of the underlying notes and any accrued and unpaid interest in the event of the consummation by the Company of any public or private offering or other financing pursuant to which the Company receives gross proceeds of at least $2,000,000 and one-hundred percent (100%) of the underlying notes plus accrued interest shall be mandatorily repaid in an amount equal to 120% of outstanding principal and interest in cases in which the Company receives gross proceeds of at least $3,000,000. In addition, pursuant to the 8% Notes Note and the October 8% Notes, so long as the underlying notes remain outstanding, the Company cannot enter into any financing transactions pursuant to which the Company sells its securities at a price lower than $0.50 cents per share without the written consent of the 8% Note Investor.

The conversion of the 8% Note and the October 8% Notes and the exercise of the underlying warrants are each subject to beneficial ownership limitations such that the 8% Note Investor and the October 8% Note Investors may not convert the underlying notes or exercise the underlying warrants to the extent that such conversion or exercise would result in any of the investors being the beneficial owner in excess of 4.99% (or, upon election of the investors, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon such conversion or exercise, which beneficial ownership limitation may be increased or decreased up to 9.99% upon notice to the Company, provided that any increase in such limitation will not be effective until 61 days following notice to the Company.

3% Convertible Notes Payable due March 31, 2026 - On March 31, 2021, the Company entered into Debt Settlement Agreements with six creditors (five of which were related parties) which extinguished accounts payable and accrued liabilities totaling $2,866,497 in exchange for the issuance of $28,665 in principal balance of 3% convertible notes payable (the “3% Notes”) with detachable warrants to purchase 5,732,994 shares of Common Stock for fifty cents ($0.50) per share (the 3% Note Warrants”). The 3% Notes allow for prepayment at any time with all principal and accrued interest becoming due and payable at maturity on March 30, 2026 (the “Maturity Date”). The 3% Notes are convertible as to principal and any accrued interest, at the option of holder, into shares of the Common Stock at any time after the issue date and prior to the close of business on the business day preceding the Maturity Date at the rate of fifty cents ($0.50) per share, subject to normal and customary adjustments. The 3% Note Warrants were valued at $1,605,178 using the Black-Scholes methodology.

Extinguishment of liabilities –

Debt Settlement Agreements - On March 31, 2021, the Company entered into Debt Settlement Agreements with six creditors (five of which were related parties) which extinguished accounts payable and accrued liabilities totaling $2,866,497 in exchange for the issuance of $28,665 in principal balance of the 3% Notes with detachable warrants to purchase the 3% Note Warrants. The 3% Notes allow for prepayment at any time with all principal and accrued interest becoming due and payable at maturity on the Maturity Date. The 3% Notes are convertible as to principal and any accrued interest, at the option of holder of the 3% Notes, into shares of the Common Stock at any time after the issue date and prior to the close of business on the business day preceding March 30, 2026 at the rate of fifty cents ($0.50) per share, subject to normal and customary adjustment. The 3% Note Warrants were valued at $1,605,178 using the Black-Scholes methodology.

Extinguishment of Convertible Note Payable - On March 26, 2021, the Company exercised its right to retire a convertible note payable originally issued in August 2020 (the “August 2020 Note”) in conjunction with the issuance of the March 2021 Series A Convertible Preferred Stock. In accordance with the prepayment provisions contained in the August 2020 Note, the Company paid $453,539 to retire all principal, accrued interest and the 15% prepayment premium.

Extinguishment of Notes Payable – On April 1, 2021, the Company and the holders of two notes payable aggregating $85,000 that were in default reached a settlement whereby the Company issued a total of 245,000 shares of Common Stock in exchange for the extinguishment of the outstanding principal, accrued interest and associated Common Stock purchase warrants, which totaled $123,830, as of April 1, 2021. The extinguishment of the debt obligations resulted in a gain of $55,230, which was recorded in the year ended December 31, 2021.

USNG Letter Agreement –

On November 9, 2021, the Company entered into a letter agreement (the “USNG Letter Agreement”) with U.S. Noble Gas, LLC (“USNG”), pursuant to which USNG provides consulting services to the Company for exploration, testing, refining, production, marketing and distribution of various potential reserves of noble gases and rare earth element/minerals on the Company’s recently acquired 11,000-care oil and gas properties in the Otis Albert Field located on the Properties. The USNG Letter Agreement would cover all of the noble gases, specifically helium, and rare earth elements/minerals potentially existing on the Properties and the Company’s future acquisitions, if any, including the Hugoton Gas Field.

The USNG Letter Agreement also provided that USNG would supply a large vessel designed for flows up to 5,000 barrels of water per day at low pressures, known as a gas extraction/separator unit. The gas extraction/separator unit is a dewatering vessel that the Company may use for multiple wells in the future.

The USNG Letter Agreement required the Company to establish a four-member board of advisors (the “Board of Advisors”) comprised of various experts in noble gas and rare earth elements/minerals. The Board of Advisors will help attract both industry partners and financial partners for developing a large helium, noble gas and/or rare earth element/mineral resources that may exist in the region where the Company currently operates. The industry partners would include helium, noble gas and/or rare earth element/mineral purchasers and exploration and development companies from the energy industry. The financial partners may include large family offices or small institutions.

Pursuant to the USNG Letter Agreement, the Company will pay USNG a $8,000 monthly cash fee beginning at the onset of commercial helium or minerals production and sales, subject to certain thresholds. Such monthly fees will become due and payable for any month that the Company receives cash receipts in excess of $25,000 derived from the sale of noble gases and/or rare earth elements/minerals. The Company has not yet achieved the $25,000 cash receipts threshold, therefore, there has been no payment or accrual liability relative to this cash fee provision through September 30, 2022.

In consideration for the consulting services to be rendered and pursuant to the terms of the USNG Letter Agreement, the Company issued warrants to purchase, in the aggregate, 2,060,000 shares of Common Stock, at an exercise price of fifty ($0.50) to three of USNG’s principal consultants and four third-party service providers. The Company also issued warrants to purchase, in the aggregate, 1,200,000 shares of Common Stock at fifty cents ($0.50) per share exercise price to three members of the Board of Advisors. The Company granted a total of 3,260,000 warrants to purchase its Common Stock with an exercise price of fifty cents ($0.50) per share in connection with the USNG Letter Agreement and the arrangements described therein. The warrants expire five years after the date of the USNG Letter Agreement.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet debt, nor did we have any transactions, arrangements, obligations (including contingent obligations) or other relationships with any unconsolidated entities or other persons that may have a material current or future effect on our financial conditions, changes in our financial conditions, or our results of operations, liquidity, capital expenditures, capital resources, or significant components of revenue or expenses except as follows:

Investment in Unconsolidated Subsidiary – GMDOC - On May 3, 2022, the Company entered into the Operating Agreement pursuant to which the Company acquired 17 (or 60.7143%) of 28 limited liability membership Interests in GMDOC, for an aggregate purchase price of $4,037,500, and was subsequently admitted as a member of GMDOC.

~~With respect to its cash capital contribution, the Company paid a non-refundable cash deposit for the membership interests in the amount of $50,000 on May 3, 2022.~~ The Company paid the ~~remainder of the~~ cash contribution for the membership interests, orof $~~800~~850,000, onin May ~~16,~~ 2022. The remainder of the Company’s capital contribution, or $3,187,500, was financed by the Bank Loan (as defined below).

GMDOC had previously acquired 70% of the working interests in the GMDOC Leases from Castelli Energy, L.L.C, an Oklahoma limited liability company. The GMDOC Leases cover approximately 10,000 acres located in Southern Kansas near the Oklahoma border. The GMDOC Leases currently produce approximately 100 barrels of oil per day and 1.5 million cubic feet of natural gas per day on a gross basis.

For the Three Months Ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022

Results of Operations

Revenue

~~The Company began generating revenues from the production and sale of crude oil since the acquisition of the Properties on April 1, 2021.~~ Revenues totaled $438,~~034~~924 and $3525,~~392~~305 for the three months ended ~~September 30~~March 31, ~~2022~~2023 and ~~2021~~2022, respectively. The $716,~~642~~381 or 2265% ~~increase~~decrease in revenues during the three months ended ~~September~~March 3031, ~~2022~~2023 as compared to the same period in ~~2021~~2022 reflects the ~~commencement~~reduction ofin ~~natural~~oil ~~gas~~ and ~~helium~~gas sales ~~from the initial Hugoton Gas Field which was connected~~form toour ~~the~~Central ~~pipeline~~Kansas onUplift ~~August 17, 2022~~properties. The Company expects its revenues to continue to improve as the market price of West Texas Intermediate (“WTI”) oil, which is the benchmark price the Company receives for the sale of its crude oil, remains strong and the Company increases the volume of natural gas and helium gas sold as it continues its drill and complete wells pursuant to its Hugoton Gas Field participation agreement.

During late 2022, the ~~three~~Company ~~months~~changed ~~ended~~its ~~September~~strategy ~~30,~~regarding ~~2022,~~the ~~our~~Central ~~revenue~~Kansas ~~was~~Uplift ~~substantially impacted~~properties byconsidering ~~inflation,~~its reduced net cash flows from the ~~COVID-19~~sale ~~pandemic~~of crude oil production. The reduction in net cash flows was attributable to lower spot crude oil prices during 2022 compared to 2021 and higher than anticipated operating costs related to the ~~Russian~~operation ~~war~~of inthe ~~Ukraine,~~horizontal ~~which~~wells on the Properties. The Company has shut ~~restricted~~down the ~~world~~horizontal ~~supply~~production wells as of ~~oil~~March 31, 2023 and ~~gas~~December 31, 2022 and is considering the deepening of the conventional ~~thereby~~wells ~~increased~~on the ~~average~~property ~~WTI~~to ~~crude~~explore ~~oil~~for ~~price.~~helium Weand ~~expect~~other ~~this~~noble ~~trend~~gases tothat ~~continue~~may be present in deeper producing zones. Accordingly, revenues during the ~~remainder~~three ofmonths ~~2022~~ended ~~and~~March ~~perhaps~~31, ~~beyond~~2023 was substantially less than the comparable period in 2022.

Oil and Gas Lease Operating Expenses

~~The Company began generating revenues from the production~~Total ~~and sale of crude~~ oil ~~since the acquisition of the Properties on April 1, 2021. Total oil~~ and gas lease operating expenses totaled $5529,~~288~~ 605 and $~~220~~86,~~767~~536 for the three months ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022, respectively. The decrease in oil and gas lease operating expenses during the three months ended ~~September~~March 3031, ~~2022~~2023 as compared to the same period in ~~2021~~ 2022 is attributable to significant repairs and rework performed in the three months ended ~~September~~March 3031, ~~2021~~2022 that did not recur induring the three months ended March 31, 2023. In addition, the Company has shut down the horizontal production wells on the Central Kansas Uplift properties as of March 31, 2023 and December 31, 2022 as management considers the deepening of the conventional wells on the property to explore for helium and other noble gases that may be present in deeper producing zones. Accordingly, oil and gas lease operating expenses during the three months ended March 31, 2023 were substantially less than the comparable period in 2022.

~~Upon completion of our acquisition of the Properties on April 1~~Depreciation, ~~2021, we commenced rework of the existing production wells on the Properties in order to restore the three producing wells~~ toDepletion ~~full operational condition. All such rework costs were expensed as routine maintenance instead of capitalized to oil~~ and gas properties and equipment under the full-cost method. In addition, we have performed certain exploration, including testing and evaluation for the existence of noble gas reserves on the Properties, including helium, argon and other rare earth minerals/gases. Testing of the Properties for noble gas reserves has provided encouraging but not conclusive results and the Company has yet to determine the possibility of commercializing the noble gas reserves on the Properties. The Company plans to assess the existing oil and gas reserves on the Properties while continuing the evaluation of the existence of new oil and gas zones and other mineral reserves and specifically the noble gas reserves that the Properties may hold.Impairment

~~During the three months ended September 30~~Depreciation, depletion ~~2022, our oil~~ and ~~gas~~amortization ~~lease operating~~expense ~~expenses~~totaled ~~have been substantially impacted by inflation~~$3,411 ~~the COVID-19 pandemic~~ and ~~the Russian war in Ukraine~~$30,834 ~~which~~during ~~has restricted~~ the ~~supply~~three ofmonths ~~production~~ended ~~pipe~~March ~~and other materials used in the drilling and rework of oil and gas wells. In addition~~31, ~~experienced~~2023 ~~oil~~ and ~~gas~~ ~~service professionals have been in high demand in the oil and gas service sector and thereby increasing the cost of oil and gas well services. We expect this trend to continue during the remainder of~~ 2022, ~~and perhaps beyond~~respectively.

49During late 2022, the Company changed its strategy regarding the Central Kansas Uplift properties considering its reduced net cash flows from the sale of crude oil production. The reduction in net cash flows was attributable to lower spot crude oil prices during 2022 compared to 2021 and higher than anticipated operating costs related to the operation of the horizontal wells on the Properties. The Company has shut down the horizontal production wells as of December 31, 2022 and is considering the deepening of the conventional wells on the property to explore for helium and other noble gases that may be present in deeper producing zones. Accordingly, the Company has recorded an impairment charge of $712,812 to reduce the capitalized tangible and intangible costs related to its Central Kansas Uplift properties to zero as of December 31, 2022 and March 31, 2023. Depreciation, depletion and impairment expense was reduced substantially during the three months ended March 31, 2023 compared to the three months ended March 31, 2022 as a result of the impairment recognized at December 31, 2022.

Depreciation, Depletion and Amortization

Depreciation, depletion and amortization expense totaled $34,292 and $30,834 during the three months ended September 30, 2022 and 2021, respectively. The Company began generating revenues from the production and sale of natural gas and helium from its Hugoton property on August 17, 2022 and crude oil resulting since the acquisition of the Properties on April 1, 2021, which was acquired for $900,000 cash plus the assumption of asset retirement obligations of $13,425. The Company allocated the purchase price of $913,425 to oil and gas properties and equipment, which is subject to depreciation, depletion and amortization as the acquisition qualified as an asset acquisition. The Company began generating revenues from the production and sale of natural gas and helium from its Hugoton property on August 17, 2022, which also marked the beginning of the related depreciation, depletion and amortization.

Accretion of Asset Retirement Obligation

Total expense for the accretion of asset retirement obligations was $~~424~~ 1,218 and $279 for the three months ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022, respectively. The Company ~~determined~~recognized ~~the~~additional ~~amount~~expenses offor ~~the~~its asset retirement ~~obligation~~ ~~assumed~~obligations relative to beboth ~~$13,425 as of April 1, 2021,~~ the ~~date~~Central ofKansas ~~the~~Uplift ~~acquisition~~and ofHugoton Gas ~~the~~Field ~~Properties~~properties. InThe ~~addition, the~~ Company commenced production from ~~its~~the ~~initial~~ Hugoton Gas Field well in later 2022 which began the accretion of its related asset retirement obligations. The obligation relates to legal requirements associated with the retirement of long-lived assets that result from the acquisitions, construction, development, or normal use of the asset. The obligation relates primarily to the requirement to plug and abandon oil and natural gas wells and support wells at the conclusion of their useful lives.

Oil and Gas Production Related Taxes

Oil and gas production related taxes totaled $55-0- and $~~1,626~~28 for the three months ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022, respectively. Such taxes are deducted from gross oil and gas revenue by the crude oil purchaser upon payment to the Company and include primarily severance taxes imposed by the State of Kansas, and Kansas conservation assessment fees. Revenues totaled $438,~~034~~924 for the three months ended ~~September~~March 3031, ~~2022~~ 2023, which resulted in the deduction of $55-0- in production related taxes~~. Revenues~~ ~~totaled $35,392 for the three months ended September 30, 2021, which resulted in the deduction of $1,626 in production related taxes primarily~~ due to ~~severance taxes paid in 2021. During~~ the ~~three~~shut-down ~~months ended September 30, 2021, the Company received a notice from the State~~ of ~~Kansas~~crude ~~that~~oil ~~exempted~~production ~~the Company~~ from ~~paying severance taxes due to~~ the ~~existing wells’ production levels. Therefore,~~Central ~~production~~Kansas ~~related~~Uplift ~~taxes~~properties ~~declined~~in aslate ~~a percentage of revenue during the three months ended September 30,~~ 2022 ~~as compared to the same period in 2021~~..

Other General and Administrative Expenses

Other general and administrative expenses were $~~283~~411,~~312~~848 for the three months ended ~~September~~March 3031, ~~2022~~2023, aan ~~decrease~~increase of $1143,~~128~~142, or 412%, from other general and administrative expenses of $~~294~~368,~~440~~706 for the three months ended ~~September~~March 3031, ~~2021~~2022. The ~~decrease~~increase in other general and administrative expenses is primarily attributable to aan ~~decrease~~increase of $2016,~~570~~ 185 in ~~geologist~~stock-based ~~fees~~compensation ~~related~~due to ~~work~~the ~~performed~~noncash incompensation awarded to the Company’s ~~three~~executives, ~~months~~members ~~ended~~of ~~September~~the 30Board of Directors, ~~2021~~the onUSNG Letter Agreement, which awarded compensatory warrants to advisory members of the ~~Properties~~Board ~~that~~of ~~did~~Advisors ~~not~~and ~~recur~~other consultants in 2022 and in late 2021. An increase in auditing fees of $17,500 and an increase of $15,028 in legal fees also contributed to the increase in other general and administrative expenses during the three months ended March ~~September 30~~31, 2023 as compared to the comparable period in 2022.

Equity in earnings of unconsolidated subsidiary – GMDOC

The Company reported equity in earnings of unconsolidated subsidiary of $~~209~~39,~~297~~813 for the three months ended ~~September~~March 3031, ~~2022~~2023, compared to $-0- for the three months ended ~~September~~March 3031, ~~2021~~2022. Such income resulted from the Company acquiring a 60.7143% membership interest in GMDOC in May 2022. The Company uses the equity method of accounting for equity investments if the investment provides the ability to exercise significant influence, but not control, over operating and financial policies of the investee, GMDOC. Management’s judgment regarding its level of influence over the operations of GMDOC included considering key factors such as the Company’s ownership interest, legal form of the investee, its’ lack of participation in policy-making decisions and its’ lack of control over the day-to-day operations of GMDOC.

GMDOC had previously acquired 70% of the working interests in in the GMDOC Leases from Castelli Energy, L.L.C., an Oklahoma limited liability company. The GMDOC Leases cover approximately 10,000 acres located in Southern Kansas near the Oklahoma border. The GMDOC leases currently produce approximately 100 barrels of oil per day and 1.5 million cubic feet of natural gas per day on a gross basis. GMDOC, LLC generated $~~209~~65,~~297~~575 of net income on ~~approximately~~ $~~929~~630,~~000~~215 of oil and gas revenues during the three months ended ~~September~~March 3031, ~~2022~~2023. The Company owns a 60.7143% membership interest in such net income or $~~209~~39,~~297~~ 813 which it has reported as equity in earnings of unconsolidated subsidiary – GMDOC during the three months ended ~~September~~March 3031, ~~2022~~2023.

Interest Expense

Interest expense increased to $~~217~~37,~~872~~412 for the three months ended ~~September 30~~March 31, ~~2022~~2023, compared to $593,~~724~~556 for the three months ended ~~September~~March 3031, ~~2021~~2022. The ~~increase~~decrease in interest expense during the three months ended ~~September~~ 30March 31, 2023 compared to the same period in 2022 was attributable to $80,667 ~~the~~of ~~issuance~~amortization of ~~the~~discount ~~various~~on convertible notes payable ~~issued~~recorded ~~2022 and in 2021 that were outstanding~~ during the three months ended ~~September~~March 3031, 2022. ~~and~~There ~~not~~was no amortization of discount on convertible notes payable recorded during the three months ended ~~September~~March 3031, ~~2021~~2023.

Income Tax

The Company recorded no income tax benefit (expense) in the three months ended September 30, 2022 and 2021. The Company has been in a cumulative tax loss position and has substantial net operating loss carryforwards available for its utilization at September 30, 2022. The Company has continued to carry a 100% reserve on its net deferred tax assets and therefore recorded no income tax expense or benefit on its income (loss) before income taxes during the three months ended September 30, 2022 and 2021.

Net Loss

The Company reported a net loss of $338,912 for the three months ended September 30, 2022, compared to a net loss of $518,278 for the three months ended September 30, 2021. This represents a decrease in net loss of $179,366 for the three months ended September 30, 2022 compared to the three months ended September 30, 2021.

Series A Convertible Preferred Stock Dividends

The Company recorded $65,406 and $57,408 for convertible preferred stock dividends in the three months ended September 30, 2022 and 2021, respectively. On March 26, 2021, the Company issued and classified its Series A Convertible Preferred Stock as equity securities on its balance sheet. During 2022, the Company issued additional shares of Series A Convertible Preferred Stock, therefore, there were more shares of Series A Convertible Preferred Stock outstanding during the three months ended September 30, 2022 as compared to the same period in 2021. All shares of Series A Convertible Preferred Stock bear a cumulative dividend at a 10% rate based on its stated/liquidation value.

Net Loss Applicable to Common Stockholders

The Series A Convertible Preferred Stock issued in 2022 and 2021 have [dividend and distribution] preferences over our Common Stock and, therefore, such accrued dividend amounts have been deducted from net loss to report net loss applicable to common stockholders of $404,318 and $575,686 for the three months ended September 30, 2022 and 2021, respectively.

Basic and Diluted Net Loss Attributable to Common Stockholders per Share

Basic net loss attributable to common stockholders per share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of shares of Common Stock outstanding during the period. Diluted net loss attributable to common stockholders per share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of shares of Common Stock and dilutive Common Stock Equivalents outstanding during the period. Common Stock Equivalents included in the diluted net loss attributable to common stockholders per share computation represent shares of Common Stock issuable upon the assumed conversion of convertible notes payable, Series A Convertible Preferred Stock and the assumed exercise of stock options and warrants using the treasury stock and “if converted” method. For periods in which net losses attributable to common stockholders are incurred, weighted average shares outstanding is the same for basic and diluted loss per share calculations, as the inclusion of Common Stock Equivalents would have an anti-dilutive effect.

The Company incurred a net loss attributable to common stockholders during the three months ended September 30, 2022, and 2021, therefore all Common Stock Equivalents were considered anti-dilutive and excluded from diluted net loss attributable to common stockholders per share computations. The basic and diluted net loss attributable to common stockholders per share were $(0.02) and $(0.03) for the three months ended September 30, 2022 and 2021, respectively.

Potential Common Stock Equivalents as of September 30, 2022 totaled 32,688,238 shares of Common Stock, which included 2,838,580 shares of Common Stock underlying the convertible notes payable, 7,976,875 shares of Common Stock underlying the conversion of Series A Convertible Preferred Stock, 20,430,783 shares of Common Stock underlying outstanding warrants and 1,442,000 shares of Common Stock underlying outstanding stock options.

For the Nine Months Ended September 30, 2022 and 2021

Results of Operations

Revenue

The Company began generating revenues from the production and sale of crude oil since the acquisition of the Properties on April 1, 2021. Revenues totaled $111,903 and $56,220 for the nine months ended September 30, 2022 and 2021, respectively. The $55,683 or 99% increase in revenues during the nine months ended September 30, 2002 as compared to the same period in 2021 reflects the commencement of natural gas and helium sales from the initial Hugoton Gas Field which was connected to the pipeline on August 17, 2022 as well as the timing of the purchase of the Properties. The Company expects its revenues to continue to improve as the price of WTI oil remains strong and the Company increases the volume of natural gas and helium gas sold as it continues its drill and complete wells pursuant to its Hugoton Gas Field participation agreement.

During the nine months ended September 30, 2022, our revenue was substantially impacted by inflation, the COVID-19 pandemic and the Russian war in Ukraine, which has restricted the world supply of oil and gas and thereby increased the average WTI crude oil price. We expect this trend to continue during the remainder of 2022 and perhaps beyond.

Oil and Gas Lease Operating Expenses

The Company began generating revenues from the production and sale of crude oil since the acquisition of the Properties on April 1, 2021. Total oil and gas lease operating expenses totaled $198,003 and $446,849 for the three months ended September 30, 2022 and 2021, respectively. The decrease in oil and gas lease operating expenses during the nine months ended September 30, 2022 as compared to the same period in 2021 is attributable to significant repairs and rework performed in the nine months ended September 30, 2021 that did not recur in the 2022 period.

Upon completion of our acquisition of the Properties on April 1, 2021, we commenced rework of the existing production wells on the Properties in order to restore the three producing wells to full operational condition. All such rework costs were expensed as routine maintenance instead of capitalized to oil and gas properties and equipment under the full-cost method. In addition, we have performed certain exploration, including testing and evaluation for the existence of noble gas reserves on the Properties, including helium, argon and other rare earth minerals/gases. Testing of the Properties for noble gas reserves has provided encouraging but not conclusive results and the Company has yet to determine the possibility of commercializing the noble gas reserves on the Properties. The Company plans to assess the existing oil and gas reserves on the Properties while continuing the evaluation of the existence of new oil and gas zones and other mineral reserves and specifically the noble gas reserves that the Properties may hold.

During the nine months ended September 30, 2022, our oil and gas lease operating expenses have been substantially impacted by inflation, the COVID-19 pandemic and the Russian war in Ukraine, which has restricted the supply of production pipe and other materials used in the drilling and rework of oil and gas wells. In addition, experienced oil and gas service professionals have been in high demand in the oil and gas service sector and thereby increasing the cost of oil and gas well services. We expect this trend to continue during the remainder of 2022 and perhaps beyond.

Depreciation, Depletion and Amortization

Depreciation, depletion and amortization expense totaled $95,961 and $61,668 during the nine months ended September 30, 2022 and 2021, respectively. The Company began generating revenues from the production and sale of natural gas and helium from its Hugoton property on August 17, 2022 and crude oil since the acquisition of the Properties on April 1, 2021, which was acquired for $900,000 cash plus the assumption of asset retirement obligations of $13,425. The Company allocated the purchase price of $913,425 to oil and gas properties and equipment, which is subject to depreciation, depletion and amortization as the acquisition qualified as an asset acquisition. The Company began generating revenues from the production and sale of natural gas and helium from its Hugoton property on August 17, 2022, which also marked the beginning of the related depreciation, depletion and amortization.

Accretion of Asset Retirement Obligation

Total expense for the accretion of asset retirement obligations was $1,004 and $558 for the nine months ended September 30, 2022 and 2021, respectively. The Company determined the amount of the asset retirement obligation assumed to be $13,425 as of April 1, 2021, the date of the acquisition of the Properties. In addition, the Company commenced production from its initial Hugoton Gas Field well which began the accretion of its related asset retirement obligations. The obligation relates to legal requirements associated with the retirement of long-lived assets that result from the acquisitions, construction, development, or normal use of the asset. The obligation relates primarily to the requirement to plug and abandon oil and natural gas wells and support wells at the conclusion of their useful lives.

Oil and Gas Production Related Taxes

Oil and gas production related taxes totaled $164 and $2,592 for the nine months ended September 30, 2022 and 2021, respectively. Such taxes are deducted from gross oil and gas revenue by the crude oil purchaser upon payment to the Company and include primarily severance taxes imposed by the State of Kansas, and Kansas conservation assessment fees. Revenues totaled $111,903 for the nine months ended September 30, 2022, which resulted in the deduction of $164 in production related taxes. Revenues totaled $56,220 for the nine months ended September 30, 2021, which resulted in the deduction of $2,592 in production related taxes primarily due to severance taxes paid in 2021. During the nine months ended September 30, 2021, the Company received a notice from the State of Kansas that exempted the Company from paying severance taxes due to the existing wells’ production levels. Therefore, production related taxes declined as a percentage of revenue during the nine months ended September 30, 2022 as compared to the same period in 2021.

Other General and Administrative Expenses

Other general and administrative expenses were $1,131,456 for the nine months ended September 30, 2022, an increase of $393,037, or 53%, from other general and administrative expenses of $738,419 for the nine months ended September 30, 2021. The increase in other general and administrative expenses is primarily attributable to an increase of $508,589 in stock-based compensation due to the noncash compensation awarded to the Company’s executives, members of the Board of Directors, the USNG Letter Agreement which awarded compensatory warrants to advisory members of the Board of Advisors and other consultants in 2022 and in late 2021. The increase in stock-based compensation was offset by a $75,000 charge-off of one option to acquire a property during the nine months ended September 30, 2021 that did not recur in the comparable period in 2022.

Equity in earnings of unconsolidated subsidiary – GMDOC

The Company reported equity in earnings of unconsolidated subsidiary of $323,633 for the nine months ended September 30, 2022, compared to $-0- for the nine months ended September 30, 2021. Such income resulted from the Company acquiring a 60.7143% membership interest in GMDOC in May 2022. The Company uses the equity method of accounting for equity investments if the investment provides the ability to exercise significant influence, but not control, over operating and financial policies of the investee, GMDOC. Management’s judgment regarding its level of influence over the operations of GMDOC included considering key factors such as the Company’s ownership interest, legal form of the investee, its’ lack of participation in policy-making decisions and its’ lack of control over the day-to-day operations of GMDOC.

GMDOC had previously acquired 70% of the working interests in the GMDOC Leases from Castelli Energy, L.L.C., an Oklahoma limited liability company. The GMDOC Leases cover approximately 10,000 acres located in Southern Kansas near the Oklahoma border. The GMDOC leases currently produce approximately 100 barrels of oil per day and 1.5 million cubic feet of natural gas per day on a gross basis. GMDOC, LLC generated $533,043 of net income on approximately $1,718,000 of oil and gas revenues during the nine months ended September 30, 2022. The Company owns a 60.7143% membership interest in such net income or $323,633 which it has reported as equity in earnings of unconsolidated subsidiary – GMDOC during the nine months ended September 30, 2022.

Interest Expense

Interest expense increased to $643,662 for the nine months ended September 30, 2022, compared to $40,163 for the nine months ended September 30, 2021. The increase in interest expense during the nine months ended September 30, 2022 was attributable to the issuance of the various convertible notes payable issued in 2022 and in 2021 that were outstanding during the nine months ended September 30, 2022 and not during the nine months ended September 30, 2021.

Gain on Extinguishment of Liabilities

The Company reported a gain on ~~exchange and~~ extinguishment of ~~liabilities~~convertible notes payable of $~~-0-~~168,962 and $~~86,602~~-0- induring the ~~nine~~three months ended March ~~September 30~~31, ~~2022~~ 2023 and ~~2021~~2022, respectively.

On January ~~April 1~~10, ~~2021~~2023, the Company and the holders of ~~two~~the October 8% Notes reached an agreement with respect to the modification/extension of the $500,000 of aggregate outstanding principal balance on its convertible notes payable. ~~aggregating~~On ~~$85~~January 10,~~000~~ ~~that~~2023, ~~were~~the inCompany ~~default~~and ~~reached~~the October 8% Note Holders amended each of the notes by entering into a ~~settlement~~Letter ~~whereby~~Agreement between the October 8% Note Investors and the Company. The ~~issued~~Letter aAgreement ~~total~~modifies the terms of ~~245,000~~the ~~shares~~October of8% ~~Common~~Notes by extending each note’s respective maturity date to September ~~stock~~30, in2023. ~~exchange~~In consideration for the ~~extinguishment~~extension, ofthe Company amended the ~~outstanding~~Fixed ~~principal,~~Conversion ~~accrued~~Price ~~interest~~(as ~~and~~defined ~~associated~~in ~~Common~~each ~~Stock~~note) ~~purchase~~to ~~warrants~~$0.10, subject ~~which~~to ~~totaled~~any ~~$123,830,~~future adjustments as ofprovided ~~April~~in 1,each ~~2021~~of the notes. The ~~245,000~~Company ~~shares~~treated ~~issued~~the torecorded ~~extinguish~~Letter Agreement as an extinguishment of the ~~debt~~old ~~obligations~~notes which resulted in a gain on extinguishment of $55103,~~230 which~~977 ~~was~~during ~~recorded in~~ the ~~nine~~three months ended ~~September~~March 3031, ~~2021~~2023.

On January ~~March 31~~10, ~~2021~~2023, the Company ~~recorded~~and athe ~~net~~two ~~gain~~May on2022 ~~extinguishment~~Note ~~of liabilities~~Holders ~~totaling~~reached ~~$31,372,~~an ~~which~~agreement ~~was~~with ~~attributable~~respect to ~~six~~the ~~transactions~~modification/extension ~~that extinguished outstanding liabilities as~~ of ~~that date. The~~the ~~Debt~~$312,500 ~~Settlement~~of ~~Agreements~~aggregate ~~extinguished~~outstanding ~~accounts~~principal ~~payable~~balance ~~and~~on ~~accrued~~its ~~liabilities~~convertible ~~with~~notes apayable. ~~total~~On ~~outstanding~~January ~~balance~~10, ~~of $2~~2023,~~866,497,~~ ~~for~~ the ~~issuance~~ ofCompany ~~$28,665~~amended ineach ~~principal balance~~ of those ~~the~~notes 3%by ~~Notes.~~entering ~~Such~~into 3%a ~~Notes~~Letter ~~were~~Agreement ~~issued~~between ~~with~~ the 3%investors ~~Warrants,~~and ~~which~~the ~~were valued at $1,605,178~~Company. The ~~transaction~~Letter ~~resulted~~Agreement inmodifies athe ~~total~~terms ~~gain~~ of ~~$1,232,654~~the May of2022 ~~which~~Notes ~~$124,177~~by ~~was~~extending ~~reported~~each asnote’s arespective ~~gain~~maturity ondate ~~extinguishment~~to ofSeptember ~~liabilities and $1~~30,~~108,477 was~~ ~~reported~~2023. asIn aconsideration ~~capital~~for ~~contribution~~the ~~during~~extension, the Company ~~nine~~amended ~~months~~the ~~ended~~Fixed ~~September~~Conversion ~~30,~~Price ~~2021.~~(as ~~The~~defined ~~$23,000~~in ~~gain~~each ~~from~~note) ~~settlement~~to ~~of litigation extinguished~~ $330.10,~~000~~ ofsubject ~~trade~~to ~~payables~~any ~~for~~future aadjustments ~~cash~~as ~~payment~~provided in each of ~~$10,000~~the notes. The ~~loss~~Company oftreated ~~$115,805~~the isrecorded ~~related~~Letter toAgreement ~~the~~as ~~early~~an ~~retirement~~extinguishment of ~~$365,169 principal~~the ~~balance~~old ofnotes ~~the~~which ~~August~~resulted ~~2020~~in ~~Note.~~a ~~There~~gain ~~were~~on noextinguishment of ~~similar~~$64,985 ~~transactions~~ during the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023.

~~Change in Derivative Fair Value~~45

~~The conversion feature in certain outstanding notes payable and Common~~Change ~~Stock purchase warrants issued~~ in ~~connection~~Warrant ~~with~~Derivative ~~short-term~~Fair notes outstanding during the nine months ended September 30, 2021 were treated as derivative instruments because such notes payable and warrants contained ratchet and anti-dilution provisions. The mark-to-market process resulted in a gain of $199 during the nine months ended September 30, 2021. There were no similar derivatives outstanding during the nine months ended September 30, 2022. All short-term notes and their related derivative warrants were terminated on April 1, 2021.Value

The change in warrant derivative liability was an expense of $367,467 during the three months ended March 31, 2023, as compared to a gain of $-0- during the three months ended March 31, 2022. The estimated fair value of the Company’s derivative liabilities, all of which were related to the detachable warrants issued in connection with the issuance of Series A Convertible Preferred Stock, were estimated using a closed-ended option pricing model utilizing assumptions related to the contractual term of the instruments, estimated volatility of the price of the Company’s common stock and current interest rates. The detachable warrants issued in connection with the issuance of certain Series A Convertible Preferred Stock contained a provision allowing the holder to require cash settlement in certain situations were fundamental transaction, as defined in the warrant agreements have occurred. An event occurred on December 31, 2022 that activated the Holder’s ability to utilize such provisions, therefore the derivative liability was recognized on December 31, 2022 and March 31, 2023. Management estimated the fair value of the underlying derivative utilizing the black-scholes methodology as of March 31, 2023 and December 31, 2023 with the change in fair value being recognized as the change in warrant derivative fair value for the three months ended March 31, 2023.

Income Tax

The Company recorded no income tax benefit (expense) in the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022. The Company has been in a cumulative tax loss position and has substantial net operating loss carryforwards available for its utilization at ~~September~~March 3031, ~~2022~~2023. The Company ~~has~~ has continued to carry a 100% reserve on its net deferred tax assets and therefore recorded no income tax expense or benefit on its income (loss) before income taxes during the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022.

Net Income (Loss)

The Company reported a net ~~loss~~income of $1101,~~634,714~~672 for the ~~nine~~three months ended ~~September~~ 30March 31, ~~2022~~2023, compared to a net loss of $1554,~~147,228~~634 for the ~~nine~~three months ended ~~September~~March 3031, ~~2021~~2022. This represents aan ~~decrease~~improvement ~~in net loss~~ of $~~487~~656,~~486~~306 for the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023 compared to the ~~nine~~three months ended ~~September~~March 3031, ~~2021~~2022.

Series A Convertible Preferred Stock Dividends

The Company recorded $~~170~~62,~~556~~941 and $~~117~~52,~~936~~861 in convertible preferred stock dividends in the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022, respectively. On March 26, 2021, the Company issued and classified its Series A Convertible Preferred Stock as equity securities on its balance sheet. During 2022, the Company issued additional shares of Series A Convertible Preferred Stock, therefore, there were more shares of Series A Convertible Preferred Stock outstanding during the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023 as compared to the ~~same~~three ~~period~~months inended ~~2021~~March 31, 2022. All shares of Series A Convertible Preferred Stock bear a cumulative dividend at a 10% rate based on its stated/liquidation value.

Net Income (Loss) Applicable to Common Stockholders

The Series A Convertible Preferred Stock issued in ~~2021~~2022 and ~~2022~~2021 have dividend and/or distribution preferences over our Common Stock and, therefore, such accrued dividend amounts have been deducted from net income (loss) to report net income (loss) applicable to common stockholders of $138,~~805,270~~731 and $1607,~~265,164~~495 for the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022, respectively.

Basic and Diluted Net Income (Loss) Attributable to Common Stockholders per Share

Basic net income (loss) attributable to common stockholders per share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of shares of Common Stock outstanding during the period. Diluted net income (loss) attributable to common stockholders per share is computed by dividing the net income (loss) attributable to common stockholders by the weighted-average number of shares of Common Stock and dilutive Common Stock Equivalents outstanding during the period. Common Stock Equivalents included in the diluted net income (loss) attributable to common stockholders per share computation represent shares of Common Stock issuable upon the assumed conversion of convertible notes payable, Series A Convertible Preferred Stock and the assumed exercise of stock options and warrants using the treasury stock and “if converted” method. For periods in which net losses attributable to common stockholders are incurred, weighted average shares outstanding is the same for basic and diluted loss per share calculations, as the inclusion of Common Stock Equivalents would have an anti-dilutive effect.

The Company incurred a net loss attributable to common stockholders during the nine months ended September 30, 2022, and 2021, therefore all Common Stock Equivalents were considered anti-dilutive and excluded from diluted net loss attributable to common stockholders per share computations. The basic and diluted net loss attributable to common stockholders per share were $(0.09) and $(0.07) for the nine months ended September 30, 2022 and 2021, respectively.46

~~Potential~~The Company ~~Common~~generated ~~Stock~~net ~~Equivalents~~income asattributable ofto ~~September~~common ~~30,~~stockholders ~~2022~~during ~~totaled~~the 32three months ended March 31,~~688~~ 2023,~~238 shares~~ ofand ~~Common~~therefore all Common Stock, ~~which~~Equivalents ~~included~~were ~~2,838,580~~considered ~~shares~~for offully ~~Common~~diluted ~~Stock~~net ~~underlying~~income per share purposes. All of the outstanding convertible notes payable, ~~7,976,875~~all ~~shares~~ of ~~Common~~ ~~Stock underlying~~ the ~~conversion of~~ Series A Convertible Preferred Stock, ~~20,430,783~~and ~~shares~~all of ~~Common~~the ~~Stock~~outstanding ~~underlying~~stock ~~outstanding~~options and common stock purchase warrants were determined to be antidilutive and ~~1,442,000~~therefore ~~shares~~excluded offrom ~~Common~~the ~~Stock~~diluted ~~underlying~~earnings ~~outstanding~~per ~~stock~~share ~~options~~calculation. The basic and diluted net income (loss) attributable to common stockholders per share was $0.00 for the three months ended March 31, 2023.

The Company incurred a net loss attributable to common stockholders during the three months ended March 31, 2022, therefore all Common Stock Equivalents were considered anti-dilutive and excluded from diluted net loss attributable to common stockholders per share computations. The basic and diluted net loss attributable to common stockholders per share were $(0.03) and $(0.03) for the three months ended March 31, 2022, respectively.

Potential Common Stock Equivalents as of March 31, 2023 totaled 38,569,025 shares of Common Stock, which included 8,719,367 shares of Common Stock underlying the convertible notes payable, 7,976,875 shares of Common Stock underlying the conversion of Series A Convertible Preferred Stock, 20,430,783 shares of Common Stock underlying outstanding warrants and 1,442,000 shares of Common Stock underlying outstanding stock options.

Liquidity and Capital Resources; Going Concern–

We have had a history of losses and have generated little or no operating revenues for a number of years~~, as we concentrated on the development of our Nicaraguan Concessions, which was a long-term, high-risk/reward exploration project in an otherwise unproven part of the world~~. WeIn ~~abandoned the Nicaraguan Concessions in early~~ 2020 ~~due to the challenging economic and political issues in Nicaragua and in the oil and gas industry in general. Subsequent to the abandoning of the Nicaraguan Concessions~~, we began assessing various opportunities and strategic alternatives involving the acquisition, exploration and development of gas and oil properties in the United States, including the possibility of acquiring businesses or assets that provide support services for the production of oil and gas in the United States. As a result, we: 1) acquired the Properties, 2) entered into the Hugoton JV and 3) entered into the GMDOC venture.

The planned development of the development projects previously identified will require us to raise additional capital to accomplish our operating plan, which cannot be assured. Historically, we financed our operations through the issuance of equity and various short and long-term debt financing that contained some level of detachable warrants to provide the holders with a level of equity participation.

Capital Raised

Historically, we have raised funds through various equity and debt instruments through private transactions. The ~~following~~Company ~~summarizes~~was able to raise liquidity during 2022 through the ~~sources~~issuance of debt and equity in private transactions with accredited investors. These financial instruments generally ~~significant~~require ~~liquidity~~the ~~raised~~Company ~~during~~to register the ~~nine~~Common ~~months~~Stock ~~ended~~underlying ~~September~~the 30conversion of the Series A Convertible Preferred Stock, ~~2022~~the Common Stock purchase warrants and the convertible notes payable. These issuances generally provide the holders with a right to participate in future capital raises and require their approval for the ~~year~~future ~~ended~~issuance ~~December~~of 31securities at rates less than their purchase price. The holders have also agreed that the conversion of the Series A Convertible Preferred Stock, ~~2021:~~the convertible notes payable and the exercise of the underlying warrants are generally subject to beneficial ownership limitations such that each holder of the financial instruments individually may not convert the underlying Series A Convertible Preferred Stock, convertible notes payable or exercise the underlying warrants to the extent that such conversion or exercise would result in any of the holders individually being the beneficial owner in excess of 4.99% (or, upon election of the holders, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon such conversion or exercise, which beneficial ownership limitation may be increased or decreased up to 9.99% upon notice to the Company, provided that any increase in such limitation will not be effective until 61 days following notice to the Company.

	Nine months ended September 30, 2022
Capital raised:
Issuance of convertible notes payable together with the issuance of 425,000 shares of Common Stock	$	850,000
Issuance of Series A Convertible Preferred Stock with detachable Common Stock purchase warrants		645,000
Issuance of convertible notes payable with detachable Common Stock purchase warrants		350,000
Total capital raised	$	1,845,000

Designation of Series B Convertible Preferred Stock

	Year ended December 31, 2021
Capital raised:
Issuance of Series A Convertible Preferred Stock with detachable Common Stock purchase warrants	$	1,929,089
Issuance of convertible notes payable with detachable Common Stock purchase warrants		650,000
Total capital raised	$	2,579,089

The Company was able to raise liquidity during 2022 and 2021 through the issuance of debt and equity in private transactions with accredited investors. These financial instruments generally require the Company to register the Common Stock underlying the conversion of the Series A Convertible Preferred Stock, the Common Stock purchase warrants and the convertible notes payable. These issuances generally provide the holders with a right to participate in future capital raises and require their approval for the future issuance of securities at rates less than their purchase price. The holders have also agreed that the conversion of the Series A Convertible Preferred Stock, the convertible notes payable and the exercise of the underlying warrants are generally subject to beneficial ownership limitations such that each holder of the financial instruments individually may not convert the underlying Series A Convertible Preferred Stock, convertible notes payable or exercise the underlying warrants to the extent that such conversion or exercise would result in any of the holders individually being the beneficial owner in excess of 4.99% (or, upon election of the holders, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon such conversion or exercise, which beneficial ownership limitation may be increased or decreased up to 9.99% upon notice to the Company, provided that any increase in such limitation will not be effective until 61 days following notice to the Company.47

WePursuant ~~will~~to ~~likely~~the ~~continue~~provisions of the Certificate of Designation of Preferences, Rights and Limitations of the Series B Preferred Stock (the “Certificate of Designation”) the Company is authorized to issue ~~such~~up ~~convertible~~to ~~notes~~50,000 ~~payable~~shares of Series B Preferred from time to time with ~~detachable~~a ~~warrants~~Stated Value/Liquidation Value of $100 per share. Each share of Series B Preferred Stock is convertible, at the option of the holders thereof, at any time, subject to ~~acquire~~certain beneficial ownership limitations, into shares of Common Stock determined on a per share basis by dividing the Stated Value of such share of Preferred Stock (as such term is defined in the Certificate of Designation) by the Conversion Price (as such term is defined in the Certificate of Designation), which Conversion Price is subject to ~~fund~~certain ~~our~~adjustments. ~~operational~~In addition, the Certificate of Designation also provides for the payment of dividends, in (I) cash, or (ii) shares of Common Stock, to the holders of the Series B Preferred Stock, of 8% per annum, based on the Stated Value, until the earlier of (i) the date on which the shares of Series B Preferred Stock are converted to Common Stock or (ii) date the Company’s obligations under the Certificate of Designation have been satisfied in full. The shares of Series B Preferred Stock also (i) vote on an as-converted to Common Stock basis, subject to certain beneficial ownership limitations, (ii) are redeemable at the option of the Company at any time, (iii) rank senior to the Common Stock and any class or series of capital ~~expenditure~~stock ~~plans~~created ~~for~~after the ~~remainder~~Series B Preferred Stock and (iv) have a special preference upon the liquidation of ~~2022~~the Company.

56Issuance of Series B Convertible Preferred Stock

The Company also entered into that certain registration rights agreement, pursuant to which the Company agreed to file a registration statement within forty-five (45) days following the closing of the May 2023 Series B Convertible Preferred Stock transaction, to register the shares of Common Stock issuable upon the conversion of the May 2023 Series B Convertible Preferred Stock and the common stock underlying the warrants. The Company is to use its best efforts to cause such registration statement to be declared effective within forty-five (45) days after the filing thereof, but in any event no later than the ninetieth (90^th) calendar day following the issuance of the May 2023 Series B Convertible Preferred Stock.

On May 5, 2023, Ozark Capital, LLC (“Ozark”) acquired 2,500 shares of Series B Preferred Stock (convertible into 5,000,000 shares of Common Stock), together with warrants to acquire 5,000,000 shares of Common Stock at five cents ($0.05) per share for a total cash contribution of $250,000. Ozark and its affiliates hold over 10% of the shares of the Company’s Common Stock as of March 31, 2023 and December 31, 2022. Accrued dividends on the Class A Convertible Preferred Stock attributable to Ozark were $2,739 and $2,739 for the three months ended March 31, 2023 and 2022, respectively. The Company has outstanding accrued and unpaid preferred dividends totaling $5,540 and $2,800 relative to Ozark’s Series A Preferred Stock as of March 31, 2023 and December 31, 2022, respectively.

We will likely continue to issue such convertible preferred stock and convertible notes payable with detachable warrants to acquire Common Stock to fund our operational and capital expenditure plans for 2023.

Capital Expenditures

As of ~~September~~March 3031, ~~2022~~2023, we ~~have~~had: 1) acquired the Properties, 2) entered into the Hugoton JV and 3) entered into the GMDOC venture as more fully described elsewhere in this Quarterly Report on Form 10-Q.

Going Concern

The Company has incurred losses from operations, has a ~~net~~ stockholders’ deficit, incurred net cash used in operating activities and has a significant working capital deficit as of and for the ~~nine~~three months ended ~~September~~ 30March 31, ~~2022~~2023 and as of and for the ~~year~~years ended December 31, 2022 and 2021. The Company must raise substantial amounts of debt and equity capital from other sources in the future in order to fund (i) the development of the Properties acquired on April 1, 2021; (ii) our obligations for exploration and development under the Hugoton Farmout Agreement; (iii) normal day-to-day operations and corporate overhead; and (iv) outstanding debt and other financial obligations as they become due. Some of the Company’s outstanding debt and other financial ~~obligations~~ obligations are currently past due and the Company anticipates that other debt and financial obligations will become past due imminently. These are substantial operational and financial issues that must be successfully addressed during ~~2022~~2023 and beyond.

The Company has made substantial progress in resolving many of its existing financial obligations ~~during~~through ~~the~~March ~~nine months ended September 30, 2022 and for the year ended December~~ 31, ~~2021~~2023.

The Company will have significant financial commitments to execute its planned exploration and development of the Properties and the Hugoton Gas Field. The Company may find it necessary to raise substantial amounts of debt or equity capital to fund such exploration and development activities and may seek offers from industry operators and other third parties for interests in the Properties in exchange for cash and a carried interest in exploration and development operations or other joint venture arrangement. There can be no assurance that it will be able to obtain such new funding or be able to reach agreements with industry operators and other third parties or on what terms.

Cash and cash equivalents balances-

As of ~~September~~March 3031, ~~2022~~2023, we had cash and cash equivalents with an aggregate balance of $172,~~096~~008, a decrease from a balance of $~~260~~10,~~590~~163 as of December 31, ~~2021~~2022. Summarized immediately below and discussed in more detail in the subsequent subsections are the main elements of the $~~243~~8,~~494~~ 155 net decrease in cash during the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023:

● Operating activities: $~~216~~8,~~522~~155 of net cash used in operating activities. Net cash used in operating activities was $~~216~~8,~~522~~155 and $~~558~~50,~~494~~211 for the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022, respectively, an improvement in net cash used in operating activities of $~~341~~42,~~972~~056. The ~~decrease~~improvement in net cash used in operating activities was primarily the result of anour ~~increase~~improvement in net income (loss) in 2023 compared to 2022. Our net income reported for 2023 was offset by increases in non-cash ~~expenses~~income including the ~~discount~~change ~~amortization~~in onwarrant ~~debt~~derivative liability and ~~stock-based~~the ~~compensation,~~gain ~~and~~on anextinguishment ~~increase~~of inconvertible ~~accounts~~notes payable as reflected in our cash flows from operating activities for the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023 compared to the same period in ~~2021~~2022.

5749

	●	Investing activities:	$~~1,179,977~~-0- of net cash used in investing activities. Cash used in investing activities was $~~1,179,977~~-0- for the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023 compared to $~~900~~9,~~000~~134 for the ~~nine~~three months ended ~~September~~March 3031, ~~2021~~2022. We utilized funds during 2022 to acquire ~~our~~equipment ~~membership~~for ~~interest~~our inCentral ~~GMDOC~~Kansas ~~and~~Uplift ~~to drill the initial exploratory well pursuant to the Hugoton Gas Field participation agreement~~properties. ~~We utilized funds during 2021 to acquire the Properties.~~
	●	Financing activities:	$~~1,153,005~~-0- of net cash ~~provided~~used byin financing activities. Cash ~~provided~~used byin financing activities for the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023 was $~~1,153,005~~-0- compared to cash ~~provided~~used byin financing activities of $152,~~457,614~~861 for the ~~nine~~three months ended ~~September~~March 3031, ~~2021~~2022. We ~~raised~~accrued adividends ~~total~~ of $162,~~200,000~~941 ~~from~~but ~~the~~did ~~issuance~~not ofpay ~~convertible~~them notes payable and $645,000 from the issuance of Series A Convertible Preferred Stock with detachable warrants during the nine months ended September 30, 2022. These financing cash inflows were offset by the repayment of $537,500 principal balance of convertible notes payable and the payment of dividends totaling $154,495 on ~~the~~our Series A Convertible Preferred Stock during the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023. ~~The~~We ~~Company~~accrued ~~raised $1,929,089 through the issuance of Series A Convertible Preferred Stock~~ and ~~$100,000~~paid ~~in convertible notes payable, which was offset by~~ the ~~repayment~~dividends of $~~453~~52,~~539~~861 ~~principal balance of convertible debt and the payment of dividends totaling $117,936 on the Series A Convertible Preferred Stock~~ during the ~~nine~~three months ended ~~September~~March 3031, 2022.

The net result of these activities was a $~~243~~8,~~494~~155 decrease in cash and cash equivalents from $~~260~~10,~~590~~163 as of December 31, ~~2021~~2022 to $172,~~096~~ 008 as of March ~~September 30~~31, ~~2022~~2023.

Commitments:

Capital Expenditures. We had no material commitments for capital expenditures at ~~September~~March 3031, ~~2022~~ 2023. However, we are required by the Hugoton Gas Field Farmout Agreement to drill at least three additional gas production wells in ~~2022~~ 2023 and ~~2023~~2024 in order to maintain the ~~participation agreement~~Hugoton JV. We drilled and completed the first Hugoton Gas Field production well in May 2022, which was connected to the pipeline and commenced production on August 17, 2022. We estimate that the expenses related to the drilling program to be approximately $~~300~~350,000 for drilling and completion of each additional exploratory well.

Repayment of Debt. Debt obligations are comprised of the following at ~~September~~March 3031, ~~2022~~2023:

	September 30, 2022
	March 31, 2023
Convertible notes payable:
Notes payable:
8% convertible notes payable due October 29, 2022 (less discount of $27,191 as of September 30, 2022) (the 8% Note and the October 8% Notes) (in default)	$	622,809
3% convertible notes payable due March 30, 2026 (the 3% Notes)	$	28,665
8% convertible notes payable due September 15, 2022 (the June 2022 Note) (in default)		350,000
8% convertible notes payable due September 30, 2023 (the October 8% Notes)		500,000
8% convertible notes payable due June 29, 2022 (the May 2022 Notes) (in default)		312,500
8% convertible note payable due October 29, 2022 (the 8% Note) (in default)		100,000
3% convertible notes payable (the 3% Notes)		28,665
8% convertible note payable due October 29, 2022 (the Second 8% Note) (in default)		50,000
Total convertible notes payable		1,313,974
8% Convertible promissory notes payable due September 15, 2022 (the June 2022 Note) (in default)		350,000
8% Convertible promissory notes payable due September 30, 2023 (the May 2022 Notes)		266,204
Total notes payable		1,294,869
Less: Long-term portion		28,665
Convertible notes payable, short-term	$	1,285,309
Notes payable, short-term	$	1,266,204

Debt obligations become due and payable as follows:

Years ended	Principal balance due
2022 (October 1, 2022 through December 31, 2022)	$	1,285,309
2023	$	1,266,204
2023		—
2024		—
2025		—
2026		28,665
2027		—
Total	$	1,313,974
2028		—
Total	$	1,294,869

On May 5, 2023, the Company reached an agreement with the holder of two separate convertible notes payable in the aggregate principal face amount of approximately $450,000 (including $100,000 principal balance of the notes payable due October 29, 2022 and $350,000 principal balance of the note payable due September 15, 2022), which the Company did not pay by their maturity dates. The Company and the holder of the two convertible notes payable entered into a new convertible promissory note (the “New Note”), exchanging the outstanding principal amount of the old convertible notes payable into the New Note, with a maturity date of September 30, 2023. Upon issuance of the New Note, the old convertible notes payable were cancelled and the repayment defaults under the prior convertible notes payable were cured with the entry into the New Note. The conversion price of the New Note was reduced from $0.50 per share to $0.40 per share however, the interest rate and other significant terms of the New Note are the same as those of the prior convertible notes payable.

With respect to the other notes that were not amended or exchanged on January 10, 2023 and May 5, 2023, the parties are negotiating a forbearance/resolution to such technical defaults which include several alternatives. Such negotiations include i) a reduction in the conversion price of the underlying convertible notes, ii) an extension and a roll-over of the principal into other Company securities, and iii) a combination of the alternatives. The Company can provide no assurance that the parties will reach a mutually agreeable resolution.

Open Litigation.

The ~~information~~nature ~~regarding~~of ~~certain~~the ~~legal~~Company’s ~~proceedings~~business inexposes ~~which~~its weproperties, ~~are~~the ~~involved~~Company, asthe ~~set~~Hugoton ~~forth~~JV and its interest in ~~Note~~GMDOC 11to –the ~~Commitments~~risk ~~and~~of ~~Contingencies~~claims ofand ~~the~~litigation ~~Notes~~in to the ~~Condensed~~normal ~~Financial~~course ~~Statements~~of ~~(Part~~business. I,Other ~~Item~~than 1as ofnoted elsewhere in this Quarterly Report on Form 10-Q), in our Notes to the Unaudited condensed Financial Statements or routine litigation arising out of the ordinary course of business, the Company is not presently subject to any material litigation nor, to its knowledge, is any material litigation threatened against the Company.

Contractual Obligations

USNG Letter Agreement - Pursuant to the USNG Letter Agreement, the Company is required to pay USNG a $8,000 monthly cash fee beginning at the onset of commercial helium or minerals production and sales, subject to certain thresholds. Such monthly fees will become due and payable for any month that the Company receives cash receipts in excess of $25,000 derived from the sale of noble gases and/or rare earth elements/minerals. The Company has not yet achieved the $25,000 cash receipts threshold, therefore, there has been no payment or accrual liability relative to this cash fee provision through ~~September~~March 3031, ~~2022~~2023.

Farmout Agreement to Explore and Develop Unconventional Gas and Brine Materials in the Hugoton Gas Field - On April 4, 2022, the Company acquired a 40% interest in a Farm-Out Agreement by and between Sunflower Exploration, LLC as the Farmee and Scout Energy Partners as Farmor with regards to its oil and gas interests in the Hugoton Gas Field, located in Haskell and Finney Counties, Kansas. The Farmout Agreement covers drilling and completion of up to 50 wells and the Company has joined three other entities in the Hugoton JV to explore for and develop potential oil, natural gas, noble gases and brine minerals on the properties underlying the Farmout Agreement Farm-Out Agreement.

The Hugoton JV will utilize Scout Energy Partner’s existing infrastructure assets, including water disposal, gas gathering and helium processing. In addition, the Farmout Agreement provides the Hugoton JV with rights to take in-kind and market its share of helium at the tailgate of Jayhawk Gas Plant, located in Grant County, Kansas, which will enable the Hugoton JV to market and sell the helium produced at prevailing market prices. The first exploratory well was completed and commenced production and sales of natural gas, natural gas liquids and helium on August 17, 2022 near Garden City, Kansas, ~~with~~The ~~encouraging~~Company is continuing to evaluate the initial ~~flow~~ ~~rates~~flows of both natural gas, natural gas liquids and helium to determine its plan for additional wells on the farmout.

Inflation and Seasonality

Inflation in general has had a material effect on us during the ~~past~~three ~~nine~~ months ended ~~September~~March 3031, ~~2022~~2023 and we do believe that inflation will continue to significantly impact our business during the remainder of ~~2022~~2023 and perhaps beyond. We do not believe that our business is seasonal in nature.

~~Our~~In addition, ~~revenue~~our ~~from the sale of~~ oil and gas ~~has~~lease operating expenses have been substantially impacted by ~~inflation,~~ the COVID-19 pandemic and the Russian war in Ukraine, which has restricted the ~~world~~ supply of production pipe and other materials used in the drilling and rework of oil and gas wells. In addition, experienced oil and gas service professionals have been in high demand in the oil and gas service sector and thereby increasing the ~~average~~cost of ~~WTI~~oil ~~crude~~and ~~oil~~gas ~~price~~well services. We expect this trend to continue during ~~the~~2023 ~~remainder of 2022~~ and perhaps beyond.

In addition, our oil and gas lease operating expenses have been substantially impacted by inflation, the COVID-19 pandemic and the Russian war in Ukraine, which has restricted the supply of production pipe and other materials used in the drilling and rework of oil and gas wells. In addition, experienced oil and gas service professionals have been in high demand in the oil and gas service sector and thereby increasing the cost of oil and gas well services. We expect this trend to continue during the remainder of 2022 and perhaps beyond.

Critical Accounting Policies

A critical accounting policy is defined as one that is both material to the presentation of our ~~condensed~~ financial statements and requires ~~management~~ management to make difficult, subjective, or complex judgments that could have a material effect on our financial condition and results of operations. Specifically, critical accounting estimates have the following attributes: 1) we are required to make assumptions about matters that are highly uncertain at the time of the estimate; and 2) different estimates we could reasonably have used, or changes in the estimate that are reasonably likely to occur, would have a material effect on our financial condition or results of operations.

Estimates and assumptions about future events and their effects cannot be determined with certainty. We base our estimates on historical experience and on various other assumptions believed to be applicable and reasonable under the circumstances. These estimates may change as new events occur, as additional information is obtained and as our operating environment changes. These changes have historically been minor and have been included in the ~~condensed~~ financial statements as soon as they became known. Based on a critical assessment of our accounting ~~policies~~ policies and the underlying judgments and uncertainties affecting the application of those policies, management believes that our financial ~~statements~~ statements are fairly stated in accordance with accounting principles generally accepted in the United States and present a meaningful ~~presentation~~ presentation of our financial condition and results of operations. We believe the following critical accounting policies reflect our more significant estimates and assumptions used in the preparation of our financial statements:

Note 1 – Going Concern Analysis - In accordance with Accounting Standards Update (“ASU”) 2014-15, Presentation of Financial Statements- Going Concern (Subtopic 205-40) – Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern, we are required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about our ability to continue as a going concern within one year after the date that our financials are issued. When management identifies conditions or events that raise substantial doubt about their ability to continue as a going concern it should consider whether its plans to mitigate those relevant conditions or events will alleviate the substantial doubt. If conditions or events raise substantial doubt about an entity’s ability to continue as a going concern, but the substantial doubt is alleviated as a result of management’s plans, the entity should disclose information that enables user of financial statements to understand the principal events that raised the substantial doubt, management’s evaluation of the significance of those conditions or events, and management’s plans that alleviated substantial doubt about the entity’s ability to continue as a going concern.

We performed the analysis and our overall assessment was there were conditions or events, considered in the aggregate, which raised substantial doubt about our ability to continue as a going concern within the next year, but such doubt was not adequately mitigated by our plans to address the substantial doubt as disclosed in Note 1 of the Notes to the ~~Condensed~~ Financial Statements ~~(Part I, Item 1 of this Quarterly Report on Form 10-Q)~~.

Note 2 – Oil and Gas Properties and Equipment – The Company was required to perform an allocation of the purchase price for the acquisition of the Properties and to provide the estimated useful lives assigned to the related equipment purchased.

In addition, the accounting for, and disclosure of, oil and gas producing activities require that we choose between two alternatives under accounting principles generally accepted in the United States (“GAAP”): the full cost method or the successful efforts method. We adopted and use the full cost method of accounting, which involves capitalizing all exploration, exploitation, development and acquisition costs. Once we incur costs, they are recorded in the depletable pool of proved properties or in unproved properties, collectively, the full cost pool. Our unproved property costs, which include unproved oil and gas properties, properties under development, and major development projects, were zero through September 30, 2022, and are not subject to depletion. We review our unproved oil and gas property costs on a quarterly basis to assess for impairment and transfer unproved costs to proved properties as a result of extensions or discoveries from drilling operations or determination that no proved reserves are attributable to such costs. We expect these costs to be evaluated in one to seven years and transferred to the depletable portion of the full cost pool during that time. The full cost pool is comprised of intangible drilling costs, lease and well equipment and exploration and development costs incurred plus acquired proved and unproved leaseholds.52

In addition, the accounting for, and disclosure of, oil and gas producing activities require that we choose between two alternatives under accounting principles generally accepted in the United States (“GAAP”): the full cost method or the successful efforts method. We adopted and use the full cost method of accounting, which involves capitalizing all exploration, exploitation, development and acquisition costs. Once we incur costs, they are recorded in the depletable pool of proved properties or in unproved properties, collectively, the full cost pool. Our unproved property costs, which include unproved oil and gas properties, properties under development, and major development projects, were zero through December 31, 2022, and are not subject to depletion. We review our unproved oil and gas property costs on a quarterly basis to assess for impairment and transfer unproved costs to proved properties as a result of extensions or discoveries from drilling operations or determination that no proved reserves are attributable to such costs. We expect these costs to be evaluated in one to seven years and transferred to the depletable portion of the full cost pool during that time. The full cost pool is comprised of intangible drilling costs, lease and well equipment and exploration and development costs incurred plus acquired proved and unproved leaseholds.

Note 3 – Investment in unconsolidated subsidiary – GMDOC - The Company’s investment in its unconsolidated subsidiary - GMDOC requires that the Company assess its control over the operations of GMDOC.

The Company uses the equity method of accounting for equity investments if the investment provides the ability to exercise significant influence, but not control, over operating and financial policies of the investee, GMDOC. Management’s judgment regarding its level of influence over the operations of GMDOC included considering key factors such as the Company’s ownership interest, legal form of the investee, its’ lack of participation in policy-making decisions and its’ lack of control over the day-to-day operations of GMDOC.

Note 4 – Debt Obligations – The Company has issued various debt and equity securities that require the Company to estimate the fair value of the debt, its embedded features and any related detachable warrants or other equity-related securities issued. Management must make significant assumption/estimates in order to allocate the proceeds of the issuance of the convertible debt securities between its debt and equity components.

Note 6 – Stock Options - The Company follows the fair value recognition provisions of Accounting Standards Codification (“ASC”) 718. Stock-based compensation expense is recognized in the financial statements for granted, modified, or settled stock options based on estimated fair values. The fair value of each option award is estimated on the date of grant using the Black-Scholes option-pricing model, which requires the input of subjective assumptions, including the expected term of the option award, expected stock price volatility and expected dividends. These estimates involve inherent uncertainties and the application of management judgment.

Note 7 – Warrants - The Company has issued various debt and equity securities (including detachable warrants) that require the Company to estimate the fair value of the debt, its embedded features and any related detachable warrants or other equity-related securities issued. Management must make significant assumption/estimates in order to allocate the proceeds of the issuance of the convertible debt securities between its debt and equity components.

Note 8 – Income Taxes - Accounting for income taxes requires significant estimates and judgments on the part of management. Such estimates and judgments include, but are not limited to, the effective tax rate anticipated to apply to tax differences that are expected to reverse in the future, the sufficiency of taxable income in future periods to realize the benefits of net deferred tax assets and net operating losses currently recorded and the likelihood that tax positions taken in tax returns will be sustained on audit.

Note 11 – Warrant Derivative Liabilities - Accounting for warrant derivative liabilities requires significant estimates and judgments on the part of management. The estimated fair value of the Company’s warrant derivative liabilities, all of which were related to the detachable warrants issued in connection with various notes payable, were estimated using a closed-ended option pricing model utilizing assumptions related to the contractual term of the instruments, estimated volatility of the price of the Company’s common stock and current interest rates.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not Applicable.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures to provide reasonable assurance of achieving the control objectives, as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act. Based on their evaluation as of ~~September~~March 3031, ~~2022~~2023, the end of the period covered by this Quarterly Report on Form 10-Q, our principal executive officer and principal financial officer concluded that the Company’s disclosure controls and procedures are not effective in assuring that financial statement presentation and disclosure are in conformity with those which are required to be included in our periodic SEC filings.

Changes in Internal Control Over Financial Reporting

There have been no changes in our internal control over financial reporting that occurred during our most recent fiscal quarter that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

Internal control systems, no matter how well designed and operated, have inherent limitations. Therefore, even a system which is determined to be effective cannot provide absolute assurance that all control issues have been detected or prevented. Our systems of internal controls are designed to provide reasonable assurance with respect to financial statement preparation and presentation.

6153

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

The information regarding certain legal proceedings in which the Company is involved is set forth in Note 1112, Commitments and Contingencies – Litigation of the Notes to the ~~Condensed~~Unaudited condensed Financial Statements (Part I, Item 1 of this Quarterly Report on Form 10-Q), and such information is incorporated by reference into this Item 1.

In addition to such legal proceedings, we may become involved in various other claims and threatened legal proceedings arising in the normal course of our businesses. At this time, we do not believe any material losses under such other claims and threatened proceedings to be probable. While the ultimate outcome of such legal proceedings cannot be predicted with certainty, it is in the opinion of management, after consultation with legal counsel, that the final outcome in such proceedings, in the aggregate, would not have a material adverse effect on our financial condition, results of operations or cash flows.

ITEM 1A. RISK FACTORS

As a smaller reporting company, we are not required to provide the information required by this Item.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

There were no sales of unregistered securities during the quarter that were not previously reported on a Current Report on Form 8-K except as set forth below.

August/September 2022 Issuances – During August and September 2022 the Company entered into a securities purchase agreements with three accredited investors providing for an aggregate investment of $145,000 by the investors for the issuance by the Company of (i) 1,450 shares of the August/September 2022 Series A Convertible Preferred Stock with a stated/liquidation value of $100 per share; and (ii) warrants, with a term of five and a half (5.5) years, exercisable six (6) months after issuance, to purchase an aggregate of up to 483,332 shares of Common Stock at an exercise price of thirty cents ($0.30) per share, subject to customary adjustments thereunder. The Series A Convertible Preferred Stock is convertible into an aggregate of up to 453,125 shares of Common Stock. The holders of the warrants may exercise them by paying the applicable cash exercise price or, if there is not an effective registration statement for the sale of the shares of Common Stock underlying the warrants within six (6) months following the closing date, as defined in the warrants, by exercising on a cashless basis pursuant to the formula provided in the warrant. Net proceeds from the issuance of Series A Convertible Preferred Stock totaled $145,000. The Company used the proceeds of the August/September 2022 Series A Convertible Preferred Stock offering to pay-off the outstanding convertible notes payable and for general working capital purposes.

The Company has accrued preferred dividends totaling $1,403 and $-0- relative to the August/September 2022 Series A Convertible Preferred Stock which was charged to additional paid in capital during the nine months ended September 30, 2022 and 2021, respectively.

The Company did not engage in general solicitation or advertising with regard to the issuance and sale of the August/September 2022 Series A Convertible Preferred Stock and the related warrants. The investors who participated in the August/September 2022 Series A Convertible Preferred Stock offering represented that they are either: (i) an “accredited investor” as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act, or (ii) a “qualified institutional buyer” as defined in Rule 144A(a) under the Securities Act, and purchased the August/September 2022 Series A Convertible Preferred Stock and any related warrants for investment and not with a view to distribution. The August/September 2022 Series A Convertible Preferred Stock and any related warrants were issued and sold by the Company in reliance upon the exemptions from the registration requirements of the Securities Act afforded by Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D promulgated thereunder.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

8% Convertible Notes Payable due ~~June~~October 29, 2022 (the ~~May~~8% ~~2022 Notes~~Note) ~~(in default)~~–

The Company isdid ~~currently~~not inpay ~~default~~the onprincipal ~~its~~balance ~~May~~due ~~2022~~on ~~Notes.~~this ~~The~~Convertible ~~Company paid~~Note ~~half~~with ofan ~~the~~outstanding ~~May 2022 Notes~~ principal balance of $100,000 upon its maturity on ~~June~~October 29, 2022 and ~~an additional $112,500 in September 2022 and~~ the remaining balance remains due and payable and is therefore in technical default. ~~The~~as ~~parties are negotiating a resolution to such technical default including an extension and a roll-over~~ of ~~the~~March ~~principal into other Company securities~~31, ~~although there can be no assurance that the parties will reach a mutually agreeable resolution~~2023.

On May 5, 2023, the Company reached an agreement with the holder of two separate convertible notes payable in the aggregate principal face amount of approximately $450,000 (including $100,000 outstanding principal balance of the 8% Note), which the Company did not pay by ~~Convertible~~their ~~Notes~~maturity ~~Payable~~dates. ~~due~~The Company and the holder of the two convertible notes payable entered into a new convertible promissory note (the “New Note”), exchanging the outstanding principal amount of the old convertible notes payable into the New Note, with a maturity date of September 1530, ~~2022~~2023. (Upon issuance of the ~~June~~New ~~2022~~Note, the old convertible notes payable were cancelled and the repayment defaults under the prior convertible notes payable were cured with the entry into the New Note). ~~(in~~The ~~default)~~conversion price of the New Note was reduced from $0.50 per share to $0.40 per share however, the interest rate and other significant terms of the New Note are the same as those of the prior convertible notes payable.

The Company is currently in default on its June 2022 Note. The June 2022 Note has matured and therefore the remaining unamortized discount relative to the June 2022 Notes was $-0- as of September 30, 2022. The parties are negotiating a resolution to such technical default including an extension and a roll-over of the principal into other Company securities, although there can be no assurance that the parties will reach a mutually agreeable resolution.54

8% Convertible Notes Payable due October 29, 2022 (the 8%Second ~~Note and the October~~ 8% ~~Notes~~Note) ~~(in default) –~~

The Company did not pay the principal balance due on ~~these~~this Convertible ~~Notes~~Note with an outstanding principal balance of $50,000 upon ~~their~~its maturity on October 29, 2022 and the remaining balance remains due and payable and is therefore in technical default. The parties are negotiating a resolution to such technical default including an extension and a roll-over of the principal into other Company securities, although there can be no assurance that the parties will reach a mutually agreeable resolution.

8% Convertible Notes Payable September 15, 2022 (the June 2022 Note)

The Company did not pay the principal balance due on this Convertible Note with an outstanding principal balance of $350,000 upon its maturity on September 15, 2022 and the remaining balance remains due and payable and is therefore in technical default.

On May 5, 2023, the Company reached an agreement with the holder of two separate convertible notes payable in the aggregate principal face amount of approximately $450,000 (including $350,000 outstanding principal balance of the June 2022 Note), which the Company did not pay by their maturity dates. The Company and the holder of the two convertible notes payable entered into a new convertible promissory note (the “New Note”), exchanging the outstanding principal amount of the old convertible notes payable into the New Note, with a maturity date of September 30, 2023. Upon issuance of the New Note, the old convertible notes payable were cancelled and the repayment defaults under the prior convertible notes payable were cured with the entry into the New Note. The conversion price of the New Note was reduced from $0.50 per share to $0.40 per share however, the interest rate and other significant terms of the New Note are the same as those of the prior convertible notes payable.

ITEM 4. MINE SAFETY DISCLOSURES

None.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

Exhibit Number		Description
3.1		Articles of Incorporation filed with the Secretary of State of the State of Nevada on ~~December~~November 723, 2021 (Incorporated by reference to Exhibit 3.3 of the Current Report on Form 8-K filed by American Noble Gas Inc on December 13, 2021.)
3.2		Bylaws of American Noble Gas Inc., adopted effective October 22, 2021 (Incorporated by reference to Exhibit 3.4 of the Current Report on Form 8-K filed by American Noble Gas Inc on December 13, 2021.)
10.1		Letter Agreement dated January 10, 2023 (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed by American Noble Gas Inc on January 13, 2023.)
31.1		Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (Filed herewith.)
31.2		Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (Filed herewith.)
32.1*		Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (Filed herewith.)
101.INS		Inline XBRL Instance Document.
101.SCH		Inline XBRL Taxonomy Extension Schema Document. (Filed herewith.)
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document. (Filed herewith.)
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document. (Filed herewith.)
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document. (Filed herewith.)
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document. (Filed herewith.)
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)
		* This certification is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended.

6355

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

American Noble Gas Inc
By:	/s/ Stanton E. Ross	Dated: November 17, 2022
	Stanton E. Ross
	Chief Executive Officer
	(Principal Executive Officer)
By:	/s/ Daniel F. Hutchins	Dated: November 17, 2022
	Daniel F. Hutchins
	Chief Financial Officer
	(Principal Financial and Accounting Officer)

Date: June 9, 2023

64AMERICAN NOBLE GAS INC, a Nevada corporation By: /s/ Thomas J. Heckman Thomas J. Heckman Chief Executive Officer and Chief Financial Officer

Filing Compare · AMERICAN NOBLE GAS, INC.